SMART WHO HIV Implmementation Guide
0.1.0 - ci-build
SMART WHO HIV Implmementation Guide - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: http://worldhealthorganization.github.io/smart-hiv/StructureDefinition/HIVD | Version: 0.1.0 | |||
| Active as of 2024-03-05 | Computable Name: HIVD | |||
Logical Model for HIV.D Care-Treatment data elements.
Usage:
Description of Profiles, Differentials, Snapshots and how the different presentations work.
This structure is derived from Base
| Name | Flags | Card. | Type | Description & Constraints![]() |
|---|---|---|---|---|
![]() | 0..* | Base | HIV.D Care-Treatment Logical Model Instances of this logical model are not marked to be the target of a Reference | |
![]() ![]() | 1..1 | string | Reason for visit | |
![]() ![]() | 1..1 | string | First clinical visit | |
![]() ![]() | 1..1 | string | Clinical visit | |
![]() ![]() | 1..1 | string | ART initiation | |
![]() ![]() | 1..1 | string | ART drug pick up | |
![]() ![]() | 1..1 | string | Issues and concerns | |
![]() ![]() | 1..1 | string | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Scheduled visit | |
![]() ![]() | 1..1 | string | Body temperature | |
![]() ![]() | 1..1 | string | Respiratory rate | |
![]() ![]() | 1..1 | string | Heart rate | |
![]() ![]() | 1..1 | string | Body height | |
![]() ![]() | 1..1 | string | Body weight | |
![]() ![]() | 1..1 | string | Systolic blood pressure | |
![]() ![]() | 1..1 | string | Diastolic blood pressure | |
![]() ![]() | 1..1 | string | Blood pressure cannot be taken | |
![]() ![]() | 1..1 | string | Signs of serious illness | |
![]() ![]() | 1..1 | string | Fever of 39 C or greater | |
![]() ![]() | 1..1 | string | Tachycardia | |
![]() ![]() | 1..1 | string | Tachypnea | |
![]() ![]() | 1..1 | string | Unable to walk unaided | |
![]() ![]() | 1..1 | string | Lethargy | |
![]() ![]() | 1..1 | string | Unconsciousness | |
![]() ![]() | 1..1 | string | Convulsions | |
![]() ![]() | 1..1 | string | Unable to drink | |
![]() ![]() | 1..1 | string | Unable to breastfeed | |
![]() ![]() | 1..1 | string | Repeated vomiting | |
![]() ![]() | 1..1 | string | Headache | |
![]() ![]() | 1..1 | string | Other sign of serious illness | |
![]() ![]() | 1..1 | string | Other sign of serious illness (specify) | |
![]() ![]() | 1..1 | string | Currently pregnant | |
![]() ![]() | 1..1 | string | Breastfeeding | |
![]() ![]() | 1..1 | string | Number of pregnancies (gravida) | |
![]() ![]() | 1..1 | string | Number of miscarriages and/or abortions | |
![]() ![]() | 1..1 | string | Number of live births | |
![]() ![]() | 1..1 | string | Parity | |
![]() ![]() | 1..1 | string | Serodiscordant partner | |
![]() ![]() | 1..1 | string | On ART | |
![]() ![]() | 1..1 | string | ART start date | |
![]() ![]() | 1..1 | string | Stopped ART | |
![]() ![]() | 1..1 | string | Date ART stopped | |
![]() ![]() | 1..1 | string | Established on ART | |
![]() ![]() | 1..1 | string | ART start type | |
![]() ![]() | 1..1 | string | First-time user of ART | |
![]() ![]() | 1..1 | string | Restarting ART | |
![]() ![]() | 1..1 | string | Date of initiation on ART | |
![]() ![]() | 1..1 | string | Time on ART | |
![]() ![]() | 1..1 | string | Date(s) ART restarted | |
![]() ![]() | 1..1 | string | ART cohort | |
![]() ![]() | 1..1 | string | Transfer in for HIV care | |
![]() ![]() | 1..1 | string | Date of transfer in | |
![]() ![]() | 1..1 | string | Facility transferred from | |
![]() ![]() | 1..1 | string | Date enrolled in HIV care | |
![]() ![]() | 1..1 | string | Age at enrolment | |
![]() ![]() | 1..1 | string | Facility where client first enrolled in HIV care | |
![]() ![]() | 1..1 | string | Antiretroviral (ARV) drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | No prior ARVs | |
![]() ![]() | 1..1 | string | Received ARVs prior without records/documentation | |
![]() ![]() | 1..1 | string | Received ARVs during pregnancy or breastfeeding | |
![]() ![]() | 1..1 | string | Received ARVs for PEP or PrEP | |
![]() ![]() | 1..1 | string | ARV prophylaxis for an HIV-exposed infant | |
![]() ![]() | 1..1 | string | Date ARV drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | Location ARV drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | ARV drug regimen received prior to enrolment | |
![]() ![]() | 1..1 | string | Existing chronic health conditions | |
![]() ![]() | 1..1 | string | No chronic or past health conditions | |
![]() ![]() | 1..1 | string | Dont know | |
![]() ![]() | 1..1 | string | Diabetes other or unspecified | |
![]() ![]() | 1..1 | string | Diabetes pre-existing type 1 | |
![]() ![]() | 1..1 | string | Diabetes pre-existing type 2 | |
![]() ![]() | 1..1 | string | Hypertension | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Original first-line ART regimen | |
![]() ![]() | 1..1 | string | Current ART regimen | |
![]() ![]() | 1..1 | string | Current ART regimen start date | |
![]() ![]() | 1..1 | string | Preferred first-line ART regimen | |
![]() ![]() | 1..1 | string | Alternative first-line ART regimen | |
![]() ![]() | 1..1 | string | First-line ART regimen under special circumstances | |
![]() ![]() | 1..1 | string | Preferred second-line ART regimen | |
![]() ![]() | 1..1 | string | Alternative second-line ART regimen | |
![]() ![]() | 1..1 | string | Optimal regimen for transition | |
![]() ![]() | 1..1 | string | Current ART regimen (first-, second-, or third-line) | |
![]() ![]() | 1..1 | string | First-line ART regimen for adults and adolescents | |
![]() ![]() | 1..1 | string | First-line ART regimen for children | |
![]() ![]() | 1..1 | string | First-line ART regimen for neonates | |
![]() ![]() | 1..1 | string | Second-line ART regimen for adults and adolescents | |
![]() ![]() | 1..1 | string | Second-line ART regimen for children | |
![]() ![]() | 1..1 | string | Third-line ART regimen | |
![]() ![]() | 1..1 | string | ART regimen | |
![]() ![]() | 1..1 | string | ABC + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | ABC + 3TC + DTG | |
![]() ![]() | 1..1 | string | ABC + 3TC + EFV | |
![]() ![]() | 1..1 | string | ABC + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | ABC + 3TC + NVP | |
![]() ![]() | 1..1 | string | ABC + 3TC + RAL | |
![]() ![]() | 1..1 | string | AZT + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + DRV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + DTG | |
![]() ![]() | 1..1 | string | AZT + 3TC + EFV | |
![]() ![]() | 1..1 | string | AZT + 3TC + EFV 600 mg | |
![]() ![]() | 1..1 | string | AZT + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + NVP | |
![]() ![]() | 1..1 | string | AZT + 3TC + RAL | |
![]() ![]() | 1..1 | string | TAF + 3TC + DTG | |
![]() ![]() | 1..1 | string | TAF + FTC + DTG | |
![]() ![]() | 1..1 | string | TDF + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + DRV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + DTG | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV 400 mg | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV 600 mg | |
![]() ![]() | 1..1 | string | TDF + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + NVP | |
![]() ![]() | 1..1 | string | TDF + 3TC + PI/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + RAL | |
![]() ![]() | 1..1 | string | TDF + FTC + ATV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + DRV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + DTG | |
![]() ![]() | 1..1 | string | TDF + FTC + EFV | |
![]() ![]() | 1..1 | string | TDF + FTC + EFV 600 mg | |
![]() ![]() | 1..1 | string | TDF + FTC + LPV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + NVP | |
![]() ![]() | 1..1 | string | TDF + FTC + PI/r | |
![]() ![]() | 1..1 | string | TDF + FTC + RAL | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | ART regimen composition | |
![]() ![]() | 1..1 | string | ABC | |
![]() ![]() | 1..1 | string | FTC | |
![]() ![]() | 1..1 | string | 3TC | |
![]() ![]() | 1..1 | string | AZT | |
![]() ![]() | 1..1 | string | DDI | |
![]() ![]() | 1..1 | string | D4T | |
![]() ![]() | 1..1 | string | TDF | |
![]() ![]() | 1..1 | string | EFV | |
![]() ![]() | 1..1 | string | ETV | |
![]() ![]() | 1..1 | string | NVP | |
![]() ![]() | 1..1 | string | RIL | |
![]() ![]() | 1..1 | string | ATV/r | |
![]() ![]() | 1..1 | string | LPV/r | |
![]() ![]() | 1..1 | string | DRV/r | |
![]() ![]() | 1..1 | string | RTV | |
![]() ![]() | 1..1 | string | DTG | |
![]() ![]() | 1..1 | string | RAL | |
![]() ![]() | 1..1 | string | ART regimen drug class | |
![]() ![]() | 1..1 | string | NRTI | |
![]() ![]() | 1..1 | string | NtRTI | |
![]() ![]() | 1..1 | string | NNRTI | |
![]() ![]() | 1..1 | string | PI | |
![]() ![]() | 1..1 | string | INSTI | |
![]() ![]() | 1..1 | string | Prevention services offered and referrals | |
![]() ![]() | 1..1 | string | Offer male and female condoms and condom-compatible lubricants | |
![]() ![]() | 1..1 | string | Harm reduction for people who inject drugs | |
![]() ![]() | 1..1 | string | Behavioural interventions to support risk reduction | |
![]() ![]() | 1..1 | string | Sexual and reproductive health integrated services | |
![]() ![]() | 1..1 | string | Contraception and family planning | |
![]() ![]() | 1..1 | string | Check pregnancy status | |
![]() ![]() | 1..1 | string | Prevention of mother-to-child transmission | |
![]() ![]() | 1..1 | string | STI testing and treatment | |
![]() ![]() | 1..1 | string | HBsAg test date | |
![]() ![]() | 1..1 | string | HBsAg test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Indeterminate | |
![]() ![]() | 1..1 | string | Date HBV test result returned to client | |
![]() ![]() | 1..1 | string | HBV treatment (TDF) start date | |
![]() ![]() | 1..1 | string | HBV treatment regimen prescribed | |
![]() ![]() | 1..1 | string | HCV test date | |
![]() ![]() | 1..1 | string | HCV test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Indeterminate | |
![]() ![]() | 1..1 | string | Date HCV test result returned to client | |
![]() ![]() | 1..1 | string | HCV treatment start date | |
![]() ![]() | 1..1 | string | HCV treatment completion date | |
![]() ![]() | 1..1 | string | HCV treatment regimen prescribed | |
![]() ![]() | 1..1 | string | HCV viral load test date | |
![]() ![]() | 1..1 | string | HCV viral load test result | |
![]() ![]() | 1..1 | string | Detected | |
![]() ![]() | 1..1 | string | Not detected | |
![]() ![]() | 1..1 | string | HCV medicine type | |
![]() ![]() | 1..1 | string | Interferon | |
![]() ![]() | 1..1 | string | Direct acting antivirals | |
![]() ![]() | 1..1 | string | Currently on TDF-based ART | |
![]() ![]() | 1..1 | string | HIV clinical stage | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 1 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 2 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 3 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 4 | |
![]() ![]() | 1..1 | string | Number of missed doses | |
![]() ![]() | 1..1 | string | Received viral load test result | |
![]() ![]() | 1..1 | string | Date viral load test results received by client | |
![]() ![]() | 1..1 | string | Date of viral load sample collection | |
![]() ![]() | 1..1 | string | Date of scheduled review of viral load test results | |
![]() ![]() | 1..1 | string | Date of ART interruption | |
![]() ![]() | 1..1 | string | Reason(s) for adherence problem | |
![]() ![]() | 1..1 | string | Forgot | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Busy | |
![]() ![]() | 1..1 | string | Change of routine | |
![]() ![]() | 1..1 | string | Travel cost | |
![]() ![]() | 1..1 | string | Distance to clinic | |
![]() ![]() | 1..1 | string | Client lost/ran out of pills | |
![]() ![]() | 1..1 | string | Stock-out | |
![]() ![]() | 1..1 | string | Too ill | |
![]() ![]() | 1..1 | string | Pill burden | |
![]() ![]() | 1..1 | string | Felt well | |
![]() ![]() | 1..1 | string | Depression | |
![]() ![]() | 1..1 | string | Alcohol use | |
![]() ![]() | 1..1 | string | Substance use | |
![]() ![]() | 1..1 | string | Stigma/disclosure concerns | |
![]() ![]() | 1..1 | string | Lack of food | |
![]() ![]() | 1..1 | string | Poor palatability | |
![]() ![]() | 1..1 | string | Other reason for nonadherence | |
![]() ![]() | 1..1 | string | Other reason for nonadherence (specify) | |
![]() ![]() | 1..1 | string | Reason ART stopped | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Severe illness, hospitalization | |
![]() ![]() | 1..1 | string | Drugs out of stock | |
![]() ![]() | 1..1 | string | Client lacks finances | |
![]() ![]() | 1..1 | string | Excluded HIV infection in infant | |
![]() ![]() | 1..1 | string | Other reason for stopping ART | |
![]() ![]() | 1..1 | string | Other reason for stopping ART (specify) | |
![]() ![]() | 1..1 | string | Treatment failure | |
![]() ![]() | 1..1 | string | Clinical failure | |
![]() ![]() | 1..1 | string | Immunological failure | |
![]() ![]() | 1..1 | string | Virological failure | |
![]() ![]() | 1..1 | string | General care activities recommended | |
![]() ![]() | 1..1 | string | Determine WHO clinical stage | |
![]() ![]() | 1..1 | string | Determine if advanced disease | |
![]() ![]() | 1..1 | string | Prepare for ART | |
![]() ![]() | 1..1 | string | Prepare, assess and support adherence | |
![]() ![]() | 1..1 | string | Manage current medications | |
![]() ![]() | 1..1 | string | Check pregnancy status | |
![]() ![]() | 1..1 | string | Provide family planning and contraception | |
![]() ![]() | 1..1 | string | Support disclosure and partner notification | |
![]() ![]() | 1..1 | string | Counsel on risk reduction and prevention | |
![]() ![]() | 1..1 | string | Assess, prevent and manage noncommunicable diseases | |
![]() ![]() | 1..1 | string | Screen for and manage mental health problems | |
![]() ![]() | 1..1 | string | Screen for and manage and substance use issues | |
![]() ![]() | 1..1 | string | Provide psychosocial counselling and support | |
![]() ![]() | 1..1 | string | Manage pain and symptoms | |
![]() ![]() | 1..1 | string | Conduct a nutritional assessment and counsel on nutrition | |
![]() ![]() | 1..1 | string | Conduct a growth and development assessment | |
![]() ![]() | 1..1 | string | Provide support on infant and child feeding | |
![]() ![]() | 1..1 | string | Preventing and treating coinfections | |
![]() ![]() | 1..1 | string | Provide co-trimoxazole preventive therapy (CPT) | |
![]() ![]() | 1..1 | string | Intensified TB case finding and linkage to TB treatment | |
![]() ![]() | 1..1 | string | Provide isoniazid preventive therapy | |
![]() ![]() | 1..1 | string | Screen for cryptococcal infection and fungal prophylaxis | |
![]() ![]() | 1..1 | string | Screen for hepatitis B | |
![]() ![]() | 1..1 | string | Screen for hepatitis C | |
![]() ![]() | 1..1 | string | Prevent malaria | |
![]() ![]() | 1..1 | string | Screen for STIs | |
![]() ![]() | 1..1 | string | Prevent and screen for cervical cancer | |
![]() ![]() | 1..1 | string | Anal cancer screening (for men who have sex with men) | |
![]() ![]() | 1..1 | string | Assessment and provision of vaccinations | |
![]() ![]() | 1..1 | string | Risk factors, comorbidities and coinfections signs and symptoms | |
![]() ![]() | 1..1 | string | Oral candidiasis | |
![]() ![]() | 1..1 | string | Vaginal candidiasis | |
![]() ![]() | 1..1 | string | Cough | |
![]() ![]() | 1..1 | string | Prolonged fever | |
![]() ![]() | 1..1 | string | Night sweats | |
![]() ![]() | 1..1 | string | Weight loss | |
![]() ![]() | 1..1 | string | Difficulty breathing | |
![]() ![]() | 1..1 | string | Pneumonia | |
![]() ![]() | 1..1 | string | Urethral discharge | |
![]() ![]() | 1..1 | string | Syphilis | |
![]() ![]() | 1..1 | string | Pelvic inflammatory disease | |
![]() ![]() | 1..1 | string | Ulcers - skin | |
![]() ![]() | 1..1 | string | Ulcers - mouth or other | |
![]() ![]() | 1..1 | string | Ulcers - male genital | |
![]() ![]() | 1..1 | string | Vaginal discharge | |
![]() ![]() | 1..1 | string | Malaria | |
![]() ![]() | 1..1 | string | Chronic obstructive pulmonary disease | |
![]() ![]() | 1..1 | string | Hypertension | |
![]() ![]() | 1..1 | string | Diabetes | |
![]() ![]() | 1..1 | string | Gestational diabetes | |
![]() ![]() | 1..1 | string | Mental health disorders | |
![]() ![]() | 1..1 | string | Diarrhoea or abdominal pain | |
![]() ![]() | 1..1 | string | Presumptive TB | |
![]() ![]() | 1..1 | string | Severe or complicated malnutrition | |
![]() ![]() | 1..1 | string | Poor growth or development | |
![]() ![]() | 1..1 | string | Oedema | |
![]() ![]() | 1..1 | string | Previously treated for TB | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage condition or symptom | |
![]() ![]() | 1..1 | string | Asymptomatic | |
![]() ![]() | 1..1 | string | Persistent generalized lymphadenopathy | |
![]() ![]() | 1..1 | string | Moderate unexplained weight loss | |
![]() ![]() | 1..1 | string | Recurrent respiratory tract infections | |
![]() ![]() | 1..1 | string | Unexplained persistent hepatosplenomegaly | |
![]() ![]() | 1..1 | string | Herpes zoster | |
![]() ![]() | 1..1 | string | Angular cheilitis | |
![]() ![]() | 1..1 | string | Linear gingival erythema | |
![]() ![]() | 1..1 | string | Recurrent oral ulceration | |
![]() ![]() | 1..1 | string | Papular pruritic eruption | |
![]() ![]() | 1..1 | string | Fungal nail infections | |
![]() ![]() | 1..1 | string | Seborrhoeic dermatitis | |
![]() ![]() | 1..1 | string | Extensive wart virus infection | |
![]() ![]() | 1..1 | string | Extensive molluscum contagiosum | |
![]() ![]() | 1..1 | string | Unexplained persistent parotid enlargement | |
![]() ![]() | 1..1 | string | Unexplained severe weight loss in adults | |
![]() ![]() | 1..1 | string | Unexplained moderate malnutrition not adequately responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained chronic diarrhoea for longer than 1 month | |
![]() ![]() | 1..1 | string | Unexplained persistent diarrhoea (14 days or more) | |
![]() ![]() | 1..1 | string | Unexplained persistent fever (above 37.5 C, intermittent or constant, for longer than one 1 month) | |
![]() ![]() | 1..1 | string | Persistent oral candidiasis | |
![]() ![]() | 1..1 | string | Oral hairy leukoplakia | |
![]() ![]() | 1..1 | string | Pulmonary TB | |
![]() ![]() | 1..1 | string | Lymph node TB | |
![]() ![]() | 1..1 | string | Severe bacterial infections (such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia) | |
![]() ![]() | 1..1 | string | Severe recurrent bacterial pneumonia | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative stomatitis | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative gingivitis | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative periodontitis | |
![]() ![]() | 1..1 | string | Unexplained anaemia (<8 g/dL) | |
![]() ![]() | 1..1 | string | Neutropaenia (<0.5 x 10^9/L) | |
![]() ![]() | 1..1 | string | Chronic thrombocytopaenia (<50 x 10^9/L) | |
![]() ![]() | 1..1 | string | Symptomatic lymphoid interstitial pneumonitis | |
![]() ![]() | 1..1 | string | Chronic HIV-associated lung disease, including bronchiectasis | |
![]() ![]() | 1..1 | string | HIV wasting syndrome | |
![]() ![]() | 1..1 | string | Unexplained severe wasting not responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained stunting not responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained severe malnutrition not responding to standard therapy | |
![]() ![]() | 1..1 | string | Pneumocystis (jirovecii) pneumonia | |
![]() ![]() | 1..1 | string | Recurrent severe bacterial pneumonia | |
![]() ![]() | 1..1 | string | Recurrent severe bacterial infections (such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia) | |
![]() ![]() | 1..1 | string | Empyema | |
![]() ![]() | 1..1 | string | Pyomyositis | |
![]() ![]() | 1..1 | string | Bone or joint infection | |
![]() ![]() | 1..1 | string | Meningitis | |
![]() ![]() | 1..1 | string | Chronic herpes simplex infection (orolabial or cutaneous of more than 1 month duration or visceral at any site) | |
![]() ![]() | 1..1 | string | Chronic herpes simplex infection (orolabial, genital or anorectal of more than 1 month in duration or visceral at any site) | |
![]() ![]() | 1..1 | string | Oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs) | |
![]() ![]() | 1..1 | string | Extrapulmonary TB | |
![]() ![]() | 1..1 | string | Kaposi sarcoma | |
![]() ![]() | 1..1 | string | Cytomegalovirus infection (retinitis or infection of other organs) | |
![]() ![]() | 1..1 | string | Central nervous system toxoplasmosis | |
![]() ![]() | 1..1 | string | HIV encephalopathy | |
![]() ![]() | 1..1 | string | Extrapulmonary cryptococcosis, including meningitis | |
![]() ![]() | 1..1 | string | Disseminated nontuberculous mycobacterial infection | |
![]() ![]() | 1..1 | string | Progressive multifocal leukoencephalopathy | |
![]() ![]() | 1..1 | string | Chronic cryptosporidiosis | |
![]() ![]() | 1..1 | string | Chronic cryptosporidiosis (with diarrhoea) | |
![]() ![]() | 1..1 | string | Chronic isosporiasis | |
![]() ![]() | 1..1 | string | Disseminated mycosis (extrapulmonary histoplasmosis, coccidioidomycosis) | |
![]() ![]() | 1..1 | string | Disseminated endemic mycosis (extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis) | |
![]() ![]() | 1..1 | string | Cerebral lymphoma | |
![]() ![]() | 1..1 | string | B-cell non-Hodgkin lymphoma | |
![]() ![]() | 1..1 | string | HIV-associated nephropathy or cardiomyopathy | |
![]() ![]() | 1..1 | string | Recurrent septicaemia (including nontyphoidal Salmonella) | |
![]() ![]() | 1..1 | string | Invasive cervical carcinoma | |
![]() ![]() | 1..1 | string | Atypical disseminated leishmaniasis | |
![]() ![]() | 1..1 | string | Neutropenia | |
![]() ![]() | 1..1 | string | Clinical stage at start of ART | |
![]() ![]() | 1..1 | string | WHO clinical stage 1 | |
![]() ![]() | 1..1 | string | WHO clinical stage 2 | |
![]() ![]() | 1..1 | string | WHO clinical stage 3 | |
![]() ![]() | 1..1 | string | WHO clinical stage 4 | |
![]() ![]() | 1..1 | string | Date of clinical status change | |
![]() ![]() | 1..1 | string | CD4 count | |
![]() ![]() | 1..1 | string | CD4 cell percentage | |
![]() ![]() | 1..1 | string | Date of CD4 count test | |
![]() ![]() | 1..1 | string | Baseline CD4 count | |
![]() ![]() | 1..1 | string | Date of baseline CD4 count test | |
![]() ![]() | 1..1 | string | Late ART initiation | |
![]() ![]() | 1..1 | string | Reasons for delayed ART initiation | |
![]() ![]() | 1..1 | string | Patient self-reported as not ready/willing | |
![]() ![]() | 1..1 | string | Not completed education, support and preparation for ART | |
![]() ![]() | 1..1 | string | Fear of disclosure | |
![]() ![]() | 1..1 | string | Patient lacks finances | |
![]() ![]() | 1..1 | string | Initiated on TB treatment | |
![]() ![]() | 1..1 | string | Patient initiated on treatment for TB meningitis | |
![]() ![]() | 1..1 | string | Patient diagnosed with cryptococcal meningitis | |
![]() ![]() | 1..1 | string | Patient diagnosed with histoplasmosis | |
![]() ![]() | 1..1 | string | Patient critically/severely ill | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | ART initiated within 7 days of diagnosis | |
![]() ![]() | 1..1 | string | Time to start ART | |
![]() ![]() | 1..1 | string | Within 7 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Within 30 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Within 90 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Viral load test result | |
![]() ![]() | 1..1 | string | Virally suppressed | |
![]() ![]() | 1..1 | string | Date viral load test results received | |
![]() ![]() | 1..1 | string | Viral load suppression date | |
![]() ![]() | 1..1 | string | Reason for HIV viral load test | |
![]() ![]() | 1..1 | string | Routine viral load test | |
![]() ![]() | 1..1 | string | Targeted viral load monitoring | |
![]() ![]() | 1..1 | string | Initial viral load test | |
![]() ![]() | 1..1 | string | Follow-up viral load test after receiving enhanced adherence counselling | |
![]() ![]() | 1..1 | string | Hepatitis B test required | |
![]() ![]() | 1..1 | string | Hepatitis C test recommended | |
![]() ![]() | 1..1 | string | Syphilis test required | |
![]() ![]() | 1..1 | string | Monitoring examinations | |
![]() ![]() | 1..1 | string | Haemoglobin (Hb) | |
![]() ![]() | 1..1 | string | Pregnancy test | |
![]() ![]() | 1..1 | string | Syphilis test | |
![]() ![]() | 1..1 | string | Chest X-ray (CXR) | |
![]() ![]() | 1..1 | string | Sputum or culture for TB | |
![]() ![]() | 1..1 | string | HBsAg test (HBV) | |
![]() ![]() | 1..1 | string | HIV viral load test ordered | |
![]() ![]() | 1..1 | string | HIV viral load test scheduled | |
![]() ![]() | 1..1 | string | CD4 count ordered | |
![]() ![]() | 1..1 | string | CD4 count test scheduled | |
![]() ![]() | 1..1 | string | Cryptococcal antigen test | |
![]() ![]() | 1..1 | string | Histoplasmosis antigen test | |
![]() ![]() | 1..1 | string | Cervical cancer screening scheduled | |
![]() ![]() | 1..1 | string | Date of scheduled monitoring examination | |
![]() ![]() | 1..1 | string | Hepatitis C test ordered | |
![]() ![]() | 1..1 | string | Syphilis test ordered | |
![]() ![]() | 1..1 | string | Received viral load test results | |
![]() ![]() | 1..1 | string | Date viral load test results received by client | |
![]() ![]() | 1..1 | string | Reason for ARV drug regimen substitution | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Drug-drug interaction | |
![]() ![]() | 1..1 | string | Pregnancy | |
![]() ![]() | 1..1 | string | New TB | |
![]() ![]() | 1..1 | string | New drug available | |
![]() ![]() | 1..1 | string | Drug out of stock | |
![]() ![]() | 1..1 | string | Other reason for regimen substitution | |
![]() ![]() | 1..1 | string | Other reason for regimen substitution (specify) | |
![]() ![]() | 1..1 | string | Switch to second-line ART regimen recommended | |
![]() ![]() | 1..1 | string | Switch to third-line ART regimen recommended | |
![]() ![]() | 1..1 | string | Regimen switch made | |
![]() ![]() | 1..1 | string | Reason for regimen switch | |
![]() ![]() | 1..1 | string | Clinical treatment failure | |
![]() ![]() | 1..1 | string | Immunological failure | |
![]() ![]() | 1..1 | string | Virological failure | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Regimen substitution recommended | |
![]() ![]() | 1..1 | string | Dose adjustment recommended | |
![]() ![]() | 1..1 | string | Regimen substitution made | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis start date | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis completion date | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis dosage | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis number of days prescribed | |
![]() ![]() | 1..1 | string | Suspicion of treatment failure or interruption | |
![]() ![]() | 1..1 | string | ART regimen prescribed | |
![]() ![]() | 1..1 | string | Antiretroviral toxicity | |
![]() ![]() | 1..1 | string | Coinfection status at ART start | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Hepatitis C | |
![]() ![]() | 1..1 | string | Pregnant and breastfeeding status at ART start | |
![]() ![]() | 1..1 | string | Pregnant at ART start | |
![]() ![]() | 1..1 | string | Postpartum at ART start | |
![]() ![]() | 1..1 | string | ART start at labour and delivery | |
![]() ![]() | 1..1 | string | Breastfeeding at ART start | |
![]() ![]() | 1..1 | string | Delivery date of infant | |
![]() ![]() | 1..1 | string | Serodiscordant partner at ART start | |
![]() ![]() | 1..1 | string | Regimen start date | |
![]() ![]() | 1..1 | string | Medications prescribed | |
![]() ![]() | 1..1 | string | Date medications prescribed | |
![]() ![]() | 1..1 | string | Dose of medications prescribed | |
![]() ![]() | 1..1 | string | Number of days medications prescribed | |
![]() ![]() | 1..1 | string | Medications dispensed | |
![]() ![]() | 1..1 | string | Number of days of medications dispensed | |
![]() ![]() | 1..1 | string | Dosage | |
![]() ![]() | 1..1 | string | Frequency | |
![]() ![]() | 1..1 | string | Adherence counselling provided | |
![]() ![]() | 1..1 | string | Type of treatment-limiting toxicity | |
![]() ![]() | 1..1 | string | Gastrointestinal | |
![]() ![]() | 1..1 | string | Skin issues | |
![]() ![]() | 1..1 | string | Peripheral neuropathy | |
![]() ![]() | 1..1 | string | Central nervous system symptoms | |
![]() ![]() | 1..1 | string | Weight gain | |
![]() ![]() | 1..1 | string | Hepatic dysfunction | |
![]() ![]() | 1..1 | string | Haematological disorders | |
![]() ![]() | 1..1 | string | Fatigue | |
![]() ![]() | 1..1 | string | Headache | |
![]() ![]() | 1..1 | string | Bone dysfunction | |
![]() ![]() | 1..1 | string | Metabolic symptoms | |
![]() ![]() | 1..1 | string | Kidney dysfunction | |
![]() ![]() | 1..1 | string | Unexpected adverse drug reaction | |
![]() ![]() | 1..1 | string | Unexpected adverse drug reaction (specify) | |
![]() ![]() | 1..1 | string | Date(s) of substitution within first-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within first-line regimen | |
![]() ![]() | 1..1 | string | New antiretroviral regimen after substitution within first-line regimen | |
![]() ![]() | 1..1 | string | Date of switch to second-line regimen | |
![]() ![]() | 1..1 | string | New regimen after switch to second-line regimen | |
![]() ![]() | 1..1 | string | Reason for switch to second-line regimen | |
![]() ![]() | 1..1 | string | Date(s) of substitution within second-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within second-line regimen | |
![]() ![]() | 1..1 | string | New regimen(s) after substitution within second-line regimen | |
![]() ![]() | 1..1 | string | Date of switch to third-line regimen | |
![]() ![]() | 1..1 | string | New regimen after switch to third-line regimen | |
![]() ![]() | 1..1 | string | Reason for switch to third-line regimen | |
![]() ![]() | 1..1 | string | Date(s) of substitution within third-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within third-line regimen | |
![]() ![]() | 1..1 | string | New regimen(s) after substitution within third-line regimen | |
![]() ![]() | 1..1 | string | Enhanced adherence counselling provided | |
![]() ![]() | 1..1 | string | First enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of first enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Second enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of second enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Third enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of third enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Name of treatment supporter | |
![]() ![]() | 1..1 | string | Address of treatment supporter | |
![]() ![]() | 1..1 | string | Telephone number of treatment supporter | |
![]() ![]() | 1..1 | string | Home-based care provider | |
![]() ![]() | 1..1 | string | Counselling provided on diagnoses | |
![]() ![]() | 1..1 | string | Hepatitis B positive counselling conducted | |
![]() ![]() | 1..1 | string | Hepatitis C positive counselling conducted | |
![]() ![]() | 1..1 | string | Syphilis counselling and treatment | |
![]() ![]() | 1..1 | string | Syphilis counselling, treatment and further testing | |
![]() ![]() | 1..1 | string | Accepted partner services | |
![]() ![]() | 1..1 | string | HIV testing for partners and biological children | |
![]() ![]() | 1..1 | string | HIV status of family member | |
![]() ![]() | 1..1 | string | Unique ID of family member | |
![]() ![]() | 1..1 | string | Date of death of family member | |
![]() ![]() | 1..1 | string | Offered voluntary partner services | |
![]() ![]() | 1..1 | string | Provided support for disclosure and partner services | |
![]() ![]() | 1..1 | string | Other support services | |
![]() ![]() | 1..1 | string | Mental health services | |
![]() ![]() | 1..1 | string | Psychosocial counselling, support and treatment adherence counselling | |
![]() ![]() | 1..1 | string | Legal and social services | |
![]() ![]() | 1..1 | string | Services for responding to violence against women | |
![]() ![]() | 1..1 | string | Date/time of follow-up appointment | |
![]() ![]() | 1..1 | string | Type of follow-up appointment | |
![]() ![]() | 1..1 | string | Clinical visit | |
![]() ![]() | 1..1 | string | Antiretroviral drug pick up | |
![]() ![]() | 1..1 | string | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Follow-up test recommended date | |
![]() ![]() | 1..1 | string | Reason blood pressure reading not done | |
![]() ![]() | 1..1 | string | BP cuff (sphygmomanometer) not available | |
![]() ![]() | 1..1 | string | BP cuff (sphygmomanometer) is broken | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Current medications | |
![]() ![]() | 1..1 | string | No medications | |
![]() ![]() | 1..1 | string | Dont know of any current medications | |
![]() ![]() | 1..1 | string | Analgesic | |
![]() ![]() | 1..1 | string | Antacids | |
![]() ![]() | 1..1 | string | Antibiotics (broad-spectrum) | |
![]() ![]() | 1..1 | string | Anticonvulsive | |
![]() ![]() | 1..1 | string | Antidiabetic | |
![]() ![]() | 1..1 | string | Antifungals | |
![]() ![]() | 1..1 | string | Antihelmintic | |
![]() ![]() | 1..1 | string | Antihypertensive | |
![]() ![]() | 1..1 | string | Antimalarials | |
![]() ![]() | 1..1 | string | Antiretrovirals (ARVs) | |
![]() ![]() | 1..1 | string | Antiparasitics | |
![]() ![]() | 1..1 | string | Antivirals | |
![]() ![]() | 1..1 | string | Buprenorphine | |
![]() ![]() | 1..1 | string | Co-trimoxazole preventive therapy (CPT) | |
![]() ![]() | 1..1 | string | Hormonal family planning method | |
![]() ![]() | 1..1 | string | Methadone | |
![]() ![]() | 1..1 | string | PrEP to prevent HIV | |
![]() ![]() | 1..1 | string | Other antibiotics | |
![]() ![]() | 1..1 | string | Other medications | |
![]() ![]() | 1..1 | string | Other medications (specify) | |
![]() ![]() | 1..1 | string | Allergies | |
![]() ![]() | 1..1 | string | No known allergies | |
![]() ![]() | 1..1 | string | Dont know of any allergies | |
![]() ![]() | 1..1 | string | Albendazole | |
![]() ![]() | 1..1 | string | Malaria medication (sulfadoxine-pyrimethamine) | |
![]() ![]() | 1..1 | string | Penicillin | |
![]() ![]() | 1..1 | string | Tenofovir disoproxil fumarate (TDF) | |
![]() ![]() | 1..1 | string | Other allergies | |
![]() ![]() | 1..1 | string | Other allergies (specify) | |
![]() ![]() | 1..1 | string | Family planning method used | |
![]() ![]() | 1..1 | string | Copper-bearing intrauterine device (Cu-IUD) | |
![]() ![]() | 1..1 | string | Levonorgestrel intrauterine device (LNG-IUD) | |
![]() ![]() | 1..1 | string | Etonogestrel (ETG) one-rod implant | |
![]() ![]() | 1..1 | string | Levonorgestrel (LNG) two-rod implant | |
![]() ![]() | 1..1 | string | DMPA-IM | |
![]() ![]() | 1..1 | string | DMPA-SC | |
![]() ![]() | 1..1 | string | NET-EN norethisterone enanthate | |
![]() ![]() | 1..1 | string | Progestogen-only pills (POP) | |
![]() ![]() | 1..1 | string | Combined oral contraceptives (COCs) | |
![]() ![]() | 1..1 | string | Combined contraceptive patch | |
![]() ![]() | 1..1 | string | Combined contraceptive vaginal ring (CVR) | |
![]() ![]() | 1..1 | string | Progesterone-releasing vaginal ring (PVR) | |
![]() ![]() | 1..1 | string | Lactational amenorrhea method (LAM) | |
![]() ![]() | 1..1 | string | Emergency contraceptive pills (ECPs) | |
![]() ![]() | 1..1 | string | Fertility awareness-based methods (FAB) | |
![]() ![]() | 1..1 | string | Male condoms | |
![]() ![]() | 1..1 | string | Female condoms | |
![]() ![]() | 1..1 | string | Withdrawal | |
![]() ![]() | 1..1 | string | Female relying on male method | |
![]() ![]() | 1..1 | string | Male relying on female method | |
![]() ![]() | 1..1 | string | Male sterilization | |
![]() ![]() | 1..1 | string | Female sterilization | |
![]() ![]() | 1..1 | string | No method | |
![]() ![]() | 1..1 | string | Medication status | |
![]() ![]() | 1..1 | string | Currently taking | |
![]() ![]() | 1..1 | string | Completed | |
![]() ![]() | 1..1 | string | Entered in error | |
![]() ![]() | 1..1 | string | Intended | |
![]() ![]() | 1..1 | string | Stopped | |
![]() ![]() | 1..1 | string | On hold | |
![]() ![]() | 1..1 | string | Unknown | |
![]() ![]() | 1..1 | string | Did not take | |
![]() ![]() | 1..1 | string | Hepatitis B negative counselling conducted | |
![]() ![]() | 1..1 | string | Vaccine brand | |
![]() ![]() | 1..1 | string | Vaccine type | |
![]() ![]() | 1..1 | string | Date and time of vaccination | |
![]() ![]() | 1..1 | string | Vaccination location | |
![]() ![]() | 1..1 | string | Dose number | |
![]() ![]() | 1..1 | string | Dose quantity | |
![]() ![]() | 1..1 | string | Total doses in series | |
![]() ![]() | 1..1 | string | Disease targeted | |
![]() ![]() | 1..1 | string | Hepatitis A | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Tetanus | |
![]() ![]() | 1..1 | string | COVID-19 | |
![]() ![]() | 1..1 | string | Influenza due to influenza B virus | |
![]() ![]() | 1..1 | string | Tuberculosis | |
![]() ![]() | 1..1 | string | Acute poliomyelitis | |
![]() ![]() | 1..1 | string | Measles | |
![]() ![]() | 1..1 | string | Diptheria | |
![]() ![]() | 1..1 | string | Rabies | |
![]() ![]() | 1..1 | string | Cholera | |
![]() ![]() | 1..1 | string | Mumps | |
![]() ![]() | 1..1 | string | HPV infection | |
![]() ![]() | 1..1 | string | Haemophilus influenzae type B | |
![]() ![]() | 1..1 | string | Varicella | |
![]() ![]() | 1..1 | string | Dengue | |
![]() ![]() | 1..1 | string | Yellow fever | |
![]() ![]() | 1..1 | string | Japanese Encephalitis | |
![]() ![]() | 1..1 | string | Rubella | |
![]() ![]() | 1..1 | string | Pertussis | |
![]() ![]() | 1..1 | string | Enteritis due to rotavirus | |
![]() ![]() | 1..1 | string | Pneumococcal disease | |
![]() ![]() | 1..1 | string | Meningococcal disease | |
![]() ![]() | 1..1 | string | Tick-borne encephalitis | |
![]() ![]() | 1..1 | string | Typhoid | |
![]() ![]() | 1..1 | string | Reason immunization was not provided | |
![]() ![]() | 1..1 | string | Stock-out | |
![]() ![]() | 1..1 | string | Client is ill | |
![]() ![]() | 1..1 | string | Client refused | |
![]() ![]() | 1..1 | string | Allergy to vaccine | |
![]() ![]() | 1..1 | string | Other reason immunization not provided | |
![]() ![]() | 1..1 | string | Other reason immunization not provided (specify) | |
![]() ![]() | 1..1 | string | Malaria prophylaxis | |
![]() ![]() | 1..1 | string | IPTp-SP dose number provided | |
![]() ![]() | 1..1 | string | Date IPTp-SP dose provided | |
![]() ![]() | 1..1 | string | Reason malaria prophylaxis not provided | |
![]() ![]() | 1..1 | string | Client was referred | |
![]() ![]() | 1..1 | string | Stock out | |
![]() ![]() | 1..1 | string | Expired | |
![]() ![]() | 1..1 | string | Other reason not provided | |
![]() ![]() | 1..1 | string | Other reason not provided (specify) | |
![]() ![]() | 1..1 | string | >28 days since last missed appointment | |
![]() ![]() | 1..1 | string | AIDS-related death | |
![]() ![]() | 1..1 | string | Date of first AIDS diagnosis | |
![]() ![]() | 1..1 | string | Age at final HPV vaccination dose received | |
![]() ![]() | 1..1 | string | Date of cervical cancer screening test | |
![]() ![]() | 1..1 | string | Lifetime screening test number | |
![]() ![]() | 1..1 | string | Cervical cancer primary screening test type | |
![]() ![]() | 1..1 | string | HPV-DNA | |
![]() ![]() | 1..1 | string | VIA | |
![]() ![]() | 1..1 | string | Cervical cytology | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | HPV-DNA cervical cancer screening test result | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Invalid | |
![]() ![]() | 1..1 | string | VIA cervical cancer screening test result | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Suspected cancer | |
![]() ![]() | 1..1 | string | Invalid | |
![]() ![]() | 1..1 | string | Cervical cytology screening test result | |
![]() ![]() | 1..1 | string | NILM | |
![]() ![]() | 1..1 | string | ASCUS | |
![]() ![]() | 1..1 | string | LSIL | |
![]() ![]() | 1..1 | string | HSIL | |
![]() ![]() | 1..1 | string | Cancer | |
![]() ![]() | 1..1 | string | Invalid/inadequate | |
![]() ![]() | 1..1 | string | Cervical cancer triage test date | |
![]() ![]() | 1..1 | string | Cervical cancer triage test type | |
![]() ![]() | 1..1 | string | VIA | |
![]() ![]() | 1..1 | string | Colposcopy | |
![]() ![]() | 1..1 | string | Cervical cytology | |
![]() ![]() | 1..1 | string | HPV16/18 | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | HPV16/18 test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Cervical cancer colposcopy result | |
![]() ![]() | 1..1 | string | Normal colposcopic findings | |
![]() ![]() | 1..1 | string | Abnormal colposcopic findings | |
![]() ![]() | 1..1 | string | Suspicious for invasive cervical cancer | |
![]() ![]() | 1..1 | string | Miscellaneous findings | |
![]() ![]() | 1..1 | string | Inadequate | |
![]() ![]() | 1..1 | string | Cervical cancer histopathology result | |
![]() ![]() | 1..1 | string | Normal | |
![]() ![]() | 1..1 | string | LSIL (inclusive of LSIL-CIN1) | |
![]() ![]() | 1..1 | string | HSIL (inclusive of HSIL-CIN2 or HSIL-CIN3) | |
![]() ![]() | 1..1 | string | Invasive cervical cancer | |
![]() ![]() | 1..1 | string | Date of additional cervical cancer triage test | |
![]() ![]() | 1..1 | string | Additional cervical cancer triage test type (specify) | |
![]() ![]() | 1..1 | string | Additional cervical cancer triage test result (specify) | |
![]() ![]() | 1..1 | string | Date of diagnosis of cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Cervical cancer screening outcome | |
![]() ![]() | 1..1 | string | Positive for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Negative for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Cervical cancer diagnosis | |
![]() ![]() | 1..1 | string | Cervical precancer lesions | |
![]() ![]() | 1..1 | string | Invasive cervical cancer | |
![]() ![]() | 1..1 | string | Cervical cancer stage at diagnosis | |
![]() ![]() | 1..1 | string | Stage 0 | |
![]() ![]() | 1..1 | string | Stage I | |
![]() ![]() | 1..1 | string | Stage II | |
![]() ![]() | 1..1 | string | Stage III | |
![]() ![]() | 1..1 | string | Stage IV | |
![]() ![]() | 1..1 | string | Date of treatment for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Treatment method for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Cryotherapy | |
![]() ![]() | 1..1 | string | Thermal ablation | |
![]() ![]() | 1..1 | string | Laser ablation | |
![]() ![]() | 1..1 | string | CKC | |
![]() ![]() | 1..1 | string | Laser cone biopsy | |
![]() ![]() | 1..1 | string | LLETZ/LEEP | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Date of follow-up for treatment for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Date of start of invasive cancer treatment | |
![]() ![]() | 1..1 | string | Invasive cervical cancer treatment episode | |
![]() ![]() | 1..1 | string | Invasive cervical cancer treatment method | |
![]() ![]() | 1..1 | string | Conization | |
![]() ![]() | 1..1 | string | Trachelectomy | |
![]() ![]() | 1..1 | string | Hysterectomy | |
![]() ![]() | 1..1 | string | Management of invasive cervical cancer | |
![]() ![]() | 1..1 | string | Radiotherapy | |
![]() ![]() | 1..1 | string | Chemotherapy | |
![]() ![]() | 1..1 | string | Chemoradiation | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Treatment outcome | |
![]() ![]() | 1..1 | string | Secondary/other cancers diagnosed | |
![]() ![]() | 1..1 | string | Cancers at other sites (HPV- and non-HPV related) | |
![]() ![]() | 1..1 | string | Date of death | |
![]() ![]() | 1..1 | string | Cervical cancer screening interval amongst WLHIV | |
![]() ![]() | 1..1 | string | Entry point for facility-level testing | |
![]() ![]() | 1..1 | string | Provider-initiated tested in a clinic or emergency facility | |
![]() ![]() | 1..1 | string | Antenatal care clinic | |
![]() ![]() | 1..1 | string | Voluntary counselling and testing (within a health facility setting) | |
![]() ![]() | 1..1 | string | Family planning clinic | |
![]() ![]() | 1..1 | string | Other facility-level testing | |
![]() ![]() | 1..1 | string | Tuberculosis (TB) clinic | |
![]() ![]() | 1..1 | string | Offer other clinical services | |
![]() ![]() | 1..1 | string | Assessment and provision of vaccinations | |
![]() ![]() | 1..1 | string | Hepatitis B (HBV) and hepatitis C virus (HCV) testing and treatment | |
![]() ![]() | 1..1 | string | Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia | |
![]() ![]() | 1..1 | string | Intensified TB case finding and linkage to TB treatment | |
![]() ![]() | 1..1 | string | Provision of isoniazid preventive therapy if person does not have TB | |
![]() ![]() | 1..1 | string | Malaria prevention (such as bed nets and prophylaxis), depending on epidemiology | |
![]() ![]() | 1..1 | string | Eligible for DSD ART | |
![]() ![]() | 1..1 | string | Date DSD ART eligibility assessed | |
![]() ![]() | 1..1 | string | Currently enrolled in DSD ART model | |
![]() ![]() | 1..1 | string | DSD ART start date | |
![]() ![]() | 1..1 | string | DSD ART model(s) | |
![]() ![]() | 1..1 | string | Fast track ART refill | |
![]() ![]() | 1..1 | string | Facility adherence club | |
![]() ![]() | 1..1 | string | Community ART distribution point | |
![]() ![]() | 1..1 | string | CHW/peer educator community ART group | |
![]() ![]() | 1..1 | string | Patient/client community ART group | |
![]() ![]() | 1..1 | string | Other DSD ART model | |
![]() ![]() | 1..1 | string | Other DSD ART model (specify) | |
![]() ![]() | 1..1 | string | Partner testing offered | |
![]() ![]() | 1..1 | string | Partner testing accepted | |
![]() ![]() | 1..1 | string | Date partner contacted for index testing | |
![]() ![]() | 1..1 | string | Date partner tested for HIV | |
![]() ![]() | 1..1 | string | Date of next scheduled follow-up appointment | |
![]() ![]() | 1..1 | string | Type of next follow-up appointment | |
![]() ![]() | 1..1 | string | Syndrome/STI diagnosed | |
![]() ![]() | 1..1 | string | Urethral discharge syndrome | |
![]() ![]() | 1..1 | string | Vaginal discharge syndrome | |
![]() ![]() | 1..1 | string | Lower Abdominal pain | |
![]() ![]() | 1..1 | string | Genital ulcer disease syndrome | |
![]() ![]() | 1..1 | string | Anorectal discharge | |
![]() ![]() | 1..1 | string | Sent for testing | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Any STI syndrome diagnosed | |
![]() ![]() | 1..1 | string | Date of STI test | |
![]() ![]() | 1..1 | string | STI tested for | |
![]() ![]() | 1..1 | string | Neisseria gonorrhoeae | |
![]() ![]() | 1..1 | string | Chlamydia trachomatis | |
![]() ![]() | 1..1 | string | Trichomonas vaginalis | |
![]() ![]() | 1..1 | string | Syphilis (Treponema pallidum) | |
![]() ![]() | 1..1 | string | Herpes simplex virus (HSV1, HSV2) | |
![]() ![]() | 1..1 | string | Mycoplasma genitalium | |
![]() ![]() | 1..1 | string | Mpox | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Hepatitis C | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Syphilis test date | |
![]() ![]() | 1..1 | string | Syphilis test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Syphilis treatment start date | |
![]() ![]() | 1..1 | string | Gonorrhoea test date | |
![]() ![]() | 1..1 | string | Gonorrhoea test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Gonorrhoea treatment start date | |
![]() ![]() | 1..1 | string | Type of specimen | |
![]() ![]() | 1..1 | string | Blood | |
![]() ![]() | 1..1 | string | Urine | |
![]() ![]() | 1..1 | string | Cervical or vaginal swab | |
![]() ![]() | 1..1 | string | Urethral or penile swab | |
![]() ![]() | 1..1 | string | Rectal swab | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other type of specimen (specify) | |
![]() ![]() | 1..1 | string | Syphilis test type | |
![]() ![]() | 1..1 | string | Treponemal | |
![]() ![]() | 1..1 | string | Non-treponemal | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other syphilis test type (specify) | |
![]() ![]() | 1..1 | string | Neisseria gonorrhoeae test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | POC Test for Neisseria gonorrhoeae (specify) | |
![]() ![]() | 1..1 | string | Chlamydia trachomatis test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | ELISA | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other test for Chlamydia (specify) | |
![]() ![]() | 1..1 | string | POC Test type for Chlamydia test (specify) | |
![]() ![]() | 1..1 | string | Trichomonas vaginalis test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | POC Test type for Trichomonas vaginalis test (specify) | |
![]() ![]() | 1..1 | string | Herpes simplex virus (HSV) test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Antibody test | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Mycoplasma genitalium test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Test type for other STI tested for (specify) | |
![]() ![]() | 1..1 | string | STI test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Date of STI confirmatory test | |
![]() ![]() | 1..1 | string | Confirmatory syphilis test type | |
![]() ![]() | 1..1 | string | Treponemal | |
![]() ![]() | 1..1 | string | Non-treponemal | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Confirmatory test type for other STI (specify) | |
![]() ![]() | 1..1 | string | Confirmatory STI test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Date STI treatment prescribed | |
![]() ![]() | 1..1 | string | Date STI treatment dispensed | |
![]() ![]() | 1..1 | string | STI treatment dispensed (specify) | |
![]() ![]() | 1..1 | string | Mid-upper arm circumference (MUAC) | |
![]() ![]() | 1..1 | string | Date of start of fluconazole prophylaxis | |
![]() ![]() | 1..1 | string | Fluconazole prophylaxis | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment induction regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment induction regimen | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment maintenance regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment maintenance regimen | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment consolidation regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment consolidation regimen | |
![]() ![]() | 1..1 | string | Staging of liver disease | |
![]() ![]() | 1..1 | string | F0-4, fibrosis staging | |
![]() ![]() | 1..1 | string | F4 or cirrhosis, presence of cirrhosis | |
![]() ![]() | 1..1 | string | Advanced HIV disease | |
![]() ![]() | 1..1 | string | WHO functional status | |
![]() ![]() | 1..1 | string | Working, able to perform usual work inside and outside the home | |
![]() ![]() | 1..1 | string | Ambulatory, able to perform activity of daily living (ADL), not able to work | |
![]() ![]() | 1..1 | string | Bedridden not able to perform ADL | |
![]() ![]() | 1..1 | string | Tailored adherence counselling for advanced HIV disease | |
![]() ![]() | 1..1 | string | Date(s) of tracing interventions | |
![]() ![]() | 1..1 | string | Medication/drug | |
![]() ![]() | 1..1 | string | Rifampicin | |
![]() ![]() | 1..1 | string | Halofantrine | |
![]() ![]() | 1..1 | string | Lovastatin | |
![]() ![]() | 1..1 | string | Simvastatin | |
![]() ![]() | 1..1 | string | Hormonal contraception | |
![]() ![]() | 1..1 | string | Metformin | |
![]() ![]() | 1..1 | string | Astemizole | |
![]() ![]() | 1..1 | string | Terfenadine | |
![]() ![]() | 1..1 | string | TDF | |
![]() ![]() | 1..1 | string | Simeprevir | |
![]() ![]() | 1..1 | string | Ombitasvir + paritaprevir/ritonavir + dasabuvir | |
![]() ![]() | 1..1 | string | Methadone | |
![]() ![]() | 1..1 | string | Buprenorphine | |
![]() ![]() | 1..1 | string | Dofetilide | |
![]() ![]() | 1..1 | string | Carbamazepine | |
![]() ![]() | 1..1 | string | Phenobarbital | |
![]() ![]() | 1..1 | string | Phenytoin | |
![]() ![]() | 1..1 | string | Polyvalent cation products containing Mg, Al, Fe, Ca and Zn | |
![]() ![]() | 1..1 | string | Amodiaquine | |
![]() ![]() | 1..1 | string | Cisapride | |
![]() ![]() | 1..1 | string | Ergotamine | |
![]() ![]() | 1..1 | string | Dihydroergotamine | |
![]() ![]() | 1..1 | string | Midazolam | |
![]() ![]() | 1..1 | string | Triazolam | |
![]() ![]() | 1..1 | string | Estrogen-based hormonal contraception | |
![]() ![]() | 1..1 | string | Ribavirin | |
![]() ![]() | 1..1 | string | Peginterferon alfa-2a | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Medication change recommended | |
Documentation for this format | ||||
| Name | Flags | Card. | Type | Description & Constraints![]() |
|---|---|---|---|---|
![]() | 0..* | Base | HIV.D Care-Treatment Logical Model Instances of this logical model are not marked to be the target of a Reference | |
![]() ![]() | 1..1 | string | Reason for visit | |
![]() ![]() | 1..1 | string | First clinical visit | |
![]() ![]() | 1..1 | string | Clinical visit | |
![]() ![]() | 1..1 | string | ART initiation | |
![]() ![]() | 1..1 | string | ART drug pick up | |
![]() ![]() | 1..1 | string | Issues and concerns | |
![]() ![]() | 1..1 | string | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Scheduled visit | |
![]() ![]() | 1..1 | string | Body temperature | |
![]() ![]() | 1..1 | string | Respiratory rate | |
![]() ![]() | 1..1 | string | Heart rate | |
![]() ![]() | 1..1 | string | Body height | |
![]() ![]() | 1..1 | string | Body weight | |
![]() ![]() | 1..1 | string | Systolic blood pressure | |
![]() ![]() | 1..1 | string | Diastolic blood pressure | |
![]() ![]() | 1..1 | string | Blood pressure cannot be taken | |
![]() ![]() | 1..1 | string | Signs of serious illness | |
![]() ![]() | 1..1 | string | Fever of 39 C or greater | |
![]() ![]() | 1..1 | string | Tachycardia | |
![]() ![]() | 1..1 | string | Tachypnea | |
![]() ![]() | 1..1 | string | Unable to walk unaided | |
![]() ![]() | 1..1 | string | Lethargy | |
![]() ![]() | 1..1 | string | Unconsciousness | |
![]() ![]() | 1..1 | string | Convulsions | |
![]() ![]() | 1..1 | string | Unable to drink | |
![]() ![]() | 1..1 | string | Unable to breastfeed | |
![]() ![]() | 1..1 | string | Repeated vomiting | |
![]() ![]() | 1..1 | string | Headache | |
![]() ![]() | 1..1 | string | Other sign of serious illness | |
![]() ![]() | 1..1 | string | Other sign of serious illness (specify) | |
![]() ![]() | 1..1 | string | Currently pregnant | |
![]() ![]() | 1..1 | string | Breastfeeding | |
![]() ![]() | 1..1 | string | Number of pregnancies (gravida) | |
![]() ![]() | 1..1 | string | Number of miscarriages and/or abortions | |
![]() ![]() | 1..1 | string | Number of live births | |
![]() ![]() | 1..1 | string | Parity | |
![]() ![]() | 1..1 | string | Serodiscordant partner | |
![]() ![]() | 1..1 | string | On ART | |
![]() ![]() | 1..1 | string | ART start date | |
![]() ![]() | 1..1 | string | Stopped ART | |
![]() ![]() | 1..1 | string | Date ART stopped | |
![]() ![]() | 1..1 | string | Established on ART | |
![]() ![]() | 1..1 | string | ART start type | |
![]() ![]() | 1..1 | string | First-time user of ART | |
![]() ![]() | 1..1 | string | Restarting ART | |
![]() ![]() | 1..1 | string | Date of initiation on ART | |
![]() ![]() | 1..1 | string | Time on ART | |
![]() ![]() | 1..1 | string | Date(s) ART restarted | |
![]() ![]() | 1..1 | string | ART cohort | |
![]() ![]() | 1..1 | string | Transfer in for HIV care | |
![]() ![]() | 1..1 | string | Date of transfer in | |
![]() ![]() | 1..1 | string | Facility transferred from | |
![]() ![]() | 1..1 | string | Date enrolled in HIV care | |
![]() ![]() | 1..1 | string | Age at enrolment | |
![]() ![]() | 1..1 | string | Facility where client first enrolled in HIV care | |
![]() ![]() | 1..1 | string | Antiretroviral (ARV) drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | No prior ARVs | |
![]() ![]() | 1..1 | string | Received ARVs prior without records/documentation | |
![]() ![]() | 1..1 | string | Received ARVs during pregnancy or breastfeeding | |
![]() ![]() | 1..1 | string | Received ARVs for PEP or PrEP | |
![]() ![]() | 1..1 | string | ARV prophylaxis for an HIV-exposed infant | |
![]() ![]() | 1..1 | string | Date ARV drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | Location ARV drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | ARV drug regimen received prior to enrolment | |
![]() ![]() | 1..1 | string | Existing chronic health conditions | |
![]() ![]() | 1..1 | string | No chronic or past health conditions | |
![]() ![]() | 1..1 | string | Dont know | |
![]() ![]() | 1..1 | string | Diabetes other or unspecified | |
![]() ![]() | 1..1 | string | Diabetes pre-existing type 1 | |
![]() ![]() | 1..1 | string | Diabetes pre-existing type 2 | |
![]() ![]() | 1..1 | string | Hypertension | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Original first-line ART regimen | |
![]() ![]() | 1..1 | string | Current ART regimen | |
![]() ![]() | 1..1 | string | Current ART regimen start date | |
![]() ![]() | 1..1 | string | Preferred first-line ART regimen | |
![]() ![]() | 1..1 | string | Alternative first-line ART regimen | |
![]() ![]() | 1..1 | string | First-line ART regimen under special circumstances | |
![]() ![]() | 1..1 | string | Preferred second-line ART regimen | |
![]() ![]() | 1..1 | string | Alternative second-line ART regimen | |
![]() ![]() | 1..1 | string | Optimal regimen for transition | |
![]() ![]() | 1..1 | string | Current ART regimen (first-, second-, or third-line) | |
![]() ![]() | 1..1 | string | First-line ART regimen for adults and adolescents | |
![]() ![]() | 1..1 | string | First-line ART regimen for children | |
![]() ![]() | 1..1 | string | First-line ART regimen for neonates | |
![]() ![]() | 1..1 | string | Second-line ART regimen for adults and adolescents | |
![]() ![]() | 1..1 | string | Second-line ART regimen for children | |
![]() ![]() | 1..1 | string | Third-line ART regimen | |
![]() ![]() | 1..1 | string | ART regimen | |
![]() ![]() | 1..1 | string | ABC + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | ABC + 3TC + DTG | |
![]() ![]() | 1..1 | string | ABC + 3TC + EFV | |
![]() ![]() | 1..1 | string | ABC + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | ABC + 3TC + NVP | |
![]() ![]() | 1..1 | string | ABC + 3TC + RAL | |
![]() ![]() | 1..1 | string | AZT + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + DRV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + DTG | |
![]() ![]() | 1..1 | string | AZT + 3TC + EFV | |
![]() ![]() | 1..1 | string | AZT + 3TC + EFV 600 mg | |
![]() ![]() | 1..1 | string | AZT + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + NVP | |
![]() ![]() | 1..1 | string | AZT + 3TC + RAL | |
![]() ![]() | 1..1 | string | TAF + 3TC + DTG | |
![]() ![]() | 1..1 | string | TAF + FTC + DTG | |
![]() ![]() | 1..1 | string | TDF + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + DRV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + DTG | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV 400 mg | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV 600 mg | |
![]() ![]() | 1..1 | string | TDF + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + NVP | |
![]() ![]() | 1..1 | string | TDF + 3TC + PI/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + RAL | |
![]() ![]() | 1..1 | string | TDF + FTC + ATV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + DRV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + DTG | |
![]() ![]() | 1..1 | string | TDF + FTC + EFV | |
![]() ![]() | 1..1 | string | TDF + FTC + EFV 600 mg | |
![]() ![]() | 1..1 | string | TDF + FTC + LPV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + NVP | |
![]() ![]() | 1..1 | string | TDF + FTC + PI/r | |
![]() ![]() | 1..1 | string | TDF + FTC + RAL | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | ART regimen composition | |
![]() ![]() | 1..1 | string | ABC | |
![]() ![]() | 1..1 | string | FTC | |
![]() ![]() | 1..1 | string | 3TC | |
![]() ![]() | 1..1 | string | AZT | |
![]() ![]() | 1..1 | string | DDI | |
![]() ![]() | 1..1 | string | D4T | |
![]() ![]() | 1..1 | string | TDF | |
![]() ![]() | 1..1 | string | EFV | |
![]() ![]() | 1..1 | string | ETV | |
![]() ![]() | 1..1 | string | NVP | |
![]() ![]() | 1..1 | string | RIL | |
![]() ![]() | 1..1 | string | ATV/r | |
![]() ![]() | 1..1 | string | LPV/r | |
![]() ![]() | 1..1 | string | DRV/r | |
![]() ![]() | 1..1 | string | RTV | |
![]() ![]() | 1..1 | string | DTG | |
![]() ![]() | 1..1 | string | RAL | |
![]() ![]() | 1..1 | string | ART regimen drug class | |
![]() ![]() | 1..1 | string | NRTI | |
![]() ![]() | 1..1 | string | NtRTI | |
![]() ![]() | 1..1 | string | NNRTI | |
![]() ![]() | 1..1 | string | PI | |
![]() ![]() | 1..1 | string | INSTI | |
![]() ![]() | 1..1 | string | Prevention services offered and referrals | |
![]() ![]() | 1..1 | string | Offer male and female condoms and condom-compatible lubricants | |
![]() ![]() | 1..1 | string | Harm reduction for people who inject drugs | |
![]() ![]() | 1..1 | string | Behavioural interventions to support risk reduction | |
![]() ![]() | 1..1 | string | Sexual and reproductive health integrated services | |
![]() ![]() | 1..1 | string | Contraception and family planning | |
![]() ![]() | 1..1 | string | Check pregnancy status | |
![]() ![]() | 1..1 | string | Prevention of mother-to-child transmission | |
![]() ![]() | 1..1 | string | STI testing and treatment | |
![]() ![]() | 1..1 | string | HBsAg test date | |
![]() ![]() | 1..1 | string | HBsAg test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Indeterminate | |
![]() ![]() | 1..1 | string | Date HBV test result returned to client | |
![]() ![]() | 1..1 | string | HBV treatment (TDF) start date | |
![]() ![]() | 1..1 | string | HBV treatment regimen prescribed | |
![]() ![]() | 1..1 | string | HCV test date | |
![]() ![]() | 1..1 | string | HCV test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Indeterminate | |
![]() ![]() | 1..1 | string | Date HCV test result returned to client | |
![]() ![]() | 1..1 | string | HCV treatment start date | |
![]() ![]() | 1..1 | string | HCV treatment completion date | |
![]() ![]() | 1..1 | string | HCV treatment regimen prescribed | |
![]() ![]() | 1..1 | string | HCV viral load test date | |
![]() ![]() | 1..1 | string | HCV viral load test result | |
![]() ![]() | 1..1 | string | Detected | |
![]() ![]() | 1..1 | string | Not detected | |
![]() ![]() | 1..1 | string | HCV medicine type | |
![]() ![]() | 1..1 | string | Interferon | |
![]() ![]() | 1..1 | string | Direct acting antivirals | |
![]() ![]() | 1..1 | string | Currently on TDF-based ART | |
![]() ![]() | 1..1 | string | HIV clinical stage | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 1 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 2 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 3 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 4 | |
![]() ![]() | 1..1 | string | Number of missed doses | |
![]() ![]() | 1..1 | string | Received viral load test result | |
![]() ![]() | 1..1 | string | Date viral load test results received by client | |
![]() ![]() | 1..1 | string | Date of viral load sample collection | |
![]() ![]() | 1..1 | string | Date of scheduled review of viral load test results | |
![]() ![]() | 1..1 | string | Date of ART interruption | |
![]() ![]() | 1..1 | string | Reason(s) for adherence problem | |
![]() ![]() | 1..1 | string | Forgot | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Busy | |
![]() ![]() | 1..1 | string | Change of routine | |
![]() ![]() | 1..1 | string | Travel cost | |
![]() ![]() | 1..1 | string | Distance to clinic | |
![]() ![]() | 1..1 | string | Client lost/ran out of pills | |
![]() ![]() | 1..1 | string | Stock-out | |
![]() ![]() | 1..1 | string | Too ill | |
![]() ![]() | 1..1 | string | Pill burden | |
![]() ![]() | 1..1 | string | Felt well | |
![]() ![]() | 1..1 | string | Depression | |
![]() ![]() | 1..1 | string | Alcohol use | |
![]() ![]() | 1..1 | string | Substance use | |
![]() ![]() | 1..1 | string | Stigma/disclosure concerns | |
![]() ![]() | 1..1 | string | Lack of food | |
![]() ![]() | 1..1 | string | Poor palatability | |
![]() ![]() | 1..1 | string | Other reason for nonadherence | |
![]() ![]() | 1..1 | string | Other reason for nonadherence (specify) | |
![]() ![]() | 1..1 | string | Reason ART stopped | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Severe illness, hospitalization | |
![]() ![]() | 1..1 | string | Drugs out of stock | |
![]() ![]() | 1..1 | string | Client lacks finances | |
![]() ![]() | 1..1 | string | Excluded HIV infection in infant | |
![]() ![]() | 1..1 | string | Other reason for stopping ART | |
![]() ![]() | 1..1 | string | Other reason for stopping ART (specify) | |
![]() ![]() | 1..1 | string | Treatment failure | |
![]() ![]() | 1..1 | string | Clinical failure | |
![]() ![]() | 1..1 | string | Immunological failure | |
![]() ![]() | 1..1 | string | Virological failure | |
![]() ![]() | 1..1 | string | General care activities recommended | |
![]() ![]() | 1..1 | string | Determine WHO clinical stage | |
![]() ![]() | 1..1 | string | Determine if advanced disease | |
![]() ![]() | 1..1 | string | Prepare for ART | |
![]() ![]() | 1..1 | string | Prepare, assess and support adherence | |
![]() ![]() | 1..1 | string | Manage current medications | |
![]() ![]() | 1..1 | string | Check pregnancy status | |
![]() ![]() | 1..1 | string | Provide family planning and contraception | |
![]() ![]() | 1..1 | string | Support disclosure and partner notification | |
![]() ![]() | 1..1 | string | Counsel on risk reduction and prevention | |
![]() ![]() | 1..1 | string | Assess, prevent and manage noncommunicable diseases | |
![]() ![]() | 1..1 | string | Screen for and manage mental health problems | |
![]() ![]() | 1..1 | string | Screen for and manage and substance use issues | |
![]() ![]() | 1..1 | string | Provide psychosocial counselling and support | |
![]() ![]() | 1..1 | string | Manage pain and symptoms | |
![]() ![]() | 1..1 | string | Conduct a nutritional assessment and counsel on nutrition | |
![]() ![]() | 1..1 | string | Conduct a growth and development assessment | |
![]() ![]() | 1..1 | string | Provide support on infant and child feeding | |
![]() ![]() | 1..1 | string | Preventing and treating coinfections | |
![]() ![]() | 1..1 | string | Provide co-trimoxazole preventive therapy (CPT) | |
![]() ![]() | 1..1 | string | Intensified TB case finding and linkage to TB treatment | |
![]() ![]() | 1..1 | string | Provide isoniazid preventive therapy | |
![]() ![]() | 1..1 | string | Screen for cryptococcal infection and fungal prophylaxis | |
![]() ![]() | 1..1 | string | Screen for hepatitis B | |
![]() ![]() | 1..1 | string | Screen for hepatitis C | |
![]() ![]() | 1..1 | string | Prevent malaria | |
![]() ![]() | 1..1 | string | Screen for STIs | |
![]() ![]() | 1..1 | string | Prevent and screen for cervical cancer | |
![]() ![]() | 1..1 | string | Anal cancer screening (for men who have sex with men) | |
![]() ![]() | 1..1 | string | Assessment and provision of vaccinations | |
![]() ![]() | 1..1 | string | Risk factors, comorbidities and coinfections signs and symptoms | |
![]() ![]() | 1..1 | string | Oral candidiasis | |
![]() ![]() | 1..1 | string | Vaginal candidiasis | |
![]() ![]() | 1..1 | string | Cough | |
![]() ![]() | 1..1 | string | Prolonged fever | |
![]() ![]() | 1..1 | string | Night sweats | |
![]() ![]() | 1..1 | string | Weight loss | |
![]() ![]() | 1..1 | string | Difficulty breathing | |
![]() ![]() | 1..1 | string | Pneumonia | |
![]() ![]() | 1..1 | string | Urethral discharge | |
![]() ![]() | 1..1 | string | Syphilis | |
![]() ![]() | 1..1 | string | Pelvic inflammatory disease | |
![]() ![]() | 1..1 | string | Ulcers - skin | |
![]() ![]() | 1..1 | string | Ulcers - mouth or other | |
![]() ![]() | 1..1 | string | Ulcers - male genital | |
![]() ![]() | 1..1 | string | Vaginal discharge | |
![]() ![]() | 1..1 | string | Malaria | |
![]() ![]() | 1..1 | string | Chronic obstructive pulmonary disease | |
![]() ![]() | 1..1 | string | Hypertension | |
![]() ![]() | 1..1 | string | Diabetes | |
![]() ![]() | 1..1 | string | Gestational diabetes | |
![]() ![]() | 1..1 | string | Mental health disorders | |
![]() ![]() | 1..1 | string | Diarrhoea or abdominal pain | |
![]() ![]() | 1..1 | string | Presumptive TB | |
![]() ![]() | 1..1 | string | Severe or complicated malnutrition | |
![]() ![]() | 1..1 | string | Poor growth or development | |
![]() ![]() | 1..1 | string | Oedema | |
![]() ![]() | 1..1 | string | Previously treated for TB | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage condition or symptom | |
![]() ![]() | 1..1 | string | Asymptomatic | |
![]() ![]() | 1..1 | string | Persistent generalized lymphadenopathy | |
![]() ![]() | 1..1 | string | Moderate unexplained weight loss | |
![]() ![]() | 1..1 | string | Recurrent respiratory tract infections | |
![]() ![]() | 1..1 | string | Unexplained persistent hepatosplenomegaly | |
![]() ![]() | 1..1 | string | Herpes zoster | |
![]() ![]() | 1..1 | string | Angular cheilitis | |
![]() ![]() | 1..1 | string | Linear gingival erythema | |
![]() ![]() | 1..1 | string | Recurrent oral ulceration | |
![]() ![]() | 1..1 | string | Papular pruritic eruption | |
![]() ![]() | 1..1 | string | Fungal nail infections | |
![]() ![]() | 1..1 | string | Seborrhoeic dermatitis | |
![]() ![]() | 1..1 | string | Extensive wart virus infection | |
![]() ![]() | 1..1 | string | Extensive molluscum contagiosum | |
![]() ![]() | 1..1 | string | Unexplained persistent parotid enlargement | |
![]() ![]() | 1..1 | string | Unexplained severe weight loss in adults | |
![]() ![]() | 1..1 | string | Unexplained moderate malnutrition not adequately responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained chronic diarrhoea for longer than 1 month | |
![]() ![]() | 1..1 | string | Unexplained persistent diarrhoea (14 days or more) | |
![]() ![]() | 1..1 | string | Unexplained persistent fever (above 37.5 C, intermittent or constant, for longer than one 1 month) | |
![]() ![]() | 1..1 | string | Persistent oral candidiasis | |
![]() ![]() | 1..1 | string | Oral hairy leukoplakia | |
![]() ![]() | 1..1 | string | Pulmonary TB | |
![]() ![]() | 1..1 | string | Lymph node TB | |
![]() ![]() | 1..1 | string | Severe bacterial infections (such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia) | |
![]() ![]() | 1..1 | string | Severe recurrent bacterial pneumonia | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative stomatitis | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative gingivitis | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative periodontitis | |
![]() ![]() | 1..1 | string | Unexplained anaemia (<8 g/dL) | |
![]() ![]() | 1..1 | string | Neutropaenia (<0.5 x 10^9/L) | |
![]() ![]() | 1..1 | string | Chronic thrombocytopaenia (<50 x 10^9/L) | |
![]() ![]() | 1..1 | string | Symptomatic lymphoid interstitial pneumonitis | |
![]() ![]() | 1..1 | string | Chronic HIV-associated lung disease, including bronchiectasis | |
![]() ![]() | 1..1 | string | HIV wasting syndrome | |
![]() ![]() | 1..1 | string | Unexplained severe wasting not responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained stunting not responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained severe malnutrition not responding to standard therapy | |
![]() ![]() | 1..1 | string | Pneumocystis (jirovecii) pneumonia | |
![]() ![]() | 1..1 | string | Recurrent severe bacterial pneumonia | |
![]() ![]() | 1..1 | string | Recurrent severe bacterial infections (such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia) | |
![]() ![]() | 1..1 | string | Empyema | |
![]() ![]() | 1..1 | string | Pyomyositis | |
![]() ![]() | 1..1 | string | Bone or joint infection | |
![]() ![]() | 1..1 | string | Meningitis | |
![]() ![]() | 1..1 | string | Chronic herpes simplex infection (orolabial or cutaneous of more than 1 month duration or visceral at any site) | |
![]() ![]() | 1..1 | string | Chronic herpes simplex infection (orolabial, genital or anorectal of more than 1 month in duration or visceral at any site) | |
![]() ![]() | 1..1 | string | Oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs) | |
![]() ![]() | 1..1 | string | Extrapulmonary TB | |
![]() ![]() | 1..1 | string | Kaposi sarcoma | |
![]() ![]() | 1..1 | string | Cytomegalovirus infection (retinitis or infection of other organs) | |
![]() ![]() | 1..1 | string | Central nervous system toxoplasmosis | |
![]() ![]() | 1..1 | string | HIV encephalopathy | |
![]() ![]() | 1..1 | string | Extrapulmonary cryptococcosis, including meningitis | |
![]() ![]() | 1..1 | string | Disseminated nontuberculous mycobacterial infection | |
![]() ![]() | 1..1 | string | Progressive multifocal leukoencephalopathy | |
![]() ![]() | 1..1 | string | Chronic cryptosporidiosis | |
![]() ![]() | 1..1 | string | Chronic cryptosporidiosis (with diarrhoea) | |
![]() ![]() | 1..1 | string | Chronic isosporiasis | |
![]() ![]() | 1..1 | string | Disseminated mycosis (extrapulmonary histoplasmosis, coccidioidomycosis) | |
![]() ![]() | 1..1 | string | Disseminated endemic mycosis (extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis) | |
![]() ![]() | 1..1 | string | Cerebral lymphoma | |
![]() ![]() | 1..1 | string | B-cell non-Hodgkin lymphoma | |
![]() ![]() | 1..1 | string | HIV-associated nephropathy or cardiomyopathy | |
![]() ![]() | 1..1 | string | Recurrent septicaemia (including nontyphoidal Salmonella) | |
![]() ![]() | 1..1 | string | Invasive cervical carcinoma | |
![]() ![]() | 1..1 | string | Atypical disseminated leishmaniasis | |
![]() ![]() | 1..1 | string | Neutropenia | |
![]() ![]() | 1..1 | string | Clinical stage at start of ART | |
![]() ![]() | 1..1 | string | WHO clinical stage 1 | |
![]() ![]() | 1..1 | string | WHO clinical stage 2 | |
![]() ![]() | 1..1 | string | WHO clinical stage 3 | |
![]() ![]() | 1..1 | string | WHO clinical stage 4 | |
![]() ![]() | 1..1 | string | Date of clinical status change | |
![]() ![]() | 1..1 | string | CD4 count | |
![]() ![]() | 1..1 | string | CD4 cell percentage | |
![]() ![]() | 1..1 | string | Date of CD4 count test | |
![]() ![]() | 1..1 | string | Baseline CD4 count | |
![]() ![]() | 1..1 | string | Date of baseline CD4 count test | |
![]() ![]() | 1..1 | string | Late ART initiation | |
![]() ![]() | 1..1 | string | Reasons for delayed ART initiation | |
![]() ![]() | 1..1 | string | Patient self-reported as not ready/willing | |
![]() ![]() | 1..1 | string | Not completed education, support and preparation for ART | |
![]() ![]() | 1..1 | string | Fear of disclosure | |
![]() ![]() | 1..1 | string | Patient lacks finances | |
![]() ![]() | 1..1 | string | Initiated on TB treatment | |
![]() ![]() | 1..1 | string | Patient initiated on treatment for TB meningitis | |
![]() ![]() | 1..1 | string | Patient diagnosed with cryptococcal meningitis | |
![]() ![]() | 1..1 | string | Patient diagnosed with histoplasmosis | |
![]() ![]() | 1..1 | string | Patient critically/severely ill | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | ART initiated within 7 days of diagnosis | |
![]() ![]() | 1..1 | string | Time to start ART | |
![]() ![]() | 1..1 | string | Within 7 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Within 30 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Within 90 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Viral load test result | |
![]() ![]() | 1..1 | string | Virally suppressed | |
![]() ![]() | 1..1 | string | Date viral load test results received | |
![]() ![]() | 1..1 | string | Viral load suppression date | |
![]() ![]() | 1..1 | string | Reason for HIV viral load test | |
![]() ![]() | 1..1 | string | Routine viral load test | |
![]() ![]() | 1..1 | string | Targeted viral load monitoring | |
![]() ![]() | 1..1 | string | Initial viral load test | |
![]() ![]() | 1..1 | string | Follow-up viral load test after receiving enhanced adherence counselling | |
![]() ![]() | 1..1 | string | Hepatitis B test required | |
![]() ![]() | 1..1 | string | Hepatitis C test recommended | |
![]() ![]() | 1..1 | string | Syphilis test required | |
![]() ![]() | 1..1 | string | Monitoring examinations | |
![]() ![]() | 1..1 | string | Haemoglobin (Hb) | |
![]() ![]() | 1..1 | string | Pregnancy test | |
![]() ![]() | 1..1 | string | Syphilis test | |
![]() ![]() | 1..1 | string | Chest X-ray (CXR) | |
![]() ![]() | 1..1 | string | Sputum or culture for TB | |
![]() ![]() | 1..1 | string | HBsAg test (HBV) | |
![]() ![]() | 1..1 | string | HIV viral load test ordered | |
![]() ![]() | 1..1 | string | HIV viral load test scheduled | |
![]() ![]() | 1..1 | string | CD4 count ordered | |
![]() ![]() | 1..1 | string | CD4 count test scheduled | |
![]() ![]() | 1..1 | string | Cryptococcal antigen test | |
![]() ![]() | 1..1 | string | Histoplasmosis antigen test | |
![]() ![]() | 1..1 | string | Cervical cancer screening scheduled | |
![]() ![]() | 1..1 | string | Date of scheduled monitoring examination | |
![]() ![]() | 1..1 | string | Hepatitis C test ordered | |
![]() ![]() | 1..1 | string | Syphilis test ordered | |
![]() ![]() | 1..1 | string | Received viral load test results | |
![]() ![]() | 1..1 | string | Date viral load test results received by client | |
![]() ![]() | 1..1 | string | Reason for ARV drug regimen substitution | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Drug-drug interaction | |
![]() ![]() | 1..1 | string | Pregnancy | |
![]() ![]() | 1..1 | string | New TB | |
![]() ![]() | 1..1 | string | New drug available | |
![]() ![]() | 1..1 | string | Drug out of stock | |
![]() ![]() | 1..1 | string | Other reason for regimen substitution | |
![]() ![]() | 1..1 | string | Other reason for regimen substitution (specify) | |
![]() ![]() | 1..1 | string | Switch to second-line ART regimen recommended | |
![]() ![]() | 1..1 | string | Switch to third-line ART regimen recommended | |
![]() ![]() | 1..1 | string | Regimen switch made | |
![]() ![]() | 1..1 | string | Reason for regimen switch | |
![]() ![]() | 1..1 | string | Clinical treatment failure | |
![]() ![]() | 1..1 | string | Immunological failure | |
![]() ![]() | 1..1 | string | Virological failure | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Regimen substitution recommended | |
![]() ![]() | 1..1 | string | Dose adjustment recommended | |
![]() ![]() | 1..1 | string | Regimen substitution made | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis start date | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis completion date | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis dosage | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis number of days prescribed | |
![]() ![]() | 1..1 | string | Suspicion of treatment failure or interruption | |
![]() ![]() | 1..1 | string | ART regimen prescribed | |
![]() ![]() | 1..1 | string | Antiretroviral toxicity | |
![]() ![]() | 1..1 | string | Coinfection status at ART start | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Hepatitis C | |
![]() ![]() | 1..1 | string | Pregnant and breastfeeding status at ART start | |
![]() ![]() | 1..1 | string | Pregnant at ART start | |
![]() ![]() | 1..1 | string | Postpartum at ART start | |
![]() ![]() | 1..1 | string | ART start at labour and delivery | |
![]() ![]() | 1..1 | string | Breastfeeding at ART start | |
![]() ![]() | 1..1 | string | Delivery date of infant | |
![]() ![]() | 1..1 | string | Serodiscordant partner at ART start | |
![]() ![]() | 1..1 | string | Regimen start date | |
![]() ![]() | 1..1 | string | Medications prescribed | |
![]() ![]() | 1..1 | string | Date medications prescribed | |
![]() ![]() | 1..1 | string | Dose of medications prescribed | |
![]() ![]() | 1..1 | string | Number of days medications prescribed | |
![]() ![]() | 1..1 | string | Medications dispensed | |
![]() ![]() | 1..1 | string | Number of days of medications dispensed | |
![]() ![]() | 1..1 | string | Dosage | |
![]() ![]() | 1..1 | string | Frequency | |
![]() ![]() | 1..1 | string | Adherence counselling provided | |
![]() ![]() | 1..1 | string | Type of treatment-limiting toxicity | |
![]() ![]() | 1..1 | string | Gastrointestinal | |
![]() ![]() | 1..1 | string | Skin issues | |
![]() ![]() | 1..1 | string | Peripheral neuropathy | |
![]() ![]() | 1..1 | string | Central nervous system symptoms | |
![]() ![]() | 1..1 | string | Weight gain | |
![]() ![]() | 1..1 | string | Hepatic dysfunction | |
![]() ![]() | 1..1 | string | Haematological disorders | |
![]() ![]() | 1..1 | string | Fatigue | |
![]() ![]() | 1..1 | string | Headache | |
![]() ![]() | 1..1 | string | Bone dysfunction | |
![]() ![]() | 1..1 | string | Metabolic symptoms | |
![]() ![]() | 1..1 | string | Kidney dysfunction | |
![]() ![]() | 1..1 | string | Unexpected adverse drug reaction | |
![]() ![]() | 1..1 | string | Unexpected adverse drug reaction (specify) | |
![]() ![]() | 1..1 | string | Date(s) of substitution within first-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within first-line regimen | |
![]() ![]() | 1..1 | string | New antiretroviral regimen after substitution within first-line regimen | |
![]() ![]() | 1..1 | string | Date of switch to second-line regimen | |
![]() ![]() | 1..1 | string | New regimen after switch to second-line regimen | |
![]() ![]() | 1..1 | string | Reason for switch to second-line regimen | |
![]() ![]() | 1..1 | string | Date(s) of substitution within second-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within second-line regimen | |
![]() ![]() | 1..1 | string | New regimen(s) after substitution within second-line regimen | |
![]() ![]() | 1..1 | string | Date of switch to third-line regimen | |
![]() ![]() | 1..1 | string | New regimen after switch to third-line regimen | |
![]() ![]() | 1..1 | string | Reason for switch to third-line regimen | |
![]() ![]() | 1..1 | string | Date(s) of substitution within third-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within third-line regimen | |
![]() ![]() | 1..1 | string | New regimen(s) after substitution within third-line regimen | |
![]() ![]() | 1..1 | string | Enhanced adherence counselling provided | |
![]() ![]() | 1..1 | string | First enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of first enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Second enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of second enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Third enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of third enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Name of treatment supporter | |
![]() ![]() | 1..1 | string | Address of treatment supporter | |
![]() ![]() | 1..1 | string | Telephone number of treatment supporter | |
![]() ![]() | 1..1 | string | Home-based care provider | |
![]() ![]() | 1..1 | string | Counselling provided on diagnoses | |
![]() ![]() | 1..1 | string | Hepatitis B positive counselling conducted | |
![]() ![]() | 1..1 | string | Hepatitis C positive counselling conducted | |
![]() ![]() | 1..1 | string | Syphilis counselling and treatment | |
![]() ![]() | 1..1 | string | Syphilis counselling, treatment and further testing | |
![]() ![]() | 1..1 | string | Accepted partner services | |
![]() ![]() | 1..1 | string | HIV testing for partners and biological children | |
![]() ![]() | 1..1 | string | HIV status of family member | |
![]() ![]() | 1..1 | string | Unique ID of family member | |
![]() ![]() | 1..1 | string | Date of death of family member | |
![]() ![]() | 1..1 | string | Offered voluntary partner services | |
![]() ![]() | 1..1 | string | Provided support for disclosure and partner services | |
![]() ![]() | 1..1 | string | Other support services | |
![]() ![]() | 1..1 | string | Mental health services | |
![]() ![]() | 1..1 | string | Psychosocial counselling, support and treatment adherence counselling | |
![]() ![]() | 1..1 | string | Legal and social services | |
![]() ![]() | 1..1 | string | Services for responding to violence against women | |
![]() ![]() | 1..1 | string | Date/time of follow-up appointment | |
![]() ![]() | 1..1 | string | Type of follow-up appointment | |
![]() ![]() | 1..1 | string | Clinical visit | |
![]() ![]() | 1..1 | string | Antiretroviral drug pick up | |
![]() ![]() | 1..1 | string | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Follow-up test recommended date | |
![]() ![]() | 1..1 | string | Reason blood pressure reading not done | |
![]() ![]() | 1..1 | string | BP cuff (sphygmomanometer) not available | |
![]() ![]() | 1..1 | string | BP cuff (sphygmomanometer) is broken | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Current medications | |
![]() ![]() | 1..1 | string | No medications | |
![]() ![]() | 1..1 | string | Dont know of any current medications | |
![]() ![]() | 1..1 | string | Analgesic | |
![]() ![]() | 1..1 | string | Antacids | |
![]() ![]() | 1..1 | string | Antibiotics (broad-spectrum) | |
![]() ![]() | 1..1 | string | Anticonvulsive | |
![]() ![]() | 1..1 | string | Antidiabetic | |
![]() ![]() | 1..1 | string | Antifungals | |
![]() ![]() | 1..1 | string | Antihelmintic | |
![]() ![]() | 1..1 | string | Antihypertensive | |
![]() ![]() | 1..1 | string | Antimalarials | |
![]() ![]() | 1..1 | string | Antiretrovirals (ARVs) | |
![]() ![]() | 1..1 | string | Antiparasitics | |
![]() ![]() | 1..1 | string | Antivirals | |
![]() ![]() | 1..1 | string | Buprenorphine | |
![]() ![]() | 1..1 | string | Co-trimoxazole preventive therapy (CPT) | |
![]() ![]() | 1..1 | string | Hormonal family planning method | |
![]() ![]() | 1..1 | string | Methadone | |
![]() ![]() | 1..1 | string | PrEP to prevent HIV | |
![]() ![]() | 1..1 | string | Other antibiotics | |
![]() ![]() | 1..1 | string | Other medications | |
![]() ![]() | 1..1 | string | Other medications (specify) | |
![]() ![]() | 1..1 | string | Allergies | |
![]() ![]() | 1..1 | string | No known allergies | |
![]() ![]() | 1..1 | string | Dont know of any allergies | |
![]() ![]() | 1..1 | string | Albendazole | |
![]() ![]() | 1..1 | string | Malaria medication (sulfadoxine-pyrimethamine) | |
![]() ![]() | 1..1 | string | Penicillin | |
![]() ![]() | 1..1 | string | Tenofovir disoproxil fumarate (TDF) | |
![]() ![]() | 1..1 | string | Other allergies | |
![]() ![]() | 1..1 | string | Other allergies (specify) | |
![]() ![]() | 1..1 | string | Family planning method used | |
![]() ![]() | 1..1 | string | Copper-bearing intrauterine device (Cu-IUD) | |
![]() ![]() | 1..1 | string | Levonorgestrel intrauterine device (LNG-IUD) | |
![]() ![]() | 1..1 | string | Etonogestrel (ETG) one-rod implant | |
![]() ![]() | 1..1 | string | Levonorgestrel (LNG) two-rod implant | |
![]() ![]() | 1..1 | string | DMPA-IM | |
![]() ![]() | 1..1 | string | DMPA-SC | |
![]() ![]() | 1..1 | string | NET-EN norethisterone enanthate | |
![]() ![]() | 1..1 | string | Progestogen-only pills (POP) | |
![]() ![]() | 1..1 | string | Combined oral contraceptives (COCs) | |
![]() ![]() | 1..1 | string | Combined contraceptive patch | |
![]() ![]() | 1..1 | string | Combined contraceptive vaginal ring (CVR) | |
![]() ![]() | 1..1 | string | Progesterone-releasing vaginal ring (PVR) | |
![]() ![]() | 1..1 | string | Lactational amenorrhea method (LAM) | |
![]() ![]() | 1..1 | string | Emergency contraceptive pills (ECPs) | |
![]() ![]() | 1..1 | string | Fertility awareness-based methods (FAB) | |
![]() ![]() | 1..1 | string | Male condoms | |
![]() ![]() | 1..1 | string | Female condoms | |
![]() ![]() | 1..1 | string | Withdrawal | |
![]() ![]() | 1..1 | string | Female relying on male method | |
![]() ![]() | 1..1 | string | Male relying on female method | |
![]() ![]() | 1..1 | string | Male sterilization | |
![]() ![]() | 1..1 | string | Female sterilization | |
![]() ![]() | 1..1 | string | No method | |
![]() ![]() | 1..1 | string | Medication status | |
![]() ![]() | 1..1 | string | Currently taking | |
![]() ![]() | 1..1 | string | Completed | |
![]() ![]() | 1..1 | string | Entered in error | |
![]() ![]() | 1..1 | string | Intended | |
![]() ![]() | 1..1 | string | Stopped | |
![]() ![]() | 1..1 | string | On hold | |
![]() ![]() | 1..1 | string | Unknown | |
![]() ![]() | 1..1 | string | Did not take | |
![]() ![]() | 1..1 | string | Hepatitis B negative counselling conducted | |
![]() ![]() | 1..1 | string | Vaccine brand | |
![]() ![]() | 1..1 | string | Vaccine type | |
![]() ![]() | 1..1 | string | Date and time of vaccination | |
![]() ![]() | 1..1 | string | Vaccination location | |
![]() ![]() | 1..1 | string | Dose number | |
![]() ![]() | 1..1 | string | Dose quantity | |
![]() ![]() | 1..1 | string | Total doses in series | |
![]() ![]() | 1..1 | string | Disease targeted | |
![]() ![]() | 1..1 | string | Hepatitis A | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Tetanus | |
![]() ![]() | 1..1 | string | COVID-19 | |
![]() ![]() | 1..1 | string | Influenza due to influenza B virus | |
![]() ![]() | 1..1 | string | Tuberculosis | |
![]() ![]() | 1..1 | string | Acute poliomyelitis | |
![]() ![]() | 1..1 | string | Measles | |
![]() ![]() | 1..1 | string | Diptheria | |
![]() ![]() | 1..1 | string | Rabies | |
![]() ![]() | 1..1 | string | Cholera | |
![]() ![]() | 1..1 | string | Mumps | |
![]() ![]() | 1..1 | string | HPV infection | |
![]() ![]() | 1..1 | string | Haemophilus influenzae type B | |
![]() ![]() | 1..1 | string | Varicella | |
![]() ![]() | 1..1 | string | Dengue | |
![]() ![]() | 1..1 | string | Yellow fever | |
![]() ![]() | 1..1 | string | Japanese Encephalitis | |
![]() ![]() | 1..1 | string | Rubella | |
![]() ![]() | 1..1 | string | Pertussis | |
![]() ![]() | 1..1 | string | Enteritis due to rotavirus | |
![]() ![]() | 1..1 | string | Pneumococcal disease | |
![]() ![]() | 1..1 | string | Meningococcal disease | |
![]() ![]() | 1..1 | string | Tick-borne encephalitis | |
![]() ![]() | 1..1 | string | Typhoid | |
![]() ![]() | 1..1 | string | Reason immunization was not provided | |
![]() ![]() | 1..1 | string | Stock-out | |
![]() ![]() | 1..1 | string | Client is ill | |
![]() ![]() | 1..1 | string | Client refused | |
![]() ![]() | 1..1 | string | Allergy to vaccine | |
![]() ![]() | 1..1 | string | Other reason immunization not provided | |
![]() ![]() | 1..1 | string | Other reason immunization not provided (specify) | |
![]() ![]() | 1..1 | string | Malaria prophylaxis | |
![]() ![]() | 1..1 | string | IPTp-SP dose number provided | |
![]() ![]() | 1..1 | string | Date IPTp-SP dose provided | |
![]() ![]() | 1..1 | string | Reason malaria prophylaxis not provided | |
![]() ![]() | 1..1 | string | Client was referred | |
![]() ![]() | 1..1 | string | Stock out | |
![]() ![]() | 1..1 | string | Expired | |
![]() ![]() | 1..1 | string | Other reason not provided | |
![]() ![]() | 1..1 | string | Other reason not provided (specify) | |
![]() ![]() | 1..1 | string | >28 days since last missed appointment | |
![]() ![]() | 1..1 | string | AIDS-related death | |
![]() ![]() | 1..1 | string | Date of first AIDS diagnosis | |
![]() ![]() | 1..1 | string | Age at final HPV vaccination dose received | |
![]() ![]() | 1..1 | string | Date of cervical cancer screening test | |
![]() ![]() | 1..1 | string | Lifetime screening test number | |
![]() ![]() | 1..1 | string | Cervical cancer primary screening test type | |
![]() ![]() | 1..1 | string | HPV-DNA | |
![]() ![]() | 1..1 | string | VIA | |
![]() ![]() | 1..1 | string | Cervical cytology | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | HPV-DNA cervical cancer screening test result | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Invalid | |
![]() ![]() | 1..1 | string | VIA cervical cancer screening test result | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Suspected cancer | |
![]() ![]() | 1..1 | string | Invalid | |
![]() ![]() | 1..1 | string | Cervical cytology screening test result | |
![]() ![]() | 1..1 | string | NILM | |
![]() ![]() | 1..1 | string | ASCUS | |
![]() ![]() | 1..1 | string | LSIL | |
![]() ![]() | 1..1 | string | HSIL | |
![]() ![]() | 1..1 | string | Cancer | |
![]() ![]() | 1..1 | string | Invalid/inadequate | |
![]() ![]() | 1..1 | string | Cervical cancer triage test date | |
![]() ![]() | 1..1 | string | Cervical cancer triage test type | |
![]() ![]() | 1..1 | string | VIA | |
![]() ![]() | 1..1 | string | Colposcopy | |
![]() ![]() | 1..1 | string | Cervical cytology | |
![]() ![]() | 1..1 | string | HPV16/18 | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | HPV16/18 test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Cervical cancer colposcopy result | |
![]() ![]() | 1..1 | string | Normal colposcopic findings | |
![]() ![]() | 1..1 | string | Abnormal colposcopic findings | |
![]() ![]() | 1..1 | string | Suspicious for invasive cervical cancer | |
![]() ![]() | 1..1 | string | Miscellaneous findings | |
![]() ![]() | 1..1 | string | Inadequate | |
![]() ![]() | 1..1 | string | Cervical cancer histopathology result | |
![]() ![]() | 1..1 | string | Normal | |
![]() ![]() | 1..1 | string | LSIL (inclusive of LSIL-CIN1) | |
![]() ![]() | 1..1 | string | HSIL (inclusive of HSIL-CIN2 or HSIL-CIN3) | |
![]() ![]() | 1..1 | string | Invasive cervical cancer | |
![]() ![]() | 1..1 | string | Date of additional cervical cancer triage test | |
![]() ![]() | 1..1 | string | Additional cervical cancer triage test type (specify) | |
![]() ![]() | 1..1 | string | Additional cervical cancer triage test result (specify) | |
![]() ![]() | 1..1 | string | Date of diagnosis of cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Cervical cancer screening outcome | |
![]() ![]() | 1..1 | string | Positive for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Negative for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Cervical cancer diagnosis | |
![]() ![]() | 1..1 | string | Cervical precancer lesions | |
![]() ![]() | 1..1 | string | Invasive cervical cancer | |
![]() ![]() | 1..1 | string | Cervical cancer stage at diagnosis | |
![]() ![]() | 1..1 | string | Stage 0 | |
![]() ![]() | 1..1 | string | Stage I | |
![]() ![]() | 1..1 | string | Stage II | |
![]() ![]() | 1..1 | string | Stage III | |
![]() ![]() | 1..1 | string | Stage IV | |
![]() ![]() | 1..1 | string | Date of treatment for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Treatment method for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Cryotherapy | |
![]() ![]() | 1..1 | string | Thermal ablation | |
![]() ![]() | 1..1 | string | Laser ablation | |
![]() ![]() | 1..1 | string | CKC | |
![]() ![]() | 1..1 | string | Laser cone biopsy | |
![]() ![]() | 1..1 | string | LLETZ/LEEP | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Date of follow-up for treatment for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Date of start of invasive cancer treatment | |
![]() ![]() | 1..1 | string | Invasive cervical cancer treatment episode | |
![]() ![]() | 1..1 | string | Invasive cervical cancer treatment method | |
![]() ![]() | 1..1 | string | Conization | |
![]() ![]() | 1..1 | string | Trachelectomy | |
![]() ![]() | 1..1 | string | Hysterectomy | |
![]() ![]() | 1..1 | string | Management of invasive cervical cancer | |
![]() ![]() | 1..1 | string | Radiotherapy | |
![]() ![]() | 1..1 | string | Chemotherapy | |
![]() ![]() | 1..1 | string | Chemoradiation | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Treatment outcome | |
![]() ![]() | 1..1 | string | Secondary/other cancers diagnosed | |
![]() ![]() | 1..1 | string | Cancers at other sites (HPV- and non-HPV related) | |
![]() ![]() | 1..1 | string | Date of death | |
![]() ![]() | 1..1 | string | Cervical cancer screening interval amongst WLHIV | |
![]() ![]() | 1..1 | string | Entry point for facility-level testing | |
![]() ![]() | 1..1 | string | Provider-initiated tested in a clinic or emergency facility | |
![]() ![]() | 1..1 | string | Antenatal care clinic | |
![]() ![]() | 1..1 | string | Voluntary counselling and testing (within a health facility setting) | |
![]() ![]() | 1..1 | string | Family planning clinic | |
![]() ![]() | 1..1 | string | Other facility-level testing | |
![]() ![]() | 1..1 | string | Tuberculosis (TB) clinic | |
![]() ![]() | 1..1 | string | Offer other clinical services | |
![]() ![]() | 1..1 | string | Assessment and provision of vaccinations | |
![]() ![]() | 1..1 | string | Hepatitis B (HBV) and hepatitis C virus (HCV) testing and treatment | |
![]() ![]() | 1..1 | string | Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia | |
![]() ![]() | 1..1 | string | Intensified TB case finding and linkage to TB treatment | |
![]() ![]() | 1..1 | string | Provision of isoniazid preventive therapy if person does not have TB | |
![]() ![]() | 1..1 | string | Malaria prevention (such as bed nets and prophylaxis), depending on epidemiology | |
![]() ![]() | 1..1 | string | Eligible for DSD ART | |
![]() ![]() | 1..1 | string | Date DSD ART eligibility assessed | |
![]() ![]() | 1..1 | string | Currently enrolled in DSD ART model | |
![]() ![]() | 1..1 | string | DSD ART start date | |
![]() ![]() | 1..1 | string | DSD ART model(s) | |
![]() ![]() | 1..1 | string | Fast track ART refill | |
![]() ![]() | 1..1 | string | Facility adherence club | |
![]() ![]() | 1..1 | string | Community ART distribution point | |
![]() ![]() | 1..1 | string | CHW/peer educator community ART group | |
![]() ![]() | 1..1 | string | Patient/client community ART group | |
![]() ![]() | 1..1 | string | Other DSD ART model | |
![]() ![]() | 1..1 | string | Other DSD ART model (specify) | |
![]() ![]() | 1..1 | string | Partner testing offered | |
![]() ![]() | 1..1 | string | Partner testing accepted | |
![]() ![]() | 1..1 | string | Date partner contacted for index testing | |
![]() ![]() | 1..1 | string | Date partner tested for HIV | |
![]() ![]() | 1..1 | string | Date of next scheduled follow-up appointment | |
![]() ![]() | 1..1 | string | Type of next follow-up appointment | |
![]() ![]() | 1..1 | string | Syndrome/STI diagnosed | |
![]() ![]() | 1..1 | string | Urethral discharge syndrome | |
![]() ![]() | 1..1 | string | Vaginal discharge syndrome | |
![]() ![]() | 1..1 | string | Lower Abdominal pain | |
![]() ![]() | 1..1 | string | Genital ulcer disease syndrome | |
![]() ![]() | 1..1 | string | Anorectal discharge | |
![]() ![]() | 1..1 | string | Sent for testing | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Any STI syndrome diagnosed | |
![]() ![]() | 1..1 | string | Date of STI test | |
![]() ![]() | 1..1 | string | STI tested for | |
![]() ![]() | 1..1 | string | Neisseria gonorrhoeae | |
![]() ![]() | 1..1 | string | Chlamydia trachomatis | |
![]() ![]() | 1..1 | string | Trichomonas vaginalis | |
![]() ![]() | 1..1 | string | Syphilis (Treponema pallidum) | |
![]() ![]() | 1..1 | string | Herpes simplex virus (HSV1, HSV2) | |
![]() ![]() | 1..1 | string | Mycoplasma genitalium | |
![]() ![]() | 1..1 | string | Mpox | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Hepatitis C | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Syphilis test date | |
![]() ![]() | 1..1 | string | Syphilis test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Syphilis treatment start date | |
![]() ![]() | 1..1 | string | Gonorrhoea test date | |
![]() ![]() | 1..1 | string | Gonorrhoea test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Gonorrhoea treatment start date | |
![]() ![]() | 1..1 | string | Type of specimen | |
![]() ![]() | 1..1 | string | Blood | |
![]() ![]() | 1..1 | string | Urine | |
![]() ![]() | 1..1 | string | Cervical or vaginal swab | |
![]() ![]() | 1..1 | string | Urethral or penile swab | |
![]() ![]() | 1..1 | string | Rectal swab | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other type of specimen (specify) | |
![]() ![]() | 1..1 | string | Syphilis test type | |
![]() ![]() | 1..1 | string | Treponemal | |
![]() ![]() | 1..1 | string | Non-treponemal | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other syphilis test type (specify) | |
![]() ![]() | 1..1 | string | Neisseria gonorrhoeae test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | POC Test for Neisseria gonorrhoeae (specify) | |
![]() ![]() | 1..1 | string | Chlamydia trachomatis test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | ELISA | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other test for Chlamydia (specify) | |
![]() ![]() | 1..1 | string | POC Test type for Chlamydia test (specify) | |
![]() ![]() | 1..1 | string | Trichomonas vaginalis test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | POC Test type for Trichomonas vaginalis test (specify) | |
![]() ![]() | 1..1 | string | Herpes simplex virus (HSV) test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Antibody test | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Mycoplasma genitalium test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Test type for other STI tested for (specify) | |
![]() ![]() | 1..1 | string | STI test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Date of STI confirmatory test | |
![]() ![]() | 1..1 | string | Confirmatory syphilis test type | |
![]() ![]() | 1..1 | string | Treponemal | |
![]() ![]() | 1..1 | string | Non-treponemal | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Confirmatory test type for other STI (specify) | |
![]() ![]() | 1..1 | string | Confirmatory STI test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Date STI treatment prescribed | |
![]() ![]() | 1..1 | string | Date STI treatment dispensed | |
![]() ![]() | 1..1 | string | STI treatment dispensed (specify) | |
![]() ![]() | 1..1 | string | Mid-upper arm circumference (MUAC) | |
![]() ![]() | 1..1 | string | Date of start of fluconazole prophylaxis | |
![]() ![]() | 1..1 | string | Fluconazole prophylaxis | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment induction regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment induction regimen | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment maintenance regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment maintenance regimen | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment consolidation regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment consolidation regimen | |
![]() ![]() | 1..1 | string | Staging of liver disease | |
![]() ![]() | 1..1 | string | F0-4, fibrosis staging | |
![]() ![]() | 1..1 | string | F4 or cirrhosis, presence of cirrhosis | |
![]() ![]() | 1..1 | string | Advanced HIV disease | |
![]() ![]() | 1..1 | string | WHO functional status | |
![]() ![]() | 1..1 | string | Working, able to perform usual work inside and outside the home | |
![]() ![]() | 1..1 | string | Ambulatory, able to perform activity of daily living (ADL), not able to work | |
![]() ![]() | 1..1 | string | Bedridden not able to perform ADL | |
![]() ![]() | 1..1 | string | Tailored adherence counselling for advanced HIV disease | |
![]() ![]() | 1..1 | string | Date(s) of tracing interventions | |
![]() ![]() | 1..1 | string | Medication/drug | |
![]() ![]() | 1..1 | string | Rifampicin | |
![]() ![]() | 1..1 | string | Halofantrine | |
![]() ![]() | 1..1 | string | Lovastatin | |
![]() ![]() | 1..1 | string | Simvastatin | |
![]() ![]() | 1..1 | string | Hormonal contraception | |
![]() ![]() | 1..1 | string | Metformin | |
![]() ![]() | 1..1 | string | Astemizole | |
![]() ![]() | 1..1 | string | Terfenadine | |
![]() ![]() | 1..1 | string | TDF | |
![]() ![]() | 1..1 | string | Simeprevir | |
![]() ![]() | 1..1 | string | Ombitasvir + paritaprevir/ritonavir + dasabuvir | |
![]() ![]() | 1..1 | string | Methadone | |
![]() ![]() | 1..1 | string | Buprenorphine | |
![]() ![]() | 1..1 | string | Dofetilide | |
![]() ![]() | 1..1 | string | Carbamazepine | |
![]() ![]() | 1..1 | string | Phenobarbital | |
![]() ![]() | 1..1 | string | Phenytoin | |
![]() ![]() | 1..1 | string | Polyvalent cation products containing Mg, Al, Fe, Ca and Zn | |
![]() ![]() | 1..1 | string | Amodiaquine | |
![]() ![]() | 1..1 | string | Cisapride | |
![]() ![]() | 1..1 | string | Ergotamine | |
![]() ![]() | 1..1 | string | Dihydroergotamine | |
![]() ![]() | 1..1 | string | Midazolam | |
![]() ![]() | 1..1 | string | Triazolam | |
![]() ![]() | 1..1 | string | Estrogen-based hormonal contraception | |
![]() ![]() | 1..1 | string | Ribavirin | |
![]() ![]() | 1..1 | string | Peginterferon alfa-2a | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Medication change recommended | |
Documentation for this format | ||||
| Name | Flags | Card. | Type | Description & Constraints![]() |
|---|---|---|---|---|
![]() | 0..* | Base | HIV.D Care-Treatment Logical Model Instances of this logical model are not marked to be the target of a Reference | |
![]() ![]() | 1..1 | string | Reason for visit | |
![]() ![]() | 1..1 | string | First clinical visit | |
![]() ![]() | 1..1 | string | Clinical visit | |
![]() ![]() | 1..1 | string | ART initiation | |
![]() ![]() | 1..1 | string | ART drug pick up | |
![]() ![]() | 1..1 | string | Issues and concerns | |
![]() ![]() | 1..1 | string | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Scheduled visit | |
![]() ![]() | 1..1 | string | Body temperature | |
![]() ![]() | 1..1 | string | Respiratory rate | |
![]() ![]() | 1..1 | string | Heart rate | |
![]() ![]() | 1..1 | string | Body height | |
![]() ![]() | 1..1 | string | Body weight | |
![]() ![]() | 1..1 | string | Systolic blood pressure | |
![]() ![]() | 1..1 | string | Diastolic blood pressure | |
![]() ![]() | 1..1 | string | Blood pressure cannot be taken | |
![]() ![]() | 1..1 | string | Signs of serious illness | |
![]() ![]() | 1..1 | string | Fever of 39 C or greater | |
![]() ![]() | 1..1 | string | Tachycardia | |
![]() ![]() | 1..1 | string | Tachypnea | |
![]() ![]() | 1..1 | string | Unable to walk unaided | |
![]() ![]() | 1..1 | string | Lethargy | |
![]() ![]() | 1..1 | string | Unconsciousness | |
![]() ![]() | 1..1 | string | Convulsions | |
![]() ![]() | 1..1 | string | Unable to drink | |
![]() ![]() | 1..1 | string | Unable to breastfeed | |
![]() ![]() | 1..1 | string | Repeated vomiting | |
![]() ![]() | 1..1 | string | Headache | |
![]() ![]() | 1..1 | string | Other sign of serious illness | |
![]() ![]() | 1..1 | string | Other sign of serious illness (specify) | |
![]() ![]() | 1..1 | string | Currently pregnant | |
![]() ![]() | 1..1 | string | Breastfeeding | |
![]() ![]() | 1..1 | string | Number of pregnancies (gravida) | |
![]() ![]() | 1..1 | string | Number of miscarriages and/or abortions | |
![]() ![]() | 1..1 | string | Number of live births | |
![]() ![]() | 1..1 | string | Parity | |
![]() ![]() | 1..1 | string | Serodiscordant partner | |
![]() ![]() | 1..1 | string | On ART | |
![]() ![]() | 1..1 | string | ART start date | |
![]() ![]() | 1..1 | string | Stopped ART | |
![]() ![]() | 1..1 | string | Date ART stopped | |
![]() ![]() | 1..1 | string | Established on ART | |
![]() ![]() | 1..1 | string | ART start type | |
![]() ![]() | 1..1 | string | First-time user of ART | |
![]() ![]() | 1..1 | string | Restarting ART | |
![]() ![]() | 1..1 | string | Date of initiation on ART | |
![]() ![]() | 1..1 | string | Time on ART | |
![]() ![]() | 1..1 | string | Date(s) ART restarted | |
![]() ![]() | 1..1 | string | ART cohort | |
![]() ![]() | 1..1 | string | Transfer in for HIV care | |
![]() ![]() | 1..1 | string | Date of transfer in | |
![]() ![]() | 1..1 | string | Facility transferred from | |
![]() ![]() | 1..1 | string | Date enrolled in HIV care | |
![]() ![]() | 1..1 | string | Age at enrolment | |
![]() ![]() | 1..1 | string | Facility where client first enrolled in HIV care | |
![]() ![]() | 1..1 | string | Antiretroviral (ARV) drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | No prior ARVs | |
![]() ![]() | 1..1 | string | Received ARVs prior without records/documentation | |
![]() ![]() | 1..1 | string | Received ARVs during pregnancy or breastfeeding | |
![]() ![]() | 1..1 | string | Received ARVs for PEP or PrEP | |
![]() ![]() | 1..1 | string | ARV prophylaxis for an HIV-exposed infant | |
![]() ![]() | 1..1 | string | Date ARV drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | Location ARV drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | ARV drug regimen received prior to enrolment | |
![]() ![]() | 1..1 | string | Existing chronic health conditions | |
![]() ![]() | 1..1 | string | No chronic or past health conditions | |
![]() ![]() | 1..1 | string | Dont know | |
![]() ![]() | 1..1 | string | Diabetes other or unspecified | |
![]() ![]() | 1..1 | string | Diabetes pre-existing type 1 | |
![]() ![]() | 1..1 | string | Diabetes pre-existing type 2 | |
![]() ![]() | 1..1 | string | Hypertension | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Original first-line ART regimen | |
![]() ![]() | 1..1 | string | Current ART regimen | |
![]() ![]() | 1..1 | string | Current ART regimen start date | |
![]() ![]() | 1..1 | string | Preferred first-line ART regimen | |
![]() ![]() | 1..1 | string | Alternative first-line ART regimen | |
![]() ![]() | 1..1 | string | First-line ART regimen under special circumstances | |
![]() ![]() | 1..1 | string | Preferred second-line ART regimen | |
![]() ![]() | 1..1 | string | Alternative second-line ART regimen | |
![]() ![]() | 1..1 | string | Optimal regimen for transition | |
![]() ![]() | 1..1 | string | Current ART regimen (first-, second-, or third-line) | |
![]() ![]() | 1..1 | string | First-line ART regimen for adults and adolescents | |
![]() ![]() | 1..1 | string | First-line ART regimen for children | |
![]() ![]() | 1..1 | string | First-line ART regimen for neonates | |
![]() ![]() | 1..1 | string | Second-line ART regimen for adults and adolescents | |
![]() ![]() | 1..1 | string | Second-line ART regimen for children | |
![]() ![]() | 1..1 | string | Third-line ART regimen | |
![]() ![]() | 1..1 | string | ART regimen | |
![]() ![]() | 1..1 | string | ABC + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | ABC + 3TC + DTG | |
![]() ![]() | 1..1 | string | ABC + 3TC + EFV | |
![]() ![]() | 1..1 | string | ABC + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | ABC + 3TC + NVP | |
![]() ![]() | 1..1 | string | ABC + 3TC + RAL | |
![]() ![]() | 1..1 | string | AZT + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + DRV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + DTG | |
![]() ![]() | 1..1 | string | AZT + 3TC + EFV | |
![]() ![]() | 1..1 | string | AZT + 3TC + EFV 600 mg | |
![]() ![]() | 1..1 | string | AZT + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + NVP | |
![]() ![]() | 1..1 | string | AZT + 3TC + RAL | |
![]() ![]() | 1..1 | string | TAF + 3TC + DTG | |
![]() ![]() | 1..1 | string | TAF + FTC + DTG | |
![]() ![]() | 1..1 | string | TDF + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + DRV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + DTG | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV 400 mg | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV 600 mg | |
![]() ![]() | 1..1 | string | TDF + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + NVP | |
![]() ![]() | 1..1 | string | TDF + 3TC + PI/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + RAL | |
![]() ![]() | 1..1 | string | TDF + FTC + ATV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + DRV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + DTG | |
![]() ![]() | 1..1 | string | TDF + FTC + EFV | |
![]() ![]() | 1..1 | string | TDF + FTC + EFV 600 mg | |
![]() ![]() | 1..1 | string | TDF + FTC + LPV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + NVP | |
![]() ![]() | 1..1 | string | TDF + FTC + PI/r | |
![]() ![]() | 1..1 | string | TDF + FTC + RAL | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | ART regimen composition | |
![]() ![]() | 1..1 | string | ABC | |
![]() ![]() | 1..1 | string | FTC | |
![]() ![]() | 1..1 | string | 3TC | |
![]() ![]() | 1..1 | string | AZT | |
![]() ![]() | 1..1 | string | DDI | |
![]() ![]() | 1..1 | string | D4T | |
![]() ![]() | 1..1 | string | TDF | |
![]() ![]() | 1..1 | string | EFV | |
![]() ![]() | 1..1 | string | ETV | |
![]() ![]() | 1..1 | string | NVP | |
![]() ![]() | 1..1 | string | RIL | |
![]() ![]() | 1..1 | string | ATV/r | |
![]() ![]() | 1..1 | string | LPV/r | |
![]() ![]() | 1..1 | string | DRV/r | |
![]() ![]() | 1..1 | string | RTV | |
![]() ![]() | 1..1 | string | DTG | |
![]() ![]() | 1..1 | string | RAL | |
![]() ![]() | 1..1 | string | ART regimen drug class | |
![]() ![]() | 1..1 | string | NRTI | |
![]() ![]() | 1..1 | string | NtRTI | |
![]() ![]() | 1..1 | string | NNRTI | |
![]() ![]() | 1..1 | string | PI | |
![]() ![]() | 1..1 | string | INSTI | |
![]() ![]() | 1..1 | string | Prevention services offered and referrals | |
![]() ![]() | 1..1 | string | Offer male and female condoms and condom-compatible lubricants | |
![]() ![]() | 1..1 | string | Harm reduction for people who inject drugs | |
![]() ![]() | 1..1 | string | Behavioural interventions to support risk reduction | |
![]() ![]() | 1..1 | string | Sexual and reproductive health integrated services | |
![]() ![]() | 1..1 | string | Contraception and family planning | |
![]() ![]() | 1..1 | string | Check pregnancy status | |
![]() ![]() | 1..1 | string | Prevention of mother-to-child transmission | |
![]() ![]() | 1..1 | string | STI testing and treatment | |
![]() ![]() | 1..1 | string | HBsAg test date | |
![]() ![]() | 1..1 | string | HBsAg test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Indeterminate | |
![]() ![]() | 1..1 | string | Date HBV test result returned to client | |
![]() ![]() | 1..1 | string | HBV treatment (TDF) start date | |
![]() ![]() | 1..1 | string | HBV treatment regimen prescribed | |
![]() ![]() | 1..1 | string | HCV test date | |
![]() ![]() | 1..1 | string | HCV test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Indeterminate | |
![]() ![]() | 1..1 | string | Date HCV test result returned to client | |
![]() ![]() | 1..1 | string | HCV treatment start date | |
![]() ![]() | 1..1 | string | HCV treatment completion date | |
![]() ![]() | 1..1 | string | HCV treatment regimen prescribed | |
![]() ![]() | 1..1 | string | HCV viral load test date | |
![]() ![]() | 1..1 | string | HCV viral load test result | |
![]() ![]() | 1..1 | string | Detected | |
![]() ![]() | 1..1 | string | Not detected | |
![]() ![]() | 1..1 | string | HCV medicine type | |
![]() ![]() | 1..1 | string | Interferon | |
![]() ![]() | 1..1 | string | Direct acting antivirals | |
![]() ![]() | 1..1 | string | Currently on TDF-based ART | |
![]() ![]() | 1..1 | string | HIV clinical stage | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 1 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 2 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 3 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 4 | |
![]() ![]() | 1..1 | string | Number of missed doses | |
![]() ![]() | 1..1 | string | Received viral load test result | |
![]() ![]() | 1..1 | string | Date viral load test results received by client | |
![]() ![]() | 1..1 | string | Date of viral load sample collection | |
![]() ![]() | 1..1 | string | Date of scheduled review of viral load test results | |
![]() ![]() | 1..1 | string | Date of ART interruption | |
![]() ![]() | 1..1 | string | Reason(s) for adherence problem | |
![]() ![]() | 1..1 | string | Forgot | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Busy | |
![]() ![]() | 1..1 | string | Change of routine | |
![]() ![]() | 1..1 | string | Travel cost | |
![]() ![]() | 1..1 | string | Distance to clinic | |
![]() ![]() | 1..1 | string | Client lost/ran out of pills | |
![]() ![]() | 1..1 | string | Stock-out | |
![]() ![]() | 1..1 | string | Too ill | |
![]() ![]() | 1..1 | string | Pill burden | |
![]() ![]() | 1..1 | string | Felt well | |
![]() ![]() | 1..1 | string | Depression | |
![]() ![]() | 1..1 | string | Alcohol use | |
![]() ![]() | 1..1 | string | Substance use | |
![]() ![]() | 1..1 | string | Stigma/disclosure concerns | |
![]() ![]() | 1..1 | string | Lack of food | |
![]() ![]() | 1..1 | string | Poor palatability | |
![]() ![]() | 1..1 | string | Other reason for nonadherence | |
![]() ![]() | 1..1 | string | Other reason for nonadherence (specify) | |
![]() ![]() | 1..1 | string | Reason ART stopped | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Severe illness, hospitalization | |
![]() ![]() | 1..1 | string | Drugs out of stock | |
![]() ![]() | 1..1 | string | Client lacks finances | |
![]() ![]() | 1..1 | string | Excluded HIV infection in infant | |
![]() ![]() | 1..1 | string | Other reason for stopping ART | |
![]() ![]() | 1..1 | string | Other reason for stopping ART (specify) | |
![]() ![]() | 1..1 | string | Treatment failure | |
![]() ![]() | 1..1 | string | Clinical failure | |
![]() ![]() | 1..1 | string | Immunological failure | |
![]() ![]() | 1..1 | string | Virological failure | |
![]() ![]() | 1..1 | string | General care activities recommended | |
![]() ![]() | 1..1 | string | Determine WHO clinical stage | |
![]() ![]() | 1..1 | string | Determine if advanced disease | |
![]() ![]() | 1..1 | string | Prepare for ART | |
![]() ![]() | 1..1 | string | Prepare, assess and support adherence | |
![]() ![]() | 1..1 | string | Manage current medications | |
![]() ![]() | 1..1 | string | Check pregnancy status | |
![]() ![]() | 1..1 | string | Provide family planning and contraception | |
![]() ![]() | 1..1 | string | Support disclosure and partner notification | |
![]() ![]() | 1..1 | string | Counsel on risk reduction and prevention | |
![]() ![]() | 1..1 | string | Assess, prevent and manage noncommunicable diseases | |
![]() ![]() | 1..1 | string | Screen for and manage mental health problems | |
![]() ![]() | 1..1 | string | Screen for and manage and substance use issues | |
![]() ![]() | 1..1 | string | Provide psychosocial counselling and support | |
![]() ![]() | 1..1 | string | Manage pain and symptoms | |
![]() ![]() | 1..1 | string | Conduct a nutritional assessment and counsel on nutrition | |
![]() ![]() | 1..1 | string | Conduct a growth and development assessment | |
![]() ![]() | 1..1 | string | Provide support on infant and child feeding | |
![]() ![]() | 1..1 | string | Preventing and treating coinfections | |
![]() ![]() | 1..1 | string | Provide co-trimoxazole preventive therapy (CPT) | |
![]() ![]() | 1..1 | string | Intensified TB case finding and linkage to TB treatment | |
![]() ![]() | 1..1 | string | Provide isoniazid preventive therapy | |
![]() ![]() | 1..1 | string | Screen for cryptococcal infection and fungal prophylaxis | |
![]() ![]() | 1..1 | string | Screen for hepatitis B | |
![]() ![]() | 1..1 | string | Screen for hepatitis C | |
![]() ![]() | 1..1 | string | Prevent malaria | |
![]() ![]() | 1..1 | string | Screen for STIs | |
![]() ![]() | 1..1 | string | Prevent and screen for cervical cancer | |
![]() ![]() | 1..1 | string | Anal cancer screening (for men who have sex with men) | |
![]() ![]() | 1..1 | string | Assessment and provision of vaccinations | |
![]() ![]() | 1..1 | string | Risk factors, comorbidities and coinfections signs and symptoms | |
![]() ![]() | 1..1 | string | Oral candidiasis | |
![]() ![]() | 1..1 | string | Vaginal candidiasis | |
![]() ![]() | 1..1 | string | Cough | |
![]() ![]() | 1..1 | string | Prolonged fever | |
![]() ![]() | 1..1 | string | Night sweats | |
![]() ![]() | 1..1 | string | Weight loss | |
![]() ![]() | 1..1 | string | Difficulty breathing | |
![]() ![]() | 1..1 | string | Pneumonia | |
![]() ![]() | 1..1 | string | Urethral discharge | |
![]() ![]() | 1..1 | string | Syphilis | |
![]() ![]() | 1..1 | string | Pelvic inflammatory disease | |
![]() ![]() | 1..1 | string | Ulcers - skin | |
![]() ![]() | 1..1 | string | Ulcers - mouth or other | |
![]() ![]() | 1..1 | string | Ulcers - male genital | |
![]() ![]() | 1..1 | string | Vaginal discharge | |
![]() ![]() | 1..1 | string | Malaria | |
![]() ![]() | 1..1 | string | Chronic obstructive pulmonary disease | |
![]() ![]() | 1..1 | string | Hypertension | |
![]() ![]() | 1..1 | string | Diabetes | |
![]() ![]() | 1..1 | string | Gestational diabetes | |
![]() ![]() | 1..1 | string | Mental health disorders | |
![]() ![]() | 1..1 | string | Diarrhoea or abdominal pain | |
![]() ![]() | 1..1 | string | Presumptive TB | |
![]() ![]() | 1..1 | string | Severe or complicated malnutrition | |
![]() ![]() | 1..1 | string | Poor growth or development | |
![]() ![]() | 1..1 | string | Oedema | |
![]() ![]() | 1..1 | string | Previously treated for TB | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage condition or symptom | |
![]() ![]() | 1..1 | string | Asymptomatic | |
![]() ![]() | 1..1 | string | Persistent generalized lymphadenopathy | |
![]() ![]() | 1..1 | string | Moderate unexplained weight loss | |
![]() ![]() | 1..1 | string | Recurrent respiratory tract infections | |
![]() ![]() | 1..1 | string | Unexplained persistent hepatosplenomegaly | |
![]() ![]() | 1..1 | string | Herpes zoster | |
![]() ![]() | 1..1 | string | Angular cheilitis | |
![]() ![]() | 1..1 | string | Linear gingival erythema | |
![]() ![]() | 1..1 | string | Recurrent oral ulceration | |
![]() ![]() | 1..1 | string | Papular pruritic eruption | |
![]() ![]() | 1..1 | string | Fungal nail infections | |
![]() ![]() | 1..1 | string | Seborrhoeic dermatitis | |
![]() ![]() | 1..1 | string | Extensive wart virus infection | |
![]() ![]() | 1..1 | string | Extensive molluscum contagiosum | |
![]() ![]() | 1..1 | string | Unexplained persistent parotid enlargement | |
![]() ![]() | 1..1 | string | Unexplained severe weight loss in adults | |
![]() ![]() | 1..1 | string | Unexplained moderate malnutrition not adequately responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained chronic diarrhoea for longer than 1 month | |
![]() ![]() | 1..1 | string | Unexplained persistent diarrhoea (14 days or more) | |
![]() ![]() | 1..1 | string | Unexplained persistent fever (above 37.5 C, intermittent or constant, for longer than one 1 month) | |
![]() ![]() | 1..1 | string | Persistent oral candidiasis | |
![]() ![]() | 1..1 | string | Oral hairy leukoplakia | |
![]() ![]() | 1..1 | string | Pulmonary TB | |
![]() ![]() | 1..1 | string | Lymph node TB | |
![]() ![]() | 1..1 | string | Severe bacterial infections (such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia) | |
![]() ![]() | 1..1 | string | Severe recurrent bacterial pneumonia | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative stomatitis | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative gingivitis | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative periodontitis | |
![]() ![]() | 1..1 | string | Unexplained anaemia (<8 g/dL) | |
![]() ![]() | 1..1 | string | Neutropaenia (<0.5 x 10^9/L) | |
![]() ![]() | 1..1 | string | Chronic thrombocytopaenia (<50 x 10^9/L) | |
![]() ![]() | 1..1 | string | Symptomatic lymphoid interstitial pneumonitis | |
![]() ![]() | 1..1 | string | Chronic HIV-associated lung disease, including bronchiectasis | |
![]() ![]() | 1..1 | string | HIV wasting syndrome | |
![]() ![]() | 1..1 | string | Unexplained severe wasting not responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained stunting not responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained severe malnutrition not responding to standard therapy | |
![]() ![]() | 1..1 | string | Pneumocystis (jirovecii) pneumonia | |
![]() ![]() | 1..1 | string | Recurrent severe bacterial pneumonia | |
![]() ![]() | 1..1 | string | Recurrent severe bacterial infections (such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia) | |
![]() ![]() | 1..1 | string | Empyema | |
![]() ![]() | 1..1 | string | Pyomyositis | |
![]() ![]() | 1..1 | string | Bone or joint infection | |
![]() ![]() | 1..1 | string | Meningitis | |
![]() ![]() | 1..1 | string | Chronic herpes simplex infection (orolabial or cutaneous of more than 1 month duration or visceral at any site) | |
![]() ![]() | 1..1 | string | Chronic herpes simplex infection (orolabial, genital or anorectal of more than 1 month in duration or visceral at any site) | |
![]() ![]() | 1..1 | string | Oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs) | |
![]() ![]() | 1..1 | string | Extrapulmonary TB | |
![]() ![]() | 1..1 | string | Kaposi sarcoma | |
![]() ![]() | 1..1 | string | Cytomegalovirus infection (retinitis or infection of other organs) | |
![]() ![]() | 1..1 | string | Central nervous system toxoplasmosis | |
![]() ![]() | 1..1 | string | HIV encephalopathy | |
![]() ![]() | 1..1 | string | Extrapulmonary cryptococcosis, including meningitis | |
![]() ![]() | 1..1 | string | Disseminated nontuberculous mycobacterial infection | |
![]() ![]() | 1..1 | string | Progressive multifocal leukoencephalopathy | |
![]() ![]() | 1..1 | string | Chronic cryptosporidiosis | |
![]() ![]() | 1..1 | string | Chronic cryptosporidiosis (with diarrhoea) | |
![]() ![]() | 1..1 | string | Chronic isosporiasis | |
![]() ![]() | 1..1 | string | Disseminated mycosis (extrapulmonary histoplasmosis, coccidioidomycosis) | |
![]() ![]() | 1..1 | string | Disseminated endemic mycosis (extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis) | |
![]() ![]() | 1..1 | string | Cerebral lymphoma | |
![]() ![]() | 1..1 | string | B-cell non-Hodgkin lymphoma | |
![]() ![]() | 1..1 | string | HIV-associated nephropathy or cardiomyopathy | |
![]() ![]() | 1..1 | string | Recurrent septicaemia (including nontyphoidal Salmonella) | |
![]() ![]() | 1..1 | string | Invasive cervical carcinoma | |
![]() ![]() | 1..1 | string | Atypical disseminated leishmaniasis | |
![]() ![]() | 1..1 | string | Neutropenia | |
![]() ![]() | 1..1 | string | Clinical stage at start of ART | |
![]() ![]() | 1..1 | string | WHO clinical stage 1 | |
![]() ![]() | 1..1 | string | WHO clinical stage 2 | |
![]() ![]() | 1..1 | string | WHO clinical stage 3 | |
![]() ![]() | 1..1 | string | WHO clinical stage 4 | |
![]() ![]() | 1..1 | string | Date of clinical status change | |
![]() ![]() | 1..1 | string | CD4 count | |
![]() ![]() | 1..1 | string | CD4 cell percentage | |
![]() ![]() | 1..1 | string | Date of CD4 count test | |
![]() ![]() | 1..1 | string | Baseline CD4 count | |
![]() ![]() | 1..1 | string | Date of baseline CD4 count test | |
![]() ![]() | 1..1 | string | Late ART initiation | |
![]() ![]() | 1..1 | string | Reasons for delayed ART initiation | |
![]() ![]() | 1..1 | string | Patient self-reported as not ready/willing | |
![]() ![]() | 1..1 | string | Not completed education, support and preparation for ART | |
![]() ![]() | 1..1 | string | Fear of disclosure | |
![]() ![]() | 1..1 | string | Patient lacks finances | |
![]() ![]() | 1..1 | string | Initiated on TB treatment | |
![]() ![]() | 1..1 | string | Patient initiated on treatment for TB meningitis | |
![]() ![]() | 1..1 | string | Patient diagnosed with cryptococcal meningitis | |
![]() ![]() | 1..1 | string | Patient diagnosed with histoplasmosis | |
![]() ![]() | 1..1 | string | Patient critically/severely ill | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | ART initiated within 7 days of diagnosis | |
![]() ![]() | 1..1 | string | Time to start ART | |
![]() ![]() | 1..1 | string | Within 7 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Within 30 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Within 90 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Viral load test result | |
![]() ![]() | 1..1 | string | Virally suppressed | |
![]() ![]() | 1..1 | string | Date viral load test results received | |
![]() ![]() | 1..1 | string | Viral load suppression date | |
![]() ![]() | 1..1 | string | Reason for HIV viral load test | |
![]() ![]() | 1..1 | string | Routine viral load test | |
![]() ![]() | 1..1 | string | Targeted viral load monitoring | |
![]() ![]() | 1..1 | string | Initial viral load test | |
![]() ![]() | 1..1 | string | Follow-up viral load test after receiving enhanced adherence counselling | |
![]() ![]() | 1..1 | string | Hepatitis B test required | |
![]() ![]() | 1..1 | string | Hepatitis C test recommended | |
![]() ![]() | 1..1 | string | Syphilis test required | |
![]() ![]() | 1..1 | string | Monitoring examinations | |
![]() ![]() | 1..1 | string | Haemoglobin (Hb) | |
![]() ![]() | 1..1 | string | Pregnancy test | |
![]() ![]() | 1..1 | string | Syphilis test | |
![]() ![]() | 1..1 | string | Chest X-ray (CXR) | |
![]() ![]() | 1..1 | string | Sputum or culture for TB | |
![]() ![]() | 1..1 | string | HBsAg test (HBV) | |
![]() ![]() | 1..1 | string | HIV viral load test ordered | |
![]() ![]() | 1..1 | string | HIV viral load test scheduled | |
![]() ![]() | 1..1 | string | CD4 count ordered | |
![]() ![]() | 1..1 | string | CD4 count test scheduled | |
![]() ![]() | 1..1 | string | Cryptococcal antigen test | |
![]() ![]() | 1..1 | string | Histoplasmosis antigen test | |
![]() ![]() | 1..1 | string | Cervical cancer screening scheduled | |
![]() ![]() | 1..1 | string | Date of scheduled monitoring examination | |
![]() ![]() | 1..1 | string | Hepatitis C test ordered | |
![]() ![]() | 1..1 | string | Syphilis test ordered | |
![]() ![]() | 1..1 | string | Received viral load test results | |
![]() ![]() | 1..1 | string | Date viral load test results received by client | |
![]() ![]() | 1..1 | string | Reason for ARV drug regimen substitution | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Drug-drug interaction | |
![]() ![]() | 1..1 | string | Pregnancy | |
![]() ![]() | 1..1 | string | New TB | |
![]() ![]() | 1..1 | string | New drug available | |
![]() ![]() | 1..1 | string | Drug out of stock | |
![]() ![]() | 1..1 | string | Other reason for regimen substitution | |
![]() ![]() | 1..1 | string | Other reason for regimen substitution (specify) | |
![]() ![]() | 1..1 | string | Switch to second-line ART regimen recommended | |
![]() ![]() | 1..1 | string | Switch to third-line ART regimen recommended | |
![]() ![]() | 1..1 | string | Regimen switch made | |
![]() ![]() | 1..1 | string | Reason for regimen switch | |
![]() ![]() | 1..1 | string | Clinical treatment failure | |
![]() ![]() | 1..1 | string | Immunological failure | |
![]() ![]() | 1..1 | string | Virological failure | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Regimen substitution recommended | |
![]() ![]() | 1..1 | string | Dose adjustment recommended | |
![]() ![]() | 1..1 | string | Regimen substitution made | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis start date | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis completion date | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis dosage | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis number of days prescribed | |
![]() ![]() | 1..1 | string | Suspicion of treatment failure or interruption | |
![]() ![]() | 1..1 | string | ART regimen prescribed | |
![]() ![]() | 1..1 | string | Antiretroviral toxicity | |
![]() ![]() | 1..1 | string | Coinfection status at ART start | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Hepatitis C | |
![]() ![]() | 1..1 | string | Pregnant and breastfeeding status at ART start | |
![]() ![]() | 1..1 | string | Pregnant at ART start | |
![]() ![]() | 1..1 | string | Postpartum at ART start | |
![]() ![]() | 1..1 | string | ART start at labour and delivery | |
![]() ![]() | 1..1 | string | Breastfeeding at ART start | |
![]() ![]() | 1..1 | string | Delivery date of infant | |
![]() ![]() | 1..1 | string | Serodiscordant partner at ART start | |
![]() ![]() | 1..1 | string | Regimen start date | |
![]() ![]() | 1..1 | string | Medications prescribed | |
![]() ![]() | 1..1 | string | Date medications prescribed | |
![]() ![]() | 1..1 | string | Dose of medications prescribed | |
![]() ![]() | 1..1 | string | Number of days medications prescribed | |
![]() ![]() | 1..1 | string | Medications dispensed | |
![]() ![]() | 1..1 | string | Number of days of medications dispensed | |
![]() ![]() | 1..1 | string | Dosage | |
![]() ![]() | 1..1 | string | Frequency | |
![]() ![]() | 1..1 | string | Adherence counselling provided | |
![]() ![]() | 1..1 | string | Type of treatment-limiting toxicity | |
![]() ![]() | 1..1 | string | Gastrointestinal | |
![]() ![]() | 1..1 | string | Skin issues | |
![]() ![]() | 1..1 | string | Peripheral neuropathy | |
![]() ![]() | 1..1 | string | Central nervous system symptoms | |
![]() ![]() | 1..1 | string | Weight gain | |
![]() ![]() | 1..1 | string | Hepatic dysfunction | |
![]() ![]() | 1..1 | string | Haematological disorders | |
![]() ![]() | 1..1 | string | Fatigue | |
![]() ![]() | 1..1 | string | Headache | |
![]() ![]() | 1..1 | string | Bone dysfunction | |
![]() ![]() | 1..1 | string | Metabolic symptoms | |
![]() ![]() | 1..1 | string | Kidney dysfunction | |
![]() ![]() | 1..1 | string | Unexpected adverse drug reaction | |
![]() ![]() | 1..1 | string | Unexpected adverse drug reaction (specify) | |
![]() ![]() | 1..1 | string | Date(s) of substitution within first-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within first-line regimen | |
![]() ![]() | 1..1 | string | New antiretroviral regimen after substitution within first-line regimen | |
![]() ![]() | 1..1 | string | Date of switch to second-line regimen | |
![]() ![]() | 1..1 | string | New regimen after switch to second-line regimen | |
![]() ![]() | 1..1 | string | Reason for switch to second-line regimen | |
![]() ![]() | 1..1 | string | Date(s) of substitution within second-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within second-line regimen | |
![]() ![]() | 1..1 | string | New regimen(s) after substitution within second-line regimen | |
![]() ![]() | 1..1 | string | Date of switch to third-line regimen | |
![]() ![]() | 1..1 | string | New regimen after switch to third-line regimen | |
![]() ![]() | 1..1 | string | Reason for switch to third-line regimen | |
![]() ![]() | 1..1 | string | Date(s) of substitution within third-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within third-line regimen | |
![]() ![]() | 1..1 | string | New regimen(s) after substitution within third-line regimen | |
![]() ![]() | 1..1 | string | Enhanced adherence counselling provided | |
![]() ![]() | 1..1 | string | First enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of first enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Second enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of second enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Third enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of third enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Name of treatment supporter | |
![]() ![]() | 1..1 | string | Address of treatment supporter | |
![]() ![]() | 1..1 | string | Telephone number of treatment supporter | |
![]() ![]() | 1..1 | string | Home-based care provider | |
![]() ![]() | 1..1 | string | Counselling provided on diagnoses | |
![]() ![]() | 1..1 | string | Hepatitis B positive counselling conducted | |
![]() ![]() | 1..1 | string | Hepatitis C positive counselling conducted | |
![]() ![]() | 1..1 | string | Syphilis counselling and treatment | |
![]() ![]() | 1..1 | string | Syphilis counselling, treatment and further testing | |
![]() ![]() | 1..1 | string | Accepted partner services | |
![]() ![]() | 1..1 | string | HIV testing for partners and biological children | |
![]() ![]() | 1..1 | string | HIV status of family member | |
![]() ![]() | 1..1 | string | Unique ID of family member | |
![]() ![]() | 1..1 | string | Date of death of family member | |
![]() ![]() | 1..1 | string | Offered voluntary partner services | |
![]() ![]() | 1..1 | string | Provided support for disclosure and partner services | |
![]() ![]() | 1..1 | string | Other support services | |
![]() ![]() | 1..1 | string | Mental health services | |
![]() ![]() | 1..1 | string | Psychosocial counselling, support and treatment adherence counselling | |
![]() ![]() | 1..1 | string | Legal and social services | |
![]() ![]() | 1..1 | string | Services for responding to violence against women | |
![]() ![]() | 1..1 | string | Date/time of follow-up appointment | |
![]() ![]() | 1..1 | string | Type of follow-up appointment | |
![]() ![]() | 1..1 | string | Clinical visit | |
![]() ![]() | 1..1 | string | Antiretroviral drug pick up | |
![]() ![]() | 1..1 | string | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Follow-up test recommended date | |
![]() ![]() | 1..1 | string | Reason blood pressure reading not done | |
![]() ![]() | 1..1 | string | BP cuff (sphygmomanometer) not available | |
![]() ![]() | 1..1 | string | BP cuff (sphygmomanometer) is broken | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Current medications | |
![]() ![]() | 1..1 | string | No medications | |
![]() ![]() | 1..1 | string | Dont know of any current medications | |
![]() ![]() | 1..1 | string | Analgesic | |
![]() ![]() | 1..1 | string | Antacids | |
![]() ![]() | 1..1 | string | Antibiotics (broad-spectrum) | |
![]() ![]() | 1..1 | string | Anticonvulsive | |
![]() ![]() | 1..1 | string | Antidiabetic | |
![]() ![]() | 1..1 | string | Antifungals | |
![]() ![]() | 1..1 | string | Antihelmintic | |
![]() ![]() | 1..1 | string | Antihypertensive | |
![]() ![]() | 1..1 | string | Antimalarials | |
![]() ![]() | 1..1 | string | Antiretrovirals (ARVs) | |
![]() ![]() | 1..1 | string | Antiparasitics | |
![]() ![]() | 1..1 | string | Antivirals | |
![]() ![]() | 1..1 | string | Buprenorphine | |
![]() ![]() | 1..1 | string | Co-trimoxazole preventive therapy (CPT) | |
![]() ![]() | 1..1 | string | Hormonal family planning method | |
![]() ![]() | 1..1 | string | Methadone | |
![]() ![]() | 1..1 | string | PrEP to prevent HIV | |
![]() ![]() | 1..1 | string | Other antibiotics | |
![]() ![]() | 1..1 | string | Other medications | |
![]() ![]() | 1..1 | string | Other medications (specify) | |
![]() ![]() | 1..1 | string | Allergies | |
![]() ![]() | 1..1 | string | No known allergies | |
![]() ![]() | 1..1 | string | Dont know of any allergies | |
![]() ![]() | 1..1 | string | Albendazole | |
![]() ![]() | 1..1 | string | Malaria medication (sulfadoxine-pyrimethamine) | |
![]() ![]() | 1..1 | string | Penicillin | |
![]() ![]() | 1..1 | string | Tenofovir disoproxil fumarate (TDF) | |
![]() ![]() | 1..1 | string | Other allergies | |
![]() ![]() | 1..1 | string | Other allergies (specify) | |
![]() ![]() | 1..1 | string | Family planning method used | |
![]() ![]() | 1..1 | string | Copper-bearing intrauterine device (Cu-IUD) | |
![]() ![]() | 1..1 | string | Levonorgestrel intrauterine device (LNG-IUD) | |
![]() ![]() | 1..1 | string | Etonogestrel (ETG) one-rod implant | |
![]() ![]() | 1..1 | string | Levonorgestrel (LNG) two-rod implant | |
![]() ![]() | 1..1 | string | DMPA-IM | |
![]() ![]() | 1..1 | string | DMPA-SC | |
![]() ![]() | 1..1 | string | NET-EN norethisterone enanthate | |
![]() ![]() | 1..1 | string | Progestogen-only pills (POP) | |
![]() ![]() | 1..1 | string | Combined oral contraceptives (COCs) | |
![]() ![]() | 1..1 | string | Combined contraceptive patch | |
![]() ![]() | 1..1 | string | Combined contraceptive vaginal ring (CVR) | |
![]() ![]() | 1..1 | string | Progesterone-releasing vaginal ring (PVR) | |
![]() ![]() | 1..1 | string | Lactational amenorrhea method (LAM) | |
![]() ![]() | 1..1 | string | Emergency contraceptive pills (ECPs) | |
![]() ![]() | 1..1 | string | Fertility awareness-based methods (FAB) | |
![]() ![]() | 1..1 | string | Male condoms | |
![]() ![]() | 1..1 | string | Female condoms | |
![]() ![]() | 1..1 | string | Withdrawal | |
![]() ![]() | 1..1 | string | Female relying on male method | |
![]() ![]() | 1..1 | string | Male relying on female method | |
![]() ![]() | 1..1 | string | Male sterilization | |
![]() ![]() | 1..1 | string | Female sterilization | |
![]() ![]() | 1..1 | string | No method | |
![]() ![]() | 1..1 | string | Medication status | |
![]() ![]() | 1..1 | string | Currently taking | |
![]() ![]() | 1..1 | string | Completed | |
![]() ![]() | 1..1 | string | Entered in error | |
![]() ![]() | 1..1 | string | Intended | |
![]() ![]() | 1..1 | string | Stopped | |
![]() ![]() | 1..1 | string | On hold | |
![]() ![]() | 1..1 | string | Unknown | |
![]() ![]() | 1..1 | string | Did not take | |
![]() ![]() | 1..1 | string | Hepatitis B negative counselling conducted | |
![]() ![]() | 1..1 | string | Vaccine brand | |
![]() ![]() | 1..1 | string | Vaccine type | |
![]() ![]() | 1..1 | string | Date and time of vaccination | |
![]() ![]() | 1..1 | string | Vaccination location | |
![]() ![]() | 1..1 | string | Dose number | |
![]() ![]() | 1..1 | string | Dose quantity | |
![]() ![]() | 1..1 | string | Total doses in series | |
![]() ![]() | 1..1 | string | Disease targeted | |
![]() ![]() | 1..1 | string | Hepatitis A | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Tetanus | |
![]() ![]() | 1..1 | string | COVID-19 | |
![]() ![]() | 1..1 | string | Influenza due to influenza B virus | |
![]() ![]() | 1..1 | string | Tuberculosis | |
![]() ![]() | 1..1 | string | Acute poliomyelitis | |
![]() ![]() | 1..1 | string | Measles | |
![]() ![]() | 1..1 | string | Diptheria | |
![]() ![]() | 1..1 | string | Rabies | |
![]() ![]() | 1..1 | string | Cholera | |
![]() ![]() | 1..1 | string | Mumps | |
![]() ![]() | 1..1 | string | HPV infection | |
![]() ![]() | 1..1 | string | Haemophilus influenzae type B | |
![]() ![]() | 1..1 | string | Varicella | |
![]() ![]() | 1..1 | string | Dengue | |
![]() ![]() | 1..1 | string | Yellow fever | |
![]() ![]() | 1..1 | string | Japanese Encephalitis | |
![]() ![]() | 1..1 | string | Rubella | |
![]() ![]() | 1..1 | string | Pertussis | |
![]() ![]() | 1..1 | string | Enteritis due to rotavirus | |
![]() ![]() | 1..1 | string | Pneumococcal disease | |
![]() ![]() | 1..1 | string | Meningococcal disease | |
![]() ![]() | 1..1 | string | Tick-borne encephalitis | |
![]() ![]() | 1..1 | string | Typhoid | |
![]() ![]() | 1..1 | string | Reason immunization was not provided | |
![]() ![]() | 1..1 | string | Stock-out | |
![]() ![]() | 1..1 | string | Client is ill | |
![]() ![]() | 1..1 | string | Client refused | |
![]() ![]() | 1..1 | string | Allergy to vaccine | |
![]() ![]() | 1..1 | string | Other reason immunization not provided | |
![]() ![]() | 1..1 | string | Other reason immunization not provided (specify) | |
![]() ![]() | 1..1 | string | Malaria prophylaxis | |
![]() ![]() | 1..1 | string | IPTp-SP dose number provided | |
![]() ![]() | 1..1 | string | Date IPTp-SP dose provided | |
![]() ![]() | 1..1 | string | Reason malaria prophylaxis not provided | |
![]() ![]() | 1..1 | string | Client was referred | |
![]() ![]() | 1..1 | string | Stock out | |
![]() ![]() | 1..1 | string | Expired | |
![]() ![]() | 1..1 | string | Other reason not provided | |
![]() ![]() | 1..1 | string | Other reason not provided (specify) | |
![]() ![]() | 1..1 | string | >28 days since last missed appointment | |
![]() ![]() | 1..1 | string | AIDS-related death | |
![]() ![]() | 1..1 | string | Date of first AIDS diagnosis | |
![]() ![]() | 1..1 | string | Age at final HPV vaccination dose received | |
![]() ![]() | 1..1 | string | Date of cervical cancer screening test | |
![]() ![]() | 1..1 | string | Lifetime screening test number | |
![]() ![]() | 1..1 | string | Cervical cancer primary screening test type | |
![]() ![]() | 1..1 | string | HPV-DNA | |
![]() ![]() | 1..1 | string | VIA | |
![]() ![]() | 1..1 | string | Cervical cytology | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | HPV-DNA cervical cancer screening test result | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Invalid | |
![]() ![]() | 1..1 | string | VIA cervical cancer screening test result | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Suspected cancer | |
![]() ![]() | 1..1 | string | Invalid | |
![]() ![]() | 1..1 | string | Cervical cytology screening test result | |
![]() ![]() | 1..1 | string | NILM | |
![]() ![]() | 1..1 | string | ASCUS | |
![]() ![]() | 1..1 | string | LSIL | |
![]() ![]() | 1..1 | string | HSIL | |
![]() ![]() | 1..1 | string | Cancer | |
![]() ![]() | 1..1 | string | Invalid/inadequate | |
![]() ![]() | 1..1 | string | Cervical cancer triage test date | |
![]() ![]() | 1..1 | string | Cervical cancer triage test type | |
![]() ![]() | 1..1 | string | VIA | |
![]() ![]() | 1..1 | string | Colposcopy | |
![]() ![]() | 1..1 | string | Cervical cytology | |
![]() ![]() | 1..1 | string | HPV16/18 | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | HPV16/18 test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Cervical cancer colposcopy result | |
![]() ![]() | 1..1 | string | Normal colposcopic findings | |
![]() ![]() | 1..1 | string | Abnormal colposcopic findings | |
![]() ![]() | 1..1 | string | Suspicious for invasive cervical cancer | |
![]() ![]() | 1..1 | string | Miscellaneous findings | |
![]() ![]() | 1..1 | string | Inadequate | |
![]() ![]() | 1..1 | string | Cervical cancer histopathology result | |
![]() ![]() | 1..1 | string | Normal | |
![]() ![]() | 1..1 | string | LSIL (inclusive of LSIL-CIN1) | |
![]() ![]() | 1..1 | string | HSIL (inclusive of HSIL-CIN2 or HSIL-CIN3) | |
![]() ![]() | 1..1 | string | Invasive cervical cancer | |
![]() ![]() | 1..1 | string | Date of additional cervical cancer triage test | |
![]() ![]() | 1..1 | string | Additional cervical cancer triage test type (specify) | |
![]() ![]() | 1..1 | string | Additional cervical cancer triage test result (specify) | |
![]() ![]() | 1..1 | string | Date of diagnosis of cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Cervical cancer screening outcome | |
![]() ![]() | 1..1 | string | Positive for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Negative for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Cervical cancer diagnosis | |
![]() ![]() | 1..1 | string | Cervical precancer lesions | |
![]() ![]() | 1..1 | string | Invasive cervical cancer | |
![]() ![]() | 1..1 | string | Cervical cancer stage at diagnosis | |
![]() ![]() | 1..1 | string | Stage 0 | |
![]() ![]() | 1..1 | string | Stage I | |
![]() ![]() | 1..1 | string | Stage II | |
![]() ![]() | 1..1 | string | Stage III | |
![]() ![]() | 1..1 | string | Stage IV | |
![]() ![]() | 1..1 | string | Date of treatment for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Treatment method for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Cryotherapy | |
![]() ![]() | 1..1 | string | Thermal ablation | |
![]() ![]() | 1..1 | string | Laser ablation | |
![]() ![]() | 1..1 | string | CKC | |
![]() ![]() | 1..1 | string | Laser cone biopsy | |
![]() ![]() | 1..1 | string | LLETZ/LEEP | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Date of follow-up for treatment for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Date of start of invasive cancer treatment | |
![]() ![]() | 1..1 | string | Invasive cervical cancer treatment episode | |
![]() ![]() | 1..1 | string | Invasive cervical cancer treatment method | |
![]() ![]() | 1..1 | string | Conization | |
![]() ![]() | 1..1 | string | Trachelectomy | |
![]() ![]() | 1..1 | string | Hysterectomy | |
![]() ![]() | 1..1 | string | Management of invasive cervical cancer | |
![]() ![]() | 1..1 | string | Radiotherapy | |
![]() ![]() | 1..1 | string | Chemotherapy | |
![]() ![]() | 1..1 | string | Chemoradiation | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Treatment outcome | |
![]() ![]() | 1..1 | string | Secondary/other cancers diagnosed | |
![]() ![]() | 1..1 | string | Cancers at other sites (HPV- and non-HPV related) | |
![]() ![]() | 1..1 | string | Date of death | |
![]() ![]() | 1..1 | string | Cervical cancer screening interval amongst WLHIV | |
![]() ![]() | 1..1 | string | Entry point for facility-level testing | |
![]() ![]() | 1..1 | string | Provider-initiated tested in a clinic or emergency facility | |
![]() ![]() | 1..1 | string | Antenatal care clinic | |
![]() ![]() | 1..1 | string | Voluntary counselling and testing (within a health facility setting) | |
![]() ![]() | 1..1 | string | Family planning clinic | |
![]() ![]() | 1..1 | string | Other facility-level testing | |
![]() ![]() | 1..1 | string | Tuberculosis (TB) clinic | |
![]() ![]() | 1..1 | string | Offer other clinical services | |
![]() ![]() | 1..1 | string | Assessment and provision of vaccinations | |
![]() ![]() | 1..1 | string | Hepatitis B (HBV) and hepatitis C virus (HCV) testing and treatment | |
![]() ![]() | 1..1 | string | Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia | |
![]() ![]() | 1..1 | string | Intensified TB case finding and linkage to TB treatment | |
![]() ![]() | 1..1 | string | Provision of isoniazid preventive therapy if person does not have TB | |
![]() ![]() | 1..1 | string | Malaria prevention (such as bed nets and prophylaxis), depending on epidemiology | |
![]() ![]() | 1..1 | string | Eligible for DSD ART | |
![]() ![]() | 1..1 | string | Date DSD ART eligibility assessed | |
![]() ![]() | 1..1 | string | Currently enrolled in DSD ART model | |
![]() ![]() | 1..1 | string | DSD ART start date | |
![]() ![]() | 1..1 | string | DSD ART model(s) | |
![]() ![]() | 1..1 | string | Fast track ART refill | |
![]() ![]() | 1..1 | string | Facility adherence club | |
![]() ![]() | 1..1 | string | Community ART distribution point | |
![]() ![]() | 1..1 | string | CHW/peer educator community ART group | |
![]() ![]() | 1..1 | string | Patient/client community ART group | |
![]() ![]() | 1..1 | string | Other DSD ART model | |
![]() ![]() | 1..1 | string | Other DSD ART model (specify) | |
![]() ![]() | 1..1 | string | Partner testing offered | |
![]() ![]() | 1..1 | string | Partner testing accepted | |
![]() ![]() | 1..1 | string | Date partner contacted for index testing | |
![]() ![]() | 1..1 | string | Date partner tested for HIV | |
![]() ![]() | 1..1 | string | Date of next scheduled follow-up appointment | |
![]() ![]() | 1..1 | string | Type of next follow-up appointment | |
![]() ![]() | 1..1 | string | Syndrome/STI diagnosed | |
![]() ![]() | 1..1 | string | Urethral discharge syndrome | |
![]() ![]() | 1..1 | string | Vaginal discharge syndrome | |
![]() ![]() | 1..1 | string | Lower Abdominal pain | |
![]() ![]() | 1..1 | string | Genital ulcer disease syndrome | |
![]() ![]() | 1..1 | string | Anorectal discharge | |
![]() ![]() | 1..1 | string | Sent for testing | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Any STI syndrome diagnosed | |
![]() ![]() | 1..1 | string | Date of STI test | |
![]() ![]() | 1..1 | string | STI tested for | |
![]() ![]() | 1..1 | string | Neisseria gonorrhoeae | |
![]() ![]() | 1..1 | string | Chlamydia trachomatis | |
![]() ![]() | 1..1 | string | Trichomonas vaginalis | |
![]() ![]() | 1..1 | string | Syphilis (Treponema pallidum) | |
![]() ![]() | 1..1 | string | Herpes simplex virus (HSV1, HSV2) | |
![]() ![]() | 1..1 | string | Mycoplasma genitalium | |
![]() ![]() | 1..1 | string | Mpox | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Hepatitis C | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Syphilis test date | |
![]() ![]() | 1..1 | string | Syphilis test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Syphilis treatment start date | |
![]() ![]() | 1..1 | string | Gonorrhoea test date | |
![]() ![]() | 1..1 | string | Gonorrhoea test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Gonorrhoea treatment start date | |
![]() ![]() | 1..1 | string | Type of specimen | |
![]() ![]() | 1..1 | string | Blood | |
![]() ![]() | 1..1 | string | Urine | |
![]() ![]() | 1..1 | string | Cervical or vaginal swab | |
![]() ![]() | 1..1 | string | Urethral or penile swab | |
![]() ![]() | 1..1 | string | Rectal swab | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other type of specimen (specify) | |
![]() ![]() | 1..1 | string | Syphilis test type | |
![]() ![]() | 1..1 | string | Treponemal | |
![]() ![]() | 1..1 | string | Non-treponemal | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other syphilis test type (specify) | |
![]() ![]() | 1..1 | string | Neisseria gonorrhoeae test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | POC Test for Neisseria gonorrhoeae (specify) | |
![]() ![]() | 1..1 | string | Chlamydia trachomatis test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | ELISA | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other test for Chlamydia (specify) | |
![]() ![]() | 1..1 | string | POC Test type for Chlamydia test (specify) | |
![]() ![]() | 1..1 | string | Trichomonas vaginalis test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | POC Test type for Trichomonas vaginalis test (specify) | |
![]() ![]() | 1..1 | string | Herpes simplex virus (HSV) test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Antibody test | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Mycoplasma genitalium test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Test type for other STI tested for (specify) | |
![]() ![]() | 1..1 | string | STI test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Date of STI confirmatory test | |
![]() ![]() | 1..1 | string | Confirmatory syphilis test type | |
![]() ![]() | 1..1 | string | Treponemal | |
![]() ![]() | 1..1 | string | Non-treponemal | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Confirmatory test type for other STI (specify) | |
![]() ![]() | 1..1 | string | Confirmatory STI test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Date STI treatment prescribed | |
![]() ![]() | 1..1 | string | Date STI treatment dispensed | |
![]() ![]() | 1..1 | string | STI treatment dispensed (specify) | |
![]() ![]() | 1..1 | string | Mid-upper arm circumference (MUAC) | |
![]() ![]() | 1..1 | string | Date of start of fluconazole prophylaxis | |
![]() ![]() | 1..1 | string | Fluconazole prophylaxis | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment induction regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment induction regimen | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment maintenance regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment maintenance regimen | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment consolidation regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment consolidation regimen | |
![]() ![]() | 1..1 | string | Staging of liver disease | |
![]() ![]() | 1..1 | string | F0-4, fibrosis staging | |
![]() ![]() | 1..1 | string | F4 or cirrhosis, presence of cirrhosis | |
![]() ![]() | 1..1 | string | Advanced HIV disease | |
![]() ![]() | 1..1 | string | WHO functional status | |
![]() ![]() | 1..1 | string | Working, able to perform usual work inside and outside the home | |
![]() ![]() | 1..1 | string | Ambulatory, able to perform activity of daily living (ADL), not able to work | |
![]() ![]() | 1..1 | string | Bedridden not able to perform ADL | |
![]() ![]() | 1..1 | string | Tailored adherence counselling for advanced HIV disease | |
![]() ![]() | 1..1 | string | Date(s) of tracing interventions | |
![]() ![]() | 1..1 | string | Medication/drug | |
![]() ![]() | 1..1 | string | Rifampicin | |
![]() ![]() | 1..1 | string | Halofantrine | |
![]() ![]() | 1..1 | string | Lovastatin | |
![]() ![]() | 1..1 | string | Simvastatin | |
![]() ![]() | 1..1 | string | Hormonal contraception | |
![]() ![]() | 1..1 | string | Metformin | |
![]() ![]() | 1..1 | string | Astemizole | |
![]() ![]() | 1..1 | string | Terfenadine | |
![]() ![]() | 1..1 | string | TDF | |
![]() ![]() | 1..1 | string | Simeprevir | |
![]() ![]() | 1..1 | string | Ombitasvir + paritaprevir/ritonavir + dasabuvir | |
![]() ![]() | 1..1 | string | Methadone | |
![]() ![]() | 1..1 | string | Buprenorphine | |
![]() ![]() | 1..1 | string | Dofetilide | |
![]() ![]() | 1..1 | string | Carbamazepine | |
![]() ![]() | 1..1 | string | Phenobarbital | |
![]() ![]() | 1..1 | string | Phenytoin | |
![]() ![]() | 1..1 | string | Polyvalent cation products containing Mg, Al, Fe, Ca and Zn | |
![]() ![]() | 1..1 | string | Amodiaquine | |
![]() ![]() | 1..1 | string | Cisapride | |
![]() ![]() | 1..1 | string | Ergotamine | |
![]() ![]() | 1..1 | string | Dihydroergotamine | |
![]() ![]() | 1..1 | string | Midazolam | |
![]() ![]() | 1..1 | string | Triazolam | |
![]() ![]() | 1..1 | string | Estrogen-based hormonal contraception | |
![]() ![]() | 1..1 | string | Ribavirin | |
![]() ![]() | 1..1 | string | Peginterferon alfa-2a | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Medication change recommended | |
Documentation for this format | ||||
This structure is derived from Base
Differential View
This structure is derived from Base
| Name | Flags | Card. | Type | Description & Constraints![]() |
|---|---|---|---|---|
![]() | 0..* | Base | HIV.D Care-Treatment Logical Model Instances of this logical model are not marked to be the target of a Reference | |
![]() ![]() | 1..1 | string | Reason for visit | |
![]() ![]() | 1..1 | string | First clinical visit | |
![]() ![]() | 1..1 | string | Clinical visit | |
![]() ![]() | 1..1 | string | ART initiation | |
![]() ![]() | 1..1 | string | ART drug pick up | |
![]() ![]() | 1..1 | string | Issues and concerns | |
![]() ![]() | 1..1 | string | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Scheduled visit | |
![]() ![]() | 1..1 | string | Body temperature | |
![]() ![]() | 1..1 | string | Respiratory rate | |
![]() ![]() | 1..1 | string | Heart rate | |
![]() ![]() | 1..1 | string | Body height | |
![]() ![]() | 1..1 | string | Body weight | |
![]() ![]() | 1..1 | string | Systolic blood pressure | |
![]() ![]() | 1..1 | string | Diastolic blood pressure | |
![]() ![]() | 1..1 | string | Blood pressure cannot be taken | |
![]() ![]() | 1..1 | string | Signs of serious illness | |
![]() ![]() | 1..1 | string | Fever of 39 C or greater | |
![]() ![]() | 1..1 | string | Tachycardia | |
![]() ![]() | 1..1 | string | Tachypnea | |
![]() ![]() | 1..1 | string | Unable to walk unaided | |
![]() ![]() | 1..1 | string | Lethargy | |
![]() ![]() | 1..1 | string | Unconsciousness | |
![]() ![]() | 1..1 | string | Convulsions | |
![]() ![]() | 1..1 | string | Unable to drink | |
![]() ![]() | 1..1 | string | Unable to breastfeed | |
![]() ![]() | 1..1 | string | Repeated vomiting | |
![]() ![]() | 1..1 | string | Headache | |
![]() ![]() | 1..1 | string | Other sign of serious illness | |
![]() ![]() | 1..1 | string | Other sign of serious illness (specify) | |
![]() ![]() | 1..1 | string | Currently pregnant | |
![]() ![]() | 1..1 | string | Breastfeeding | |
![]() ![]() | 1..1 | string | Number of pregnancies (gravida) | |
![]() ![]() | 1..1 | string | Number of miscarriages and/or abortions | |
![]() ![]() | 1..1 | string | Number of live births | |
![]() ![]() | 1..1 | string | Parity | |
![]() ![]() | 1..1 | string | Serodiscordant partner | |
![]() ![]() | 1..1 | string | On ART | |
![]() ![]() | 1..1 | string | ART start date | |
![]() ![]() | 1..1 | string | Stopped ART | |
![]() ![]() | 1..1 | string | Date ART stopped | |
![]() ![]() | 1..1 | string | Established on ART | |
![]() ![]() | 1..1 | string | ART start type | |
![]() ![]() | 1..1 | string | First-time user of ART | |
![]() ![]() | 1..1 | string | Restarting ART | |
![]() ![]() | 1..1 | string | Date of initiation on ART | |
![]() ![]() | 1..1 | string | Time on ART | |
![]() ![]() | 1..1 | string | Date(s) ART restarted | |
![]() ![]() | 1..1 | string | ART cohort | |
![]() ![]() | 1..1 | string | Transfer in for HIV care | |
![]() ![]() | 1..1 | string | Date of transfer in | |
![]() ![]() | 1..1 | string | Facility transferred from | |
![]() ![]() | 1..1 | string | Date enrolled in HIV care | |
![]() ![]() | 1..1 | string | Age at enrolment | |
![]() ![]() | 1..1 | string | Facility where client first enrolled in HIV care | |
![]() ![]() | 1..1 | string | Antiretroviral (ARV) drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | No prior ARVs | |
![]() ![]() | 1..1 | string | Received ARVs prior without records/documentation | |
![]() ![]() | 1..1 | string | Received ARVs during pregnancy or breastfeeding | |
![]() ![]() | 1..1 | string | Received ARVs for PEP or PrEP | |
![]() ![]() | 1..1 | string | ARV prophylaxis for an HIV-exposed infant | |
![]() ![]() | 1..1 | string | Date ARV drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | Location ARV drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | ARV drug regimen received prior to enrolment | |
![]() ![]() | 1..1 | string | Existing chronic health conditions | |
![]() ![]() | 1..1 | string | No chronic or past health conditions | |
![]() ![]() | 1..1 | string | Dont know | |
![]() ![]() | 1..1 | string | Diabetes other or unspecified | |
![]() ![]() | 1..1 | string | Diabetes pre-existing type 1 | |
![]() ![]() | 1..1 | string | Diabetes pre-existing type 2 | |
![]() ![]() | 1..1 | string | Hypertension | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Original first-line ART regimen | |
![]() ![]() | 1..1 | string | Current ART regimen | |
![]() ![]() | 1..1 | string | Current ART regimen start date | |
![]() ![]() | 1..1 | string | Preferred first-line ART regimen | |
![]() ![]() | 1..1 | string | Alternative first-line ART regimen | |
![]() ![]() | 1..1 | string | First-line ART regimen under special circumstances | |
![]() ![]() | 1..1 | string | Preferred second-line ART regimen | |
![]() ![]() | 1..1 | string | Alternative second-line ART regimen | |
![]() ![]() | 1..1 | string | Optimal regimen for transition | |
![]() ![]() | 1..1 | string | Current ART regimen (first-, second-, or third-line) | |
![]() ![]() | 1..1 | string | First-line ART regimen for adults and adolescents | |
![]() ![]() | 1..1 | string | First-line ART regimen for children | |
![]() ![]() | 1..1 | string | First-line ART regimen for neonates | |
![]() ![]() | 1..1 | string | Second-line ART regimen for adults and adolescents | |
![]() ![]() | 1..1 | string | Second-line ART regimen for children | |
![]() ![]() | 1..1 | string | Third-line ART regimen | |
![]() ![]() | 1..1 | string | ART regimen | |
![]() ![]() | 1..1 | string | ABC + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | ABC + 3TC + DTG | |
![]() ![]() | 1..1 | string | ABC + 3TC + EFV | |
![]() ![]() | 1..1 | string | ABC + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | ABC + 3TC + NVP | |
![]() ![]() | 1..1 | string | ABC + 3TC + RAL | |
![]() ![]() | 1..1 | string | AZT + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + DRV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + DTG | |
![]() ![]() | 1..1 | string | AZT + 3TC + EFV | |
![]() ![]() | 1..1 | string | AZT + 3TC + EFV 600 mg | |
![]() ![]() | 1..1 | string | AZT + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + NVP | |
![]() ![]() | 1..1 | string | AZT + 3TC + RAL | |
![]() ![]() | 1..1 | string | TAF + 3TC + DTG | |
![]() ![]() | 1..1 | string | TAF + FTC + DTG | |
![]() ![]() | 1..1 | string | TDF + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + DRV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + DTG | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV 400 mg | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV 600 mg | |
![]() ![]() | 1..1 | string | TDF + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + NVP | |
![]() ![]() | 1..1 | string | TDF + 3TC + PI/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + RAL | |
![]() ![]() | 1..1 | string | TDF + FTC + ATV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + DRV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + DTG | |
![]() ![]() | 1..1 | string | TDF + FTC + EFV | |
![]() ![]() | 1..1 | string | TDF + FTC + EFV 600 mg | |
![]() ![]() | 1..1 | string | TDF + FTC + LPV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + NVP | |
![]() ![]() | 1..1 | string | TDF + FTC + PI/r | |
![]() ![]() | 1..1 | string | TDF + FTC + RAL | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | ART regimen composition | |
![]() ![]() | 1..1 | string | ABC | |
![]() ![]() | 1..1 | string | FTC | |
![]() ![]() | 1..1 | string | 3TC | |
![]() ![]() | 1..1 | string | AZT | |
![]() ![]() | 1..1 | string | DDI | |
![]() ![]() | 1..1 | string | D4T | |
![]() ![]() | 1..1 | string | TDF | |
![]() ![]() | 1..1 | string | EFV | |
![]() ![]() | 1..1 | string | ETV | |
![]() ![]() | 1..1 | string | NVP | |
![]() ![]() | 1..1 | string | RIL | |
![]() ![]() | 1..1 | string | ATV/r | |
![]() ![]() | 1..1 | string | LPV/r | |
![]() ![]() | 1..1 | string | DRV/r | |
![]() ![]() | 1..1 | string | RTV | |
![]() ![]() | 1..1 | string | DTG | |
![]() ![]() | 1..1 | string | RAL | |
![]() ![]() | 1..1 | string | ART regimen drug class | |
![]() ![]() | 1..1 | string | NRTI | |
![]() ![]() | 1..1 | string | NtRTI | |
![]() ![]() | 1..1 | string | NNRTI | |
![]() ![]() | 1..1 | string | PI | |
![]() ![]() | 1..1 | string | INSTI | |
![]() ![]() | 1..1 | string | Prevention services offered and referrals | |
![]() ![]() | 1..1 | string | Offer male and female condoms and condom-compatible lubricants | |
![]() ![]() | 1..1 | string | Harm reduction for people who inject drugs | |
![]() ![]() | 1..1 | string | Behavioural interventions to support risk reduction | |
![]() ![]() | 1..1 | string | Sexual and reproductive health integrated services | |
![]() ![]() | 1..1 | string | Contraception and family planning | |
![]() ![]() | 1..1 | string | Check pregnancy status | |
![]() ![]() | 1..1 | string | Prevention of mother-to-child transmission | |
![]() ![]() | 1..1 | string | STI testing and treatment | |
![]() ![]() | 1..1 | string | HBsAg test date | |
![]() ![]() | 1..1 | string | HBsAg test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Indeterminate | |
![]() ![]() | 1..1 | string | Date HBV test result returned to client | |
![]() ![]() | 1..1 | string | HBV treatment (TDF) start date | |
![]() ![]() | 1..1 | string | HBV treatment regimen prescribed | |
![]() ![]() | 1..1 | string | HCV test date | |
![]() ![]() | 1..1 | string | HCV test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Indeterminate | |
![]() ![]() | 1..1 | string | Date HCV test result returned to client | |
![]() ![]() | 1..1 | string | HCV treatment start date | |
![]() ![]() | 1..1 | string | HCV treatment completion date | |
![]() ![]() | 1..1 | string | HCV treatment regimen prescribed | |
![]() ![]() | 1..1 | string | HCV viral load test date | |
![]() ![]() | 1..1 | string | HCV viral load test result | |
![]() ![]() | 1..1 | string | Detected | |
![]() ![]() | 1..1 | string | Not detected | |
![]() ![]() | 1..1 | string | HCV medicine type | |
![]() ![]() | 1..1 | string | Interferon | |
![]() ![]() | 1..1 | string | Direct acting antivirals | |
![]() ![]() | 1..1 | string | Currently on TDF-based ART | |
![]() ![]() | 1..1 | string | HIV clinical stage | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 1 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 2 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 3 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 4 | |
![]() ![]() | 1..1 | string | Number of missed doses | |
![]() ![]() | 1..1 | string | Received viral load test result | |
![]() ![]() | 1..1 | string | Date viral load test results received by client | |
![]() ![]() | 1..1 | string | Date of viral load sample collection | |
![]() ![]() | 1..1 | string | Date of scheduled review of viral load test results | |
![]() ![]() | 1..1 | string | Date of ART interruption | |
![]() ![]() | 1..1 | string | Reason(s) for adherence problem | |
![]() ![]() | 1..1 | string | Forgot | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Busy | |
![]() ![]() | 1..1 | string | Change of routine | |
![]() ![]() | 1..1 | string | Travel cost | |
![]() ![]() | 1..1 | string | Distance to clinic | |
![]() ![]() | 1..1 | string | Client lost/ran out of pills | |
![]() ![]() | 1..1 | string | Stock-out | |
![]() ![]() | 1..1 | string | Too ill | |
![]() ![]() | 1..1 | string | Pill burden | |
![]() ![]() | 1..1 | string | Felt well | |
![]() ![]() | 1..1 | string | Depression | |
![]() ![]() | 1..1 | string | Alcohol use | |
![]() ![]() | 1..1 | string | Substance use | |
![]() ![]() | 1..1 | string | Stigma/disclosure concerns | |
![]() ![]() | 1..1 | string | Lack of food | |
![]() ![]() | 1..1 | string | Poor palatability | |
![]() ![]() | 1..1 | string | Other reason for nonadherence | |
![]() ![]() | 1..1 | string | Other reason for nonadherence (specify) | |
![]() ![]() | 1..1 | string | Reason ART stopped | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Severe illness, hospitalization | |
![]() ![]() | 1..1 | string | Drugs out of stock | |
![]() ![]() | 1..1 | string | Client lacks finances | |
![]() ![]() | 1..1 | string | Excluded HIV infection in infant | |
![]() ![]() | 1..1 | string | Other reason for stopping ART | |
![]() ![]() | 1..1 | string | Other reason for stopping ART (specify) | |
![]() ![]() | 1..1 | string | Treatment failure | |
![]() ![]() | 1..1 | string | Clinical failure | |
![]() ![]() | 1..1 | string | Immunological failure | |
![]() ![]() | 1..1 | string | Virological failure | |
![]() ![]() | 1..1 | string | General care activities recommended | |
![]() ![]() | 1..1 | string | Determine WHO clinical stage | |
![]() ![]() | 1..1 | string | Determine if advanced disease | |
![]() ![]() | 1..1 | string | Prepare for ART | |
![]() ![]() | 1..1 | string | Prepare, assess and support adherence | |
![]() ![]() | 1..1 | string | Manage current medications | |
![]() ![]() | 1..1 | string | Check pregnancy status | |
![]() ![]() | 1..1 | string | Provide family planning and contraception | |
![]() ![]() | 1..1 | string | Support disclosure and partner notification | |
![]() ![]() | 1..1 | string | Counsel on risk reduction and prevention | |
![]() ![]() | 1..1 | string | Assess, prevent and manage noncommunicable diseases | |
![]() ![]() | 1..1 | string | Screen for and manage mental health problems | |
![]() ![]() | 1..1 | string | Screen for and manage and substance use issues | |
![]() ![]() | 1..1 | string | Provide psychosocial counselling and support | |
![]() ![]() | 1..1 | string | Manage pain and symptoms | |
![]() ![]() | 1..1 | string | Conduct a nutritional assessment and counsel on nutrition | |
![]() ![]() | 1..1 | string | Conduct a growth and development assessment | |
![]() ![]() | 1..1 | string | Provide support on infant and child feeding | |
![]() ![]() | 1..1 | string | Preventing and treating coinfections | |
![]() ![]() | 1..1 | string | Provide co-trimoxazole preventive therapy (CPT) | |
![]() ![]() | 1..1 | string | Intensified TB case finding and linkage to TB treatment | |
![]() ![]() | 1..1 | string | Provide isoniazid preventive therapy | |
![]() ![]() | 1..1 | string | Screen for cryptococcal infection and fungal prophylaxis | |
![]() ![]() | 1..1 | string | Screen for hepatitis B | |
![]() ![]() | 1..1 | string | Screen for hepatitis C | |
![]() ![]() | 1..1 | string | Prevent malaria | |
![]() ![]() | 1..1 | string | Screen for STIs | |
![]() ![]() | 1..1 | string | Prevent and screen for cervical cancer | |
![]() ![]() | 1..1 | string | Anal cancer screening (for men who have sex with men) | |
![]() ![]() | 1..1 | string | Assessment and provision of vaccinations | |
![]() ![]() | 1..1 | string | Risk factors, comorbidities and coinfections signs and symptoms | |
![]() ![]() | 1..1 | string | Oral candidiasis | |
![]() ![]() | 1..1 | string | Vaginal candidiasis | |
![]() ![]() | 1..1 | string | Cough | |
![]() ![]() | 1..1 | string | Prolonged fever | |
![]() ![]() | 1..1 | string | Night sweats | |
![]() ![]() | 1..1 | string | Weight loss | |
![]() ![]() | 1..1 | string | Difficulty breathing | |
![]() ![]() | 1..1 | string | Pneumonia | |
![]() ![]() | 1..1 | string | Urethral discharge | |
![]() ![]() | 1..1 | string | Syphilis | |
![]() ![]() | 1..1 | string | Pelvic inflammatory disease | |
![]() ![]() | 1..1 | string | Ulcers - skin | |
![]() ![]() | 1..1 | string | Ulcers - mouth or other | |
![]() ![]() | 1..1 | string | Ulcers - male genital | |
![]() ![]() | 1..1 | string | Vaginal discharge | |
![]() ![]() | 1..1 | string | Malaria | |
![]() ![]() | 1..1 | string | Chronic obstructive pulmonary disease | |
![]() ![]() | 1..1 | string | Hypertension | |
![]() ![]() | 1..1 | string | Diabetes | |
![]() ![]() | 1..1 | string | Gestational diabetes | |
![]() ![]() | 1..1 | string | Mental health disorders | |
![]() ![]() | 1..1 | string | Diarrhoea or abdominal pain | |
![]() ![]() | 1..1 | string | Presumptive TB | |
![]() ![]() | 1..1 | string | Severe or complicated malnutrition | |
![]() ![]() | 1..1 | string | Poor growth or development | |
![]() ![]() | 1..1 | string | Oedema | |
![]() ![]() | 1..1 | string | Previously treated for TB | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage condition or symptom | |
![]() ![]() | 1..1 | string | Asymptomatic | |
![]() ![]() | 1..1 | string | Persistent generalized lymphadenopathy | |
![]() ![]() | 1..1 | string | Moderate unexplained weight loss | |
![]() ![]() | 1..1 | string | Recurrent respiratory tract infections | |
![]() ![]() | 1..1 | string | Unexplained persistent hepatosplenomegaly | |
![]() ![]() | 1..1 | string | Herpes zoster | |
![]() ![]() | 1..1 | string | Angular cheilitis | |
![]() ![]() | 1..1 | string | Linear gingival erythema | |
![]() ![]() | 1..1 | string | Recurrent oral ulceration | |
![]() ![]() | 1..1 | string | Papular pruritic eruption | |
![]() ![]() | 1..1 | string | Fungal nail infections | |
![]() ![]() | 1..1 | string | Seborrhoeic dermatitis | |
![]() ![]() | 1..1 | string | Extensive wart virus infection | |
![]() ![]() | 1..1 | string | Extensive molluscum contagiosum | |
![]() ![]() | 1..1 | string | Unexplained persistent parotid enlargement | |
![]() ![]() | 1..1 | string | Unexplained severe weight loss in adults | |
![]() ![]() | 1..1 | string | Unexplained moderate malnutrition not adequately responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained chronic diarrhoea for longer than 1 month | |
![]() ![]() | 1..1 | string | Unexplained persistent diarrhoea (14 days or more) | |
![]() ![]() | 1..1 | string | Unexplained persistent fever (above 37.5 C, intermittent or constant, for longer than one 1 month) | |
![]() ![]() | 1..1 | string | Persistent oral candidiasis | |
![]() ![]() | 1..1 | string | Oral hairy leukoplakia | |
![]() ![]() | 1..1 | string | Pulmonary TB | |
![]() ![]() | 1..1 | string | Lymph node TB | |
![]() ![]() | 1..1 | string | Severe bacterial infections (such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia) | |
![]() ![]() | 1..1 | string | Severe recurrent bacterial pneumonia | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative stomatitis | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative gingivitis | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative periodontitis | |
![]() ![]() | 1..1 | string | Unexplained anaemia (<8 g/dL) | |
![]() ![]() | 1..1 | string | Neutropaenia (<0.5 x 10^9/L) | |
![]() ![]() | 1..1 | string | Chronic thrombocytopaenia (<50 x 10^9/L) | |
![]() ![]() | 1..1 | string | Symptomatic lymphoid interstitial pneumonitis | |
![]() ![]() | 1..1 | string | Chronic HIV-associated lung disease, including bronchiectasis | |
![]() ![]() | 1..1 | string | HIV wasting syndrome | |
![]() ![]() | 1..1 | string | Unexplained severe wasting not responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained stunting not responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained severe malnutrition not responding to standard therapy | |
![]() ![]() | 1..1 | string | Pneumocystis (jirovecii) pneumonia | |
![]() ![]() | 1..1 | string | Recurrent severe bacterial pneumonia | |
![]() ![]() | 1..1 | string | Recurrent severe bacterial infections (such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia) | |
![]() ![]() | 1..1 | string | Empyema | |
![]() ![]() | 1..1 | string | Pyomyositis | |
![]() ![]() | 1..1 | string | Bone or joint infection | |
![]() ![]() | 1..1 | string | Meningitis | |
![]() ![]() | 1..1 | string | Chronic herpes simplex infection (orolabial or cutaneous of more than 1 month duration or visceral at any site) | |
![]() ![]() | 1..1 | string | Chronic herpes simplex infection (orolabial, genital or anorectal of more than 1 month in duration or visceral at any site) | |
![]() ![]() | 1..1 | string | Oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs) | |
![]() ![]() | 1..1 | string | Extrapulmonary TB | |
![]() ![]() | 1..1 | string | Kaposi sarcoma | |
![]() ![]() | 1..1 | string | Cytomegalovirus infection (retinitis or infection of other organs) | |
![]() ![]() | 1..1 | string | Central nervous system toxoplasmosis | |
![]() ![]() | 1..1 | string | HIV encephalopathy | |
![]() ![]() | 1..1 | string | Extrapulmonary cryptococcosis, including meningitis | |
![]() ![]() | 1..1 | string | Disseminated nontuberculous mycobacterial infection | |
![]() ![]() | 1..1 | string | Progressive multifocal leukoencephalopathy | |
![]() ![]() | 1..1 | string | Chronic cryptosporidiosis | |
![]() ![]() | 1..1 | string | Chronic cryptosporidiosis (with diarrhoea) | |
![]() ![]() | 1..1 | string | Chronic isosporiasis | |
![]() ![]() | 1..1 | string | Disseminated mycosis (extrapulmonary histoplasmosis, coccidioidomycosis) | |
![]() ![]() | 1..1 | string | Disseminated endemic mycosis (extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis) | |
![]() ![]() | 1..1 | string | Cerebral lymphoma | |
![]() ![]() | 1..1 | string | B-cell non-Hodgkin lymphoma | |
![]() ![]() | 1..1 | string | HIV-associated nephropathy or cardiomyopathy | |
![]() ![]() | 1..1 | string | Recurrent septicaemia (including nontyphoidal Salmonella) | |
![]() ![]() | 1..1 | string | Invasive cervical carcinoma | |
![]() ![]() | 1..1 | string | Atypical disseminated leishmaniasis | |
![]() ![]() | 1..1 | string | Neutropenia | |
![]() ![]() | 1..1 | string | Clinical stage at start of ART | |
![]() ![]() | 1..1 | string | WHO clinical stage 1 | |
![]() ![]() | 1..1 | string | WHO clinical stage 2 | |
![]() ![]() | 1..1 | string | WHO clinical stage 3 | |
![]() ![]() | 1..1 | string | WHO clinical stage 4 | |
![]() ![]() | 1..1 | string | Date of clinical status change | |
![]() ![]() | 1..1 | string | CD4 count | |
![]() ![]() | 1..1 | string | CD4 cell percentage | |
![]() ![]() | 1..1 | string | Date of CD4 count test | |
![]() ![]() | 1..1 | string | Baseline CD4 count | |
![]() ![]() | 1..1 | string | Date of baseline CD4 count test | |
![]() ![]() | 1..1 | string | Late ART initiation | |
![]() ![]() | 1..1 | string | Reasons for delayed ART initiation | |
![]() ![]() | 1..1 | string | Patient self-reported as not ready/willing | |
![]() ![]() | 1..1 | string | Not completed education, support and preparation for ART | |
![]() ![]() | 1..1 | string | Fear of disclosure | |
![]() ![]() | 1..1 | string | Patient lacks finances | |
![]() ![]() | 1..1 | string | Initiated on TB treatment | |
![]() ![]() | 1..1 | string | Patient initiated on treatment for TB meningitis | |
![]() ![]() | 1..1 | string | Patient diagnosed with cryptococcal meningitis | |
![]() ![]() | 1..1 | string | Patient diagnosed with histoplasmosis | |
![]() ![]() | 1..1 | string | Patient critically/severely ill | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | ART initiated within 7 days of diagnosis | |
![]() ![]() | 1..1 | string | Time to start ART | |
![]() ![]() | 1..1 | string | Within 7 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Within 30 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Within 90 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Viral load test result | |
![]() ![]() | 1..1 | string | Virally suppressed | |
![]() ![]() | 1..1 | string | Date viral load test results received | |
![]() ![]() | 1..1 | string | Viral load suppression date | |
![]() ![]() | 1..1 | string | Reason for HIV viral load test | |
![]() ![]() | 1..1 | string | Routine viral load test | |
![]() ![]() | 1..1 | string | Targeted viral load monitoring | |
![]() ![]() | 1..1 | string | Initial viral load test | |
![]() ![]() | 1..1 | string | Follow-up viral load test after receiving enhanced adherence counselling | |
![]() ![]() | 1..1 | string | Hepatitis B test required | |
![]() ![]() | 1..1 | string | Hepatitis C test recommended | |
![]() ![]() | 1..1 | string | Syphilis test required | |
![]() ![]() | 1..1 | string | Monitoring examinations | |
![]() ![]() | 1..1 | string | Haemoglobin (Hb) | |
![]() ![]() | 1..1 | string | Pregnancy test | |
![]() ![]() | 1..1 | string | Syphilis test | |
![]() ![]() | 1..1 | string | Chest X-ray (CXR) | |
![]() ![]() | 1..1 | string | Sputum or culture for TB | |
![]() ![]() | 1..1 | string | HBsAg test (HBV) | |
![]() ![]() | 1..1 | string | HIV viral load test ordered | |
![]() ![]() | 1..1 | string | HIV viral load test scheduled | |
![]() ![]() | 1..1 | string | CD4 count ordered | |
![]() ![]() | 1..1 | string | CD4 count test scheduled | |
![]() ![]() | 1..1 | string | Cryptococcal antigen test | |
![]() ![]() | 1..1 | string | Histoplasmosis antigen test | |
![]() ![]() | 1..1 | string | Cervical cancer screening scheduled | |
![]() ![]() | 1..1 | string | Date of scheduled monitoring examination | |
![]() ![]() | 1..1 | string | Hepatitis C test ordered | |
![]() ![]() | 1..1 | string | Syphilis test ordered | |
![]() ![]() | 1..1 | string | Received viral load test results | |
![]() ![]() | 1..1 | string | Date viral load test results received by client | |
![]() ![]() | 1..1 | string | Reason for ARV drug regimen substitution | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Drug-drug interaction | |
![]() ![]() | 1..1 | string | Pregnancy | |
![]() ![]() | 1..1 | string | New TB | |
![]() ![]() | 1..1 | string | New drug available | |
![]() ![]() | 1..1 | string | Drug out of stock | |
![]() ![]() | 1..1 | string | Other reason for regimen substitution | |
![]() ![]() | 1..1 | string | Other reason for regimen substitution (specify) | |
![]() ![]() | 1..1 | string | Switch to second-line ART regimen recommended | |
![]() ![]() | 1..1 | string | Switch to third-line ART regimen recommended | |
![]() ![]() | 1..1 | string | Regimen switch made | |
![]() ![]() | 1..1 | string | Reason for regimen switch | |
![]() ![]() | 1..1 | string | Clinical treatment failure | |
![]() ![]() | 1..1 | string | Immunological failure | |
![]() ![]() | 1..1 | string | Virological failure | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Regimen substitution recommended | |
![]() ![]() | 1..1 | string | Dose adjustment recommended | |
![]() ![]() | 1..1 | string | Regimen substitution made | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis start date | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis completion date | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis dosage | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis number of days prescribed | |
![]() ![]() | 1..1 | string | Suspicion of treatment failure or interruption | |
![]() ![]() | 1..1 | string | ART regimen prescribed | |
![]() ![]() | 1..1 | string | Antiretroviral toxicity | |
![]() ![]() | 1..1 | string | Coinfection status at ART start | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Hepatitis C | |
![]() ![]() | 1..1 | string | Pregnant and breastfeeding status at ART start | |
![]() ![]() | 1..1 | string | Pregnant at ART start | |
![]() ![]() | 1..1 | string | Postpartum at ART start | |
![]() ![]() | 1..1 | string | ART start at labour and delivery | |
![]() ![]() | 1..1 | string | Breastfeeding at ART start | |
![]() ![]() | 1..1 | string | Delivery date of infant | |
![]() ![]() | 1..1 | string | Serodiscordant partner at ART start | |
![]() ![]() | 1..1 | string | Regimen start date | |
![]() ![]() | 1..1 | string | Medications prescribed | |
![]() ![]() | 1..1 | string | Date medications prescribed | |
![]() ![]() | 1..1 | string | Dose of medications prescribed | |
![]() ![]() | 1..1 | string | Number of days medications prescribed | |
![]() ![]() | 1..1 | string | Medications dispensed | |
![]() ![]() | 1..1 | string | Number of days of medications dispensed | |
![]() ![]() | 1..1 | string | Dosage | |
![]() ![]() | 1..1 | string | Frequency | |
![]() ![]() | 1..1 | string | Adherence counselling provided | |
![]() ![]() | 1..1 | string | Type of treatment-limiting toxicity | |
![]() ![]() | 1..1 | string | Gastrointestinal | |
![]() ![]() | 1..1 | string | Skin issues | |
![]() ![]() | 1..1 | string | Peripheral neuropathy | |
![]() ![]() | 1..1 | string | Central nervous system symptoms | |
![]() ![]() | 1..1 | string | Weight gain | |
![]() ![]() | 1..1 | string | Hepatic dysfunction | |
![]() ![]() | 1..1 | string | Haematological disorders | |
![]() ![]() | 1..1 | string | Fatigue | |
![]() ![]() | 1..1 | string | Headache | |
![]() ![]() | 1..1 | string | Bone dysfunction | |
![]() ![]() | 1..1 | string | Metabolic symptoms | |
![]() ![]() | 1..1 | string | Kidney dysfunction | |
![]() ![]() | 1..1 | string | Unexpected adverse drug reaction | |
![]() ![]() | 1..1 | string | Unexpected adverse drug reaction (specify) | |
![]() ![]() | 1..1 | string | Date(s) of substitution within first-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within first-line regimen | |
![]() ![]() | 1..1 | string | New antiretroviral regimen after substitution within first-line regimen | |
![]() ![]() | 1..1 | string | Date of switch to second-line regimen | |
![]() ![]() | 1..1 | string | New regimen after switch to second-line regimen | |
![]() ![]() | 1..1 | string | Reason for switch to second-line regimen | |
![]() ![]() | 1..1 | string | Date(s) of substitution within second-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within second-line regimen | |
![]() ![]() | 1..1 | string | New regimen(s) after substitution within second-line regimen | |
![]() ![]() | 1..1 | string | Date of switch to third-line regimen | |
![]() ![]() | 1..1 | string | New regimen after switch to third-line regimen | |
![]() ![]() | 1..1 | string | Reason for switch to third-line regimen | |
![]() ![]() | 1..1 | string | Date(s) of substitution within third-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within third-line regimen | |
![]() ![]() | 1..1 | string | New regimen(s) after substitution within third-line regimen | |
![]() ![]() | 1..1 | string | Enhanced adherence counselling provided | |
![]() ![]() | 1..1 | string | First enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of first enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Second enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of second enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Third enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of third enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Name of treatment supporter | |
![]() ![]() | 1..1 | string | Address of treatment supporter | |
![]() ![]() | 1..1 | string | Telephone number of treatment supporter | |
![]() ![]() | 1..1 | string | Home-based care provider | |
![]() ![]() | 1..1 | string | Counselling provided on diagnoses | |
![]() ![]() | 1..1 | string | Hepatitis B positive counselling conducted | |
![]() ![]() | 1..1 | string | Hepatitis C positive counselling conducted | |
![]() ![]() | 1..1 | string | Syphilis counselling and treatment | |
![]() ![]() | 1..1 | string | Syphilis counselling, treatment and further testing | |
![]() ![]() | 1..1 | string | Accepted partner services | |
![]() ![]() | 1..1 | string | HIV testing for partners and biological children | |
![]() ![]() | 1..1 | string | HIV status of family member | |
![]() ![]() | 1..1 | string | Unique ID of family member | |
![]() ![]() | 1..1 | string | Date of death of family member | |
![]() ![]() | 1..1 | string | Offered voluntary partner services | |
![]() ![]() | 1..1 | string | Provided support for disclosure and partner services | |
![]() ![]() | 1..1 | string | Other support services | |
![]() ![]() | 1..1 | string | Mental health services | |
![]() ![]() | 1..1 | string | Psychosocial counselling, support and treatment adherence counselling | |
![]() ![]() | 1..1 | string | Legal and social services | |
![]() ![]() | 1..1 | string | Services for responding to violence against women | |
![]() ![]() | 1..1 | string | Date/time of follow-up appointment | |
![]() ![]() | 1..1 | string | Type of follow-up appointment | |
![]() ![]() | 1..1 | string | Clinical visit | |
![]() ![]() | 1..1 | string | Antiretroviral drug pick up | |
![]() ![]() | 1..1 | string | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Follow-up test recommended date | |
![]() ![]() | 1..1 | string | Reason blood pressure reading not done | |
![]() ![]() | 1..1 | string | BP cuff (sphygmomanometer) not available | |
![]() ![]() | 1..1 | string | BP cuff (sphygmomanometer) is broken | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Current medications | |
![]() ![]() | 1..1 | string | No medications | |
![]() ![]() | 1..1 | string | Dont know of any current medications | |
![]() ![]() | 1..1 | string | Analgesic | |
![]() ![]() | 1..1 | string | Antacids | |
![]() ![]() | 1..1 | string | Antibiotics (broad-spectrum) | |
![]() ![]() | 1..1 | string | Anticonvulsive | |
![]() ![]() | 1..1 | string | Antidiabetic | |
![]() ![]() | 1..1 | string | Antifungals | |
![]() ![]() | 1..1 | string | Antihelmintic | |
![]() ![]() | 1..1 | string | Antihypertensive | |
![]() ![]() | 1..1 | string | Antimalarials | |
![]() ![]() | 1..1 | string | Antiretrovirals (ARVs) | |
![]() ![]() | 1..1 | string | Antiparasitics | |
![]() ![]() | 1..1 | string | Antivirals | |
![]() ![]() | 1..1 | string | Buprenorphine | |
![]() ![]() | 1..1 | string | Co-trimoxazole preventive therapy (CPT) | |
![]() ![]() | 1..1 | string | Hormonal family planning method | |
![]() ![]() | 1..1 | string | Methadone | |
![]() ![]() | 1..1 | string | PrEP to prevent HIV | |
![]() ![]() | 1..1 | string | Other antibiotics | |
![]() ![]() | 1..1 | string | Other medications | |
![]() ![]() | 1..1 | string | Other medications (specify) | |
![]() ![]() | 1..1 | string | Allergies | |
![]() ![]() | 1..1 | string | No known allergies | |
![]() ![]() | 1..1 | string | Dont know of any allergies | |
![]() ![]() | 1..1 | string | Albendazole | |
![]() ![]() | 1..1 | string | Malaria medication (sulfadoxine-pyrimethamine) | |
![]() ![]() | 1..1 | string | Penicillin | |
![]() ![]() | 1..1 | string | Tenofovir disoproxil fumarate (TDF) | |
![]() ![]() | 1..1 | string | Other allergies | |
![]() ![]() | 1..1 | string | Other allergies (specify) | |
![]() ![]() | 1..1 | string | Family planning method used | |
![]() ![]() | 1..1 | string | Copper-bearing intrauterine device (Cu-IUD) | |
![]() ![]() | 1..1 | string | Levonorgestrel intrauterine device (LNG-IUD) | |
![]() ![]() | 1..1 | string | Etonogestrel (ETG) one-rod implant | |
![]() ![]() | 1..1 | string | Levonorgestrel (LNG) two-rod implant | |
![]() ![]() | 1..1 | string | DMPA-IM | |
![]() ![]() | 1..1 | string | DMPA-SC | |
![]() ![]() | 1..1 | string | NET-EN norethisterone enanthate | |
![]() ![]() | 1..1 | string | Progestogen-only pills (POP) | |
![]() ![]() | 1..1 | string | Combined oral contraceptives (COCs) | |
![]() ![]() | 1..1 | string | Combined contraceptive patch | |
![]() ![]() | 1..1 | string | Combined contraceptive vaginal ring (CVR) | |
![]() ![]() | 1..1 | string | Progesterone-releasing vaginal ring (PVR) | |
![]() ![]() | 1..1 | string | Lactational amenorrhea method (LAM) | |
![]() ![]() | 1..1 | string | Emergency contraceptive pills (ECPs) | |
![]() ![]() | 1..1 | string | Fertility awareness-based methods (FAB) | |
![]() ![]() | 1..1 | string | Male condoms | |
![]() ![]() | 1..1 | string | Female condoms | |
![]() ![]() | 1..1 | string | Withdrawal | |
![]() ![]() | 1..1 | string | Female relying on male method | |
![]() ![]() | 1..1 | string | Male relying on female method | |
![]() ![]() | 1..1 | string | Male sterilization | |
![]() ![]() | 1..1 | string | Female sterilization | |
![]() ![]() | 1..1 | string | No method | |
![]() ![]() | 1..1 | string | Medication status | |
![]() ![]() | 1..1 | string | Currently taking | |
![]() ![]() | 1..1 | string | Completed | |
![]() ![]() | 1..1 | string | Entered in error | |
![]() ![]() | 1..1 | string | Intended | |
![]() ![]() | 1..1 | string | Stopped | |
![]() ![]() | 1..1 | string | On hold | |
![]() ![]() | 1..1 | string | Unknown | |
![]() ![]() | 1..1 | string | Did not take | |
![]() ![]() | 1..1 | string | Hepatitis B negative counselling conducted | |
![]() ![]() | 1..1 | string | Vaccine brand | |
![]() ![]() | 1..1 | string | Vaccine type | |
![]() ![]() | 1..1 | string | Date and time of vaccination | |
![]() ![]() | 1..1 | string | Vaccination location | |
![]() ![]() | 1..1 | string | Dose number | |
![]() ![]() | 1..1 | string | Dose quantity | |
![]() ![]() | 1..1 | string | Total doses in series | |
![]() ![]() | 1..1 | string | Disease targeted | |
![]() ![]() | 1..1 | string | Hepatitis A | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Tetanus | |
![]() ![]() | 1..1 | string | COVID-19 | |
![]() ![]() | 1..1 | string | Influenza due to influenza B virus | |
![]() ![]() | 1..1 | string | Tuberculosis | |
![]() ![]() | 1..1 | string | Acute poliomyelitis | |
![]() ![]() | 1..1 | string | Measles | |
![]() ![]() | 1..1 | string | Diptheria | |
![]() ![]() | 1..1 | string | Rabies | |
![]() ![]() | 1..1 | string | Cholera | |
![]() ![]() | 1..1 | string | Mumps | |
![]() ![]() | 1..1 | string | HPV infection | |
![]() ![]() | 1..1 | string | Haemophilus influenzae type B | |
![]() ![]() | 1..1 | string | Varicella | |
![]() ![]() | 1..1 | string | Dengue | |
![]() ![]() | 1..1 | string | Yellow fever | |
![]() ![]() | 1..1 | string | Japanese Encephalitis | |
![]() ![]() | 1..1 | string | Rubella | |
![]() ![]() | 1..1 | string | Pertussis | |
![]() ![]() | 1..1 | string | Enteritis due to rotavirus | |
![]() ![]() | 1..1 | string | Pneumococcal disease | |
![]() ![]() | 1..1 | string | Meningococcal disease | |
![]() ![]() | 1..1 | string | Tick-borne encephalitis | |
![]() ![]() | 1..1 | string | Typhoid | |
![]() ![]() | 1..1 | string | Reason immunization was not provided | |
![]() ![]() | 1..1 | string | Stock-out | |
![]() ![]() | 1..1 | string | Client is ill | |
![]() ![]() | 1..1 | string | Client refused | |
![]() ![]() | 1..1 | string | Allergy to vaccine | |
![]() ![]() | 1..1 | string | Other reason immunization not provided | |
![]() ![]() | 1..1 | string | Other reason immunization not provided (specify) | |
![]() ![]() | 1..1 | string | Malaria prophylaxis | |
![]() ![]() | 1..1 | string | IPTp-SP dose number provided | |
![]() ![]() | 1..1 | string | Date IPTp-SP dose provided | |
![]() ![]() | 1..1 | string | Reason malaria prophylaxis not provided | |
![]() ![]() | 1..1 | string | Client was referred | |
![]() ![]() | 1..1 | string | Stock out | |
![]() ![]() | 1..1 | string | Expired | |
![]() ![]() | 1..1 | string | Other reason not provided | |
![]() ![]() | 1..1 | string | Other reason not provided (specify) | |
![]() ![]() | 1..1 | string | >28 days since last missed appointment | |
![]() ![]() | 1..1 | string | AIDS-related death | |
![]() ![]() | 1..1 | string | Date of first AIDS diagnosis | |
![]() ![]() | 1..1 | string | Age at final HPV vaccination dose received | |
![]() ![]() | 1..1 | string | Date of cervical cancer screening test | |
![]() ![]() | 1..1 | string | Lifetime screening test number | |
![]() ![]() | 1..1 | string | Cervical cancer primary screening test type | |
![]() ![]() | 1..1 | string | HPV-DNA | |
![]() ![]() | 1..1 | string | VIA | |
![]() ![]() | 1..1 | string | Cervical cytology | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | HPV-DNA cervical cancer screening test result | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Invalid | |
![]() ![]() | 1..1 | string | VIA cervical cancer screening test result | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Suspected cancer | |
![]() ![]() | 1..1 | string | Invalid | |
![]() ![]() | 1..1 | string | Cervical cytology screening test result | |
![]() ![]() | 1..1 | string | NILM | |
![]() ![]() | 1..1 | string | ASCUS | |
![]() ![]() | 1..1 | string | LSIL | |
![]() ![]() | 1..1 | string | HSIL | |
![]() ![]() | 1..1 | string | Cancer | |
![]() ![]() | 1..1 | string | Invalid/inadequate | |
![]() ![]() | 1..1 | string | Cervical cancer triage test date | |
![]() ![]() | 1..1 | string | Cervical cancer triage test type | |
![]() ![]() | 1..1 | string | VIA | |
![]() ![]() | 1..1 | string | Colposcopy | |
![]() ![]() | 1..1 | string | Cervical cytology | |
![]() ![]() | 1..1 | string | HPV16/18 | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | HPV16/18 test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Cervical cancer colposcopy result | |
![]() ![]() | 1..1 | string | Normal colposcopic findings | |
![]() ![]() | 1..1 | string | Abnormal colposcopic findings | |
![]() ![]() | 1..1 | string | Suspicious for invasive cervical cancer | |
![]() ![]() | 1..1 | string | Miscellaneous findings | |
![]() ![]() | 1..1 | string | Inadequate | |
![]() ![]() | 1..1 | string | Cervical cancer histopathology result | |
![]() ![]() | 1..1 | string | Normal | |
![]() ![]() | 1..1 | string | LSIL (inclusive of LSIL-CIN1) | |
![]() ![]() | 1..1 | string | HSIL (inclusive of HSIL-CIN2 or HSIL-CIN3) | |
![]() ![]() | 1..1 | string | Invasive cervical cancer | |
![]() ![]() | 1..1 | string | Date of additional cervical cancer triage test | |
![]() ![]() | 1..1 | string | Additional cervical cancer triage test type (specify) | |
![]() ![]() | 1..1 | string | Additional cervical cancer triage test result (specify) | |
![]() ![]() | 1..1 | string | Date of diagnosis of cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Cervical cancer screening outcome | |
![]() ![]() | 1..1 | string | Positive for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Negative for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Cervical cancer diagnosis | |
![]() ![]() | 1..1 | string | Cervical precancer lesions | |
![]() ![]() | 1..1 | string | Invasive cervical cancer | |
![]() ![]() | 1..1 | string | Cervical cancer stage at diagnosis | |
![]() ![]() | 1..1 | string | Stage 0 | |
![]() ![]() | 1..1 | string | Stage I | |
![]() ![]() | 1..1 | string | Stage II | |
![]() ![]() | 1..1 | string | Stage III | |
![]() ![]() | 1..1 | string | Stage IV | |
![]() ![]() | 1..1 | string | Date of treatment for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Treatment method for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Cryotherapy | |
![]() ![]() | 1..1 | string | Thermal ablation | |
![]() ![]() | 1..1 | string | Laser ablation | |
![]() ![]() | 1..1 | string | CKC | |
![]() ![]() | 1..1 | string | Laser cone biopsy | |
![]() ![]() | 1..1 | string | LLETZ/LEEP | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Date of follow-up for treatment for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Date of start of invasive cancer treatment | |
![]() ![]() | 1..1 | string | Invasive cervical cancer treatment episode | |
![]() ![]() | 1..1 | string | Invasive cervical cancer treatment method | |
![]() ![]() | 1..1 | string | Conization | |
![]() ![]() | 1..1 | string | Trachelectomy | |
![]() ![]() | 1..1 | string | Hysterectomy | |
![]() ![]() | 1..1 | string | Management of invasive cervical cancer | |
![]() ![]() | 1..1 | string | Radiotherapy | |
![]() ![]() | 1..1 | string | Chemotherapy | |
![]() ![]() | 1..1 | string | Chemoradiation | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Treatment outcome | |
![]() ![]() | 1..1 | string | Secondary/other cancers diagnosed | |
![]() ![]() | 1..1 | string | Cancers at other sites (HPV- and non-HPV related) | |
![]() ![]() | 1..1 | string | Date of death | |
![]() ![]() | 1..1 | string | Cervical cancer screening interval amongst WLHIV | |
![]() ![]() | 1..1 | string | Entry point for facility-level testing | |
![]() ![]() | 1..1 | string | Provider-initiated tested in a clinic or emergency facility | |
![]() ![]() | 1..1 | string | Antenatal care clinic | |
![]() ![]() | 1..1 | string | Voluntary counselling and testing (within a health facility setting) | |
![]() ![]() | 1..1 | string | Family planning clinic | |
![]() ![]() | 1..1 | string | Other facility-level testing | |
![]() ![]() | 1..1 | string | Tuberculosis (TB) clinic | |
![]() ![]() | 1..1 | string | Offer other clinical services | |
![]() ![]() | 1..1 | string | Assessment and provision of vaccinations | |
![]() ![]() | 1..1 | string | Hepatitis B (HBV) and hepatitis C virus (HCV) testing and treatment | |
![]() ![]() | 1..1 | string | Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia | |
![]() ![]() | 1..1 | string | Intensified TB case finding and linkage to TB treatment | |
![]() ![]() | 1..1 | string | Provision of isoniazid preventive therapy if person does not have TB | |
![]() ![]() | 1..1 | string | Malaria prevention (such as bed nets and prophylaxis), depending on epidemiology | |
![]() ![]() | 1..1 | string | Eligible for DSD ART | |
![]() ![]() | 1..1 | string | Date DSD ART eligibility assessed | |
![]() ![]() | 1..1 | string | Currently enrolled in DSD ART model | |
![]() ![]() | 1..1 | string | DSD ART start date | |
![]() ![]() | 1..1 | string | DSD ART model(s) | |
![]() ![]() | 1..1 | string | Fast track ART refill | |
![]() ![]() | 1..1 | string | Facility adherence club | |
![]() ![]() | 1..1 | string | Community ART distribution point | |
![]() ![]() | 1..1 | string | CHW/peer educator community ART group | |
![]() ![]() | 1..1 | string | Patient/client community ART group | |
![]() ![]() | 1..1 | string | Other DSD ART model | |
![]() ![]() | 1..1 | string | Other DSD ART model (specify) | |
![]() ![]() | 1..1 | string | Partner testing offered | |
![]() ![]() | 1..1 | string | Partner testing accepted | |
![]() ![]() | 1..1 | string | Date partner contacted for index testing | |
![]() ![]() | 1..1 | string | Date partner tested for HIV | |
![]() ![]() | 1..1 | string | Date of next scheduled follow-up appointment | |
![]() ![]() | 1..1 | string | Type of next follow-up appointment | |
![]() ![]() | 1..1 | string | Syndrome/STI diagnosed | |
![]() ![]() | 1..1 | string | Urethral discharge syndrome | |
![]() ![]() | 1..1 | string | Vaginal discharge syndrome | |
![]() ![]() | 1..1 | string | Lower Abdominal pain | |
![]() ![]() | 1..1 | string | Genital ulcer disease syndrome | |
![]() ![]() | 1..1 | string | Anorectal discharge | |
![]() ![]() | 1..1 | string | Sent for testing | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Any STI syndrome diagnosed | |
![]() ![]() | 1..1 | string | Date of STI test | |
![]() ![]() | 1..1 | string | STI tested for | |
![]() ![]() | 1..1 | string | Neisseria gonorrhoeae | |
![]() ![]() | 1..1 | string | Chlamydia trachomatis | |
![]() ![]() | 1..1 | string | Trichomonas vaginalis | |
![]() ![]() | 1..1 | string | Syphilis (Treponema pallidum) | |
![]() ![]() | 1..1 | string | Herpes simplex virus (HSV1, HSV2) | |
![]() ![]() | 1..1 | string | Mycoplasma genitalium | |
![]() ![]() | 1..1 | string | Mpox | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Hepatitis C | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Syphilis test date | |
![]() ![]() | 1..1 | string | Syphilis test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Syphilis treatment start date | |
![]() ![]() | 1..1 | string | Gonorrhoea test date | |
![]() ![]() | 1..1 | string | Gonorrhoea test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Gonorrhoea treatment start date | |
![]() ![]() | 1..1 | string | Type of specimen | |
![]() ![]() | 1..1 | string | Blood | |
![]() ![]() | 1..1 | string | Urine | |
![]() ![]() | 1..1 | string | Cervical or vaginal swab | |
![]() ![]() | 1..1 | string | Urethral or penile swab | |
![]() ![]() | 1..1 | string | Rectal swab | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other type of specimen (specify) | |
![]() ![]() | 1..1 | string | Syphilis test type | |
![]() ![]() | 1..1 | string | Treponemal | |
![]() ![]() | 1..1 | string | Non-treponemal | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other syphilis test type (specify) | |
![]() ![]() | 1..1 | string | Neisseria gonorrhoeae test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | POC Test for Neisseria gonorrhoeae (specify) | |
![]() ![]() | 1..1 | string | Chlamydia trachomatis test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | ELISA | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other test for Chlamydia (specify) | |
![]() ![]() | 1..1 | string | POC Test type for Chlamydia test (specify) | |
![]() ![]() | 1..1 | string | Trichomonas vaginalis test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | POC Test type for Trichomonas vaginalis test (specify) | |
![]() ![]() | 1..1 | string | Herpes simplex virus (HSV) test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Antibody test | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Mycoplasma genitalium test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Test type for other STI tested for (specify) | |
![]() ![]() | 1..1 | string | STI test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Date of STI confirmatory test | |
![]() ![]() | 1..1 | string | Confirmatory syphilis test type | |
![]() ![]() | 1..1 | string | Treponemal | |
![]() ![]() | 1..1 | string | Non-treponemal | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Confirmatory test type for other STI (specify) | |
![]() ![]() | 1..1 | string | Confirmatory STI test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Date STI treatment prescribed | |
![]() ![]() | 1..1 | string | Date STI treatment dispensed | |
![]() ![]() | 1..1 | string | STI treatment dispensed (specify) | |
![]() ![]() | 1..1 | string | Mid-upper arm circumference (MUAC) | |
![]() ![]() | 1..1 | string | Date of start of fluconazole prophylaxis | |
![]() ![]() | 1..1 | string | Fluconazole prophylaxis | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment induction regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment induction regimen | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment maintenance regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment maintenance regimen | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment consolidation regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment consolidation regimen | |
![]() ![]() | 1..1 | string | Staging of liver disease | |
![]() ![]() | 1..1 | string | F0-4, fibrosis staging | |
![]() ![]() | 1..1 | string | F4 or cirrhosis, presence of cirrhosis | |
![]() ![]() | 1..1 | string | Advanced HIV disease | |
![]() ![]() | 1..1 | string | WHO functional status | |
![]() ![]() | 1..1 | string | Working, able to perform usual work inside and outside the home | |
![]() ![]() | 1..1 | string | Ambulatory, able to perform activity of daily living (ADL), not able to work | |
![]() ![]() | 1..1 | string | Bedridden not able to perform ADL | |
![]() ![]() | 1..1 | string | Tailored adherence counselling for advanced HIV disease | |
![]() ![]() | 1..1 | string | Date(s) of tracing interventions | |
![]() ![]() | 1..1 | string | Medication/drug | |
![]() ![]() | 1..1 | string | Rifampicin | |
![]() ![]() | 1..1 | string | Halofantrine | |
![]() ![]() | 1..1 | string | Lovastatin | |
![]() ![]() | 1..1 | string | Simvastatin | |
![]() ![]() | 1..1 | string | Hormonal contraception | |
![]() ![]() | 1..1 | string | Metformin | |
![]() ![]() | 1..1 | string | Astemizole | |
![]() ![]() | 1..1 | string | Terfenadine | |
![]() ![]() | 1..1 | string | TDF | |
![]() ![]() | 1..1 | string | Simeprevir | |
![]() ![]() | 1..1 | string | Ombitasvir + paritaprevir/ritonavir + dasabuvir | |
![]() ![]() | 1..1 | string | Methadone | |
![]() ![]() | 1..1 | string | Buprenorphine | |
![]() ![]() | 1..1 | string | Dofetilide | |
![]() ![]() | 1..1 | string | Carbamazepine | |
![]() ![]() | 1..1 | string | Phenobarbital | |
![]() ![]() | 1..1 | string | Phenytoin | |
![]() ![]() | 1..1 | string | Polyvalent cation products containing Mg, Al, Fe, Ca and Zn | |
![]() ![]() | 1..1 | string | Amodiaquine | |
![]() ![]() | 1..1 | string | Cisapride | |
![]() ![]() | 1..1 | string | Ergotamine | |
![]() ![]() | 1..1 | string | Dihydroergotamine | |
![]() ![]() | 1..1 | string | Midazolam | |
![]() ![]() | 1..1 | string | Triazolam | |
![]() ![]() | 1..1 | string | Estrogen-based hormonal contraception | |
![]() ![]() | 1..1 | string | Ribavirin | |
![]() ![]() | 1..1 | string | Peginterferon alfa-2a | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Medication change recommended | |
Documentation for this format | ||||
Key Elements View
| Name | Flags | Card. | Type | Description & Constraints![]() |
|---|---|---|---|---|
![]() | 0..* | Base | HIV.D Care-Treatment Logical Model Instances of this logical model are not marked to be the target of a Reference | |
![]() ![]() | 1..1 | string | Reason for visit | |
![]() ![]() | 1..1 | string | First clinical visit | |
![]() ![]() | 1..1 | string | Clinical visit | |
![]() ![]() | 1..1 | string | ART initiation | |
![]() ![]() | 1..1 | string | ART drug pick up | |
![]() ![]() | 1..1 | string | Issues and concerns | |
![]() ![]() | 1..1 | string | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Scheduled visit | |
![]() ![]() | 1..1 | string | Body temperature | |
![]() ![]() | 1..1 | string | Respiratory rate | |
![]() ![]() | 1..1 | string | Heart rate | |
![]() ![]() | 1..1 | string | Body height | |
![]() ![]() | 1..1 | string | Body weight | |
![]() ![]() | 1..1 | string | Systolic blood pressure | |
![]() ![]() | 1..1 | string | Diastolic blood pressure | |
![]() ![]() | 1..1 | string | Blood pressure cannot be taken | |
![]() ![]() | 1..1 | string | Signs of serious illness | |
![]() ![]() | 1..1 | string | Fever of 39 C or greater | |
![]() ![]() | 1..1 | string | Tachycardia | |
![]() ![]() | 1..1 | string | Tachypnea | |
![]() ![]() | 1..1 | string | Unable to walk unaided | |
![]() ![]() | 1..1 | string | Lethargy | |
![]() ![]() | 1..1 | string | Unconsciousness | |
![]() ![]() | 1..1 | string | Convulsions | |
![]() ![]() | 1..1 | string | Unable to drink | |
![]() ![]() | 1..1 | string | Unable to breastfeed | |
![]() ![]() | 1..1 | string | Repeated vomiting | |
![]() ![]() | 1..1 | string | Headache | |
![]() ![]() | 1..1 | string | Other sign of serious illness | |
![]() ![]() | 1..1 | string | Other sign of serious illness (specify) | |
![]() ![]() | 1..1 | string | Currently pregnant | |
![]() ![]() | 1..1 | string | Breastfeeding | |
![]() ![]() | 1..1 | string | Number of pregnancies (gravida) | |
![]() ![]() | 1..1 | string | Number of miscarriages and/or abortions | |
![]() ![]() | 1..1 | string | Number of live births | |
![]() ![]() | 1..1 | string | Parity | |
![]() ![]() | 1..1 | string | Serodiscordant partner | |
![]() ![]() | 1..1 | string | On ART | |
![]() ![]() | 1..1 | string | ART start date | |
![]() ![]() | 1..1 | string | Stopped ART | |
![]() ![]() | 1..1 | string | Date ART stopped | |
![]() ![]() | 1..1 | string | Established on ART | |
![]() ![]() | 1..1 | string | ART start type | |
![]() ![]() | 1..1 | string | First-time user of ART | |
![]() ![]() | 1..1 | string | Restarting ART | |
![]() ![]() | 1..1 | string | Date of initiation on ART | |
![]() ![]() | 1..1 | string | Time on ART | |
![]() ![]() | 1..1 | string | Date(s) ART restarted | |
![]() ![]() | 1..1 | string | ART cohort | |
![]() ![]() | 1..1 | string | Transfer in for HIV care | |
![]() ![]() | 1..1 | string | Date of transfer in | |
![]() ![]() | 1..1 | string | Facility transferred from | |
![]() ![]() | 1..1 | string | Date enrolled in HIV care | |
![]() ![]() | 1..1 | string | Age at enrolment | |
![]() ![]() | 1..1 | string | Facility where client first enrolled in HIV care | |
![]() ![]() | 1..1 | string | Antiretroviral (ARV) drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | No prior ARVs | |
![]() ![]() | 1..1 | string | Received ARVs prior without records/documentation | |
![]() ![]() | 1..1 | string | Received ARVs during pregnancy or breastfeeding | |
![]() ![]() | 1..1 | string | Received ARVs for PEP or PrEP | |
![]() ![]() | 1..1 | string | ARV prophylaxis for an HIV-exposed infant | |
![]() ![]() | 1..1 | string | Date ARV drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | Location ARV drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | ARV drug regimen received prior to enrolment | |
![]() ![]() | 1..1 | string | Existing chronic health conditions | |
![]() ![]() | 1..1 | string | No chronic or past health conditions | |
![]() ![]() | 1..1 | string | Dont know | |
![]() ![]() | 1..1 | string | Diabetes other or unspecified | |
![]() ![]() | 1..1 | string | Diabetes pre-existing type 1 | |
![]() ![]() | 1..1 | string | Diabetes pre-existing type 2 | |
![]() ![]() | 1..1 | string | Hypertension | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Original first-line ART regimen | |
![]() ![]() | 1..1 | string | Current ART regimen | |
![]() ![]() | 1..1 | string | Current ART regimen start date | |
![]() ![]() | 1..1 | string | Preferred first-line ART regimen | |
![]() ![]() | 1..1 | string | Alternative first-line ART regimen | |
![]() ![]() | 1..1 | string | First-line ART regimen under special circumstances | |
![]() ![]() | 1..1 | string | Preferred second-line ART regimen | |
![]() ![]() | 1..1 | string | Alternative second-line ART regimen | |
![]() ![]() | 1..1 | string | Optimal regimen for transition | |
![]() ![]() | 1..1 | string | Current ART regimen (first-, second-, or third-line) | |
![]() ![]() | 1..1 | string | First-line ART regimen for adults and adolescents | |
![]() ![]() | 1..1 | string | First-line ART regimen for children | |
![]() ![]() | 1..1 | string | First-line ART regimen for neonates | |
![]() ![]() | 1..1 | string | Second-line ART regimen for adults and adolescents | |
![]() ![]() | 1..1 | string | Second-line ART regimen for children | |
![]() ![]() | 1..1 | string | Third-line ART regimen | |
![]() ![]() | 1..1 | string | ART regimen | |
![]() ![]() | 1..1 | string | ABC + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | ABC + 3TC + DTG | |
![]() ![]() | 1..1 | string | ABC + 3TC + EFV | |
![]() ![]() | 1..1 | string | ABC + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | ABC + 3TC + NVP | |
![]() ![]() | 1..1 | string | ABC + 3TC + RAL | |
![]() ![]() | 1..1 | string | AZT + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + DRV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + DTG | |
![]() ![]() | 1..1 | string | AZT + 3TC + EFV | |
![]() ![]() | 1..1 | string | AZT + 3TC + EFV 600 mg | |
![]() ![]() | 1..1 | string | AZT + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + NVP | |
![]() ![]() | 1..1 | string | AZT + 3TC + RAL | |
![]() ![]() | 1..1 | string | TAF + 3TC + DTG | |
![]() ![]() | 1..1 | string | TAF + FTC + DTG | |
![]() ![]() | 1..1 | string | TDF + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + DRV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + DTG | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV 400 mg | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV 600 mg | |
![]() ![]() | 1..1 | string | TDF + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + NVP | |
![]() ![]() | 1..1 | string | TDF + 3TC + PI/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + RAL | |
![]() ![]() | 1..1 | string | TDF + FTC + ATV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + DRV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + DTG | |
![]() ![]() | 1..1 | string | TDF + FTC + EFV | |
![]() ![]() | 1..1 | string | TDF + FTC + EFV 600 mg | |
![]() ![]() | 1..1 | string | TDF + FTC + LPV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + NVP | |
![]() ![]() | 1..1 | string | TDF + FTC + PI/r | |
![]() ![]() | 1..1 | string | TDF + FTC + RAL | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | ART regimen composition | |
![]() ![]() | 1..1 | string | ABC | |
![]() ![]() | 1..1 | string | FTC | |
![]() ![]() | 1..1 | string | 3TC | |
![]() ![]() | 1..1 | string | AZT | |
![]() ![]() | 1..1 | string | DDI | |
![]() ![]() | 1..1 | string | D4T | |
![]() ![]() | 1..1 | string | TDF | |
![]() ![]() | 1..1 | string | EFV | |
![]() ![]() | 1..1 | string | ETV | |
![]() ![]() | 1..1 | string | NVP | |
![]() ![]() | 1..1 | string | RIL | |
![]() ![]() | 1..1 | string | ATV/r | |
![]() ![]() | 1..1 | string | LPV/r | |
![]() ![]() | 1..1 | string | DRV/r | |
![]() ![]() | 1..1 | string | RTV | |
![]() ![]() | 1..1 | string | DTG | |
![]() ![]() | 1..1 | string | RAL | |
![]() ![]() | 1..1 | string | ART regimen drug class | |
![]() ![]() | 1..1 | string | NRTI | |
![]() ![]() | 1..1 | string | NtRTI | |
![]() ![]() | 1..1 | string | NNRTI | |
![]() ![]() | 1..1 | string | PI | |
![]() ![]() | 1..1 | string | INSTI | |
![]() ![]() | 1..1 | string | Prevention services offered and referrals | |
![]() ![]() | 1..1 | string | Offer male and female condoms and condom-compatible lubricants | |
![]() ![]() | 1..1 | string | Harm reduction for people who inject drugs | |
![]() ![]() | 1..1 | string | Behavioural interventions to support risk reduction | |
![]() ![]() | 1..1 | string | Sexual and reproductive health integrated services | |
![]() ![]() | 1..1 | string | Contraception and family planning | |
![]() ![]() | 1..1 | string | Check pregnancy status | |
![]() ![]() | 1..1 | string | Prevention of mother-to-child transmission | |
![]() ![]() | 1..1 | string | STI testing and treatment | |
![]() ![]() | 1..1 | string | HBsAg test date | |
![]() ![]() | 1..1 | string | HBsAg test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Indeterminate | |
![]() ![]() | 1..1 | string | Date HBV test result returned to client | |
![]() ![]() | 1..1 | string | HBV treatment (TDF) start date | |
![]() ![]() | 1..1 | string | HBV treatment regimen prescribed | |
![]() ![]() | 1..1 | string | HCV test date | |
![]() ![]() | 1..1 | string | HCV test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Indeterminate | |
![]() ![]() | 1..1 | string | Date HCV test result returned to client | |
![]() ![]() | 1..1 | string | HCV treatment start date | |
![]() ![]() | 1..1 | string | HCV treatment completion date | |
![]() ![]() | 1..1 | string | HCV treatment regimen prescribed | |
![]() ![]() | 1..1 | string | HCV viral load test date | |
![]() ![]() | 1..1 | string | HCV viral load test result | |
![]() ![]() | 1..1 | string | Detected | |
![]() ![]() | 1..1 | string | Not detected | |
![]() ![]() | 1..1 | string | HCV medicine type | |
![]() ![]() | 1..1 | string | Interferon | |
![]() ![]() | 1..1 | string | Direct acting antivirals | |
![]() ![]() | 1..1 | string | Currently on TDF-based ART | |
![]() ![]() | 1..1 | string | HIV clinical stage | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 1 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 2 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 3 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 4 | |
![]() ![]() | 1..1 | string | Number of missed doses | |
![]() ![]() | 1..1 | string | Received viral load test result | |
![]() ![]() | 1..1 | string | Date viral load test results received by client | |
![]() ![]() | 1..1 | string | Date of viral load sample collection | |
![]() ![]() | 1..1 | string | Date of scheduled review of viral load test results | |
![]() ![]() | 1..1 | string | Date of ART interruption | |
![]() ![]() | 1..1 | string | Reason(s) for adherence problem | |
![]() ![]() | 1..1 | string | Forgot | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Busy | |
![]() ![]() | 1..1 | string | Change of routine | |
![]() ![]() | 1..1 | string | Travel cost | |
![]() ![]() | 1..1 | string | Distance to clinic | |
![]() ![]() | 1..1 | string | Client lost/ran out of pills | |
![]() ![]() | 1..1 | string | Stock-out | |
![]() ![]() | 1..1 | string | Too ill | |
![]() ![]() | 1..1 | string | Pill burden | |
![]() ![]() | 1..1 | string | Felt well | |
![]() ![]() | 1..1 | string | Depression | |
![]() ![]() | 1..1 | string | Alcohol use | |
![]() ![]() | 1..1 | string | Substance use | |
![]() ![]() | 1..1 | string | Stigma/disclosure concerns | |
![]() ![]() | 1..1 | string | Lack of food | |
![]() ![]() | 1..1 | string | Poor palatability | |
![]() ![]() | 1..1 | string | Other reason for nonadherence | |
![]() ![]() | 1..1 | string | Other reason for nonadherence (specify) | |
![]() ![]() | 1..1 | string | Reason ART stopped | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Severe illness, hospitalization | |
![]() ![]() | 1..1 | string | Drugs out of stock | |
![]() ![]() | 1..1 | string | Client lacks finances | |
![]() ![]() | 1..1 | string | Excluded HIV infection in infant | |
![]() ![]() | 1..1 | string | Other reason for stopping ART | |
![]() ![]() | 1..1 | string | Other reason for stopping ART (specify) | |
![]() ![]() | 1..1 | string | Treatment failure | |
![]() ![]() | 1..1 | string | Clinical failure | |
![]() ![]() | 1..1 | string | Immunological failure | |
![]() ![]() | 1..1 | string | Virological failure | |
![]() ![]() | 1..1 | string | General care activities recommended | |
![]() ![]() | 1..1 | string | Determine WHO clinical stage | |
![]() ![]() | 1..1 | string | Determine if advanced disease | |
![]() ![]() | 1..1 | string | Prepare for ART | |
![]() ![]() | 1..1 | string | Prepare, assess and support adherence | |
![]() ![]() | 1..1 | string | Manage current medications | |
![]() ![]() | 1..1 | string | Check pregnancy status | |
![]() ![]() | 1..1 | string | Provide family planning and contraception | |
![]() ![]() | 1..1 | string | Support disclosure and partner notification | |
![]() ![]() | 1..1 | string | Counsel on risk reduction and prevention | |
![]() ![]() | 1..1 | string | Assess, prevent and manage noncommunicable diseases | |
![]() ![]() | 1..1 | string | Screen for and manage mental health problems | |
![]() ![]() | 1..1 | string | Screen for and manage and substance use issues | |
![]() ![]() | 1..1 | string | Provide psychosocial counselling and support | |
![]() ![]() | 1..1 | string | Manage pain and symptoms | |
![]() ![]() | 1..1 | string | Conduct a nutritional assessment and counsel on nutrition | |
![]() ![]() | 1..1 | string | Conduct a growth and development assessment | |
![]() ![]() | 1..1 | string | Provide support on infant and child feeding | |
![]() ![]() | 1..1 | string | Preventing and treating coinfections | |
![]() ![]() | 1..1 | string | Provide co-trimoxazole preventive therapy (CPT) | |
![]() ![]() | 1..1 | string | Intensified TB case finding and linkage to TB treatment | |
![]() ![]() | 1..1 | string | Provide isoniazid preventive therapy | |
![]() ![]() | 1..1 | string | Screen for cryptococcal infection and fungal prophylaxis | |
![]() ![]() | 1..1 | string | Screen for hepatitis B | |
![]() ![]() | 1..1 | string | Screen for hepatitis C | |
![]() ![]() | 1..1 | string | Prevent malaria | |
![]() ![]() | 1..1 | string | Screen for STIs | |
![]() ![]() | 1..1 | string | Prevent and screen for cervical cancer | |
![]() ![]() | 1..1 | string | Anal cancer screening (for men who have sex with men) | |
![]() ![]() | 1..1 | string | Assessment and provision of vaccinations | |
![]() ![]() | 1..1 | string | Risk factors, comorbidities and coinfections signs and symptoms | |
![]() ![]() | 1..1 | string | Oral candidiasis | |
![]() ![]() | 1..1 | string | Vaginal candidiasis | |
![]() ![]() | 1..1 | string | Cough | |
![]() ![]() | 1..1 | string | Prolonged fever | |
![]() ![]() | 1..1 | string | Night sweats | |
![]() ![]() | 1..1 | string | Weight loss | |
![]() ![]() | 1..1 | string | Difficulty breathing | |
![]() ![]() | 1..1 | string | Pneumonia | |
![]() ![]() | 1..1 | string | Urethral discharge | |
![]() ![]() | 1..1 | string | Syphilis | |
![]() ![]() | 1..1 | string | Pelvic inflammatory disease | |
![]() ![]() | 1..1 | string | Ulcers - skin | |
![]() ![]() | 1..1 | string | Ulcers - mouth or other | |
![]() ![]() | 1..1 | string | Ulcers - male genital | |
![]() ![]() | 1..1 | string | Vaginal discharge | |
![]() ![]() | 1..1 | string | Malaria | |
![]() ![]() | 1..1 | string | Chronic obstructive pulmonary disease | |
![]() ![]() | 1..1 | string | Hypertension | |
![]() ![]() | 1..1 | string | Diabetes | |
![]() ![]() | 1..1 | string | Gestational diabetes | |
![]() ![]() | 1..1 | string | Mental health disorders | |
![]() ![]() | 1..1 | string | Diarrhoea or abdominal pain | |
![]() ![]() | 1..1 | string | Presumptive TB | |
![]() ![]() | 1..1 | string | Severe or complicated malnutrition | |
![]() ![]() | 1..1 | string | Poor growth or development | |
![]() ![]() | 1..1 | string | Oedema | |
![]() ![]() | 1..1 | string | Previously treated for TB | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage condition or symptom | |
![]() ![]() | 1..1 | string | Asymptomatic | |
![]() ![]() | 1..1 | string | Persistent generalized lymphadenopathy | |
![]() ![]() | 1..1 | string | Moderate unexplained weight loss | |
![]() ![]() | 1..1 | string | Recurrent respiratory tract infections | |
![]() ![]() | 1..1 | string | Unexplained persistent hepatosplenomegaly | |
![]() ![]() | 1..1 | string | Herpes zoster | |
![]() ![]() | 1..1 | string | Angular cheilitis | |
![]() ![]() | 1..1 | string | Linear gingival erythema | |
![]() ![]() | 1..1 | string | Recurrent oral ulceration | |
![]() ![]() | 1..1 | string | Papular pruritic eruption | |
![]() ![]() | 1..1 | string | Fungal nail infections | |
![]() ![]() | 1..1 | string | Seborrhoeic dermatitis | |
![]() ![]() | 1..1 | string | Extensive wart virus infection | |
![]() ![]() | 1..1 | string | Extensive molluscum contagiosum | |
![]() ![]() | 1..1 | string | Unexplained persistent parotid enlargement | |
![]() ![]() | 1..1 | string | Unexplained severe weight loss in adults | |
![]() ![]() | 1..1 | string | Unexplained moderate malnutrition not adequately responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained chronic diarrhoea for longer than 1 month | |
![]() ![]() | 1..1 | string | Unexplained persistent diarrhoea (14 days or more) | |
![]() ![]() | 1..1 | string | Unexplained persistent fever (above 37.5 C, intermittent or constant, for longer than one 1 month) | |
![]() ![]() | 1..1 | string | Persistent oral candidiasis | |
![]() ![]() | 1..1 | string | Oral hairy leukoplakia | |
![]() ![]() | 1..1 | string | Pulmonary TB | |
![]() ![]() | 1..1 | string | Lymph node TB | |
![]() ![]() | 1..1 | string | Severe bacterial infections (such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia) | |
![]() ![]() | 1..1 | string | Severe recurrent bacterial pneumonia | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative stomatitis | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative gingivitis | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative periodontitis | |
![]() ![]() | 1..1 | string | Unexplained anaemia (<8 g/dL) | |
![]() ![]() | 1..1 | string | Neutropaenia (<0.5 x 10^9/L) | |
![]() ![]() | 1..1 | string | Chronic thrombocytopaenia (<50 x 10^9/L) | |
![]() ![]() | 1..1 | string | Symptomatic lymphoid interstitial pneumonitis | |
![]() ![]() | 1..1 | string | Chronic HIV-associated lung disease, including bronchiectasis | |
![]() ![]() | 1..1 | string | HIV wasting syndrome | |
![]() ![]() | 1..1 | string | Unexplained severe wasting not responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained stunting not responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained severe malnutrition not responding to standard therapy | |
![]() ![]() | 1..1 | string | Pneumocystis (jirovecii) pneumonia | |
![]() ![]() | 1..1 | string | Recurrent severe bacterial pneumonia | |
![]() ![]() | 1..1 | string | Recurrent severe bacterial infections (such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia) | |
![]() ![]() | 1..1 | string | Empyema | |
![]() ![]() | 1..1 | string | Pyomyositis | |
![]() ![]() | 1..1 | string | Bone or joint infection | |
![]() ![]() | 1..1 | string | Meningitis | |
![]() ![]() | 1..1 | string | Chronic herpes simplex infection (orolabial or cutaneous of more than 1 month duration or visceral at any site) | |
![]() ![]() | 1..1 | string | Chronic herpes simplex infection (orolabial, genital or anorectal of more than 1 month in duration or visceral at any site) | |
![]() ![]() | 1..1 | string | Oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs) | |
![]() ![]() | 1..1 | string | Extrapulmonary TB | |
![]() ![]() | 1..1 | string | Kaposi sarcoma | |
![]() ![]() | 1..1 | string | Cytomegalovirus infection (retinitis or infection of other organs) | |
![]() ![]() | 1..1 | string | Central nervous system toxoplasmosis | |
![]() ![]() | 1..1 | string | HIV encephalopathy | |
![]() ![]() | 1..1 | string | Extrapulmonary cryptococcosis, including meningitis | |
![]() ![]() | 1..1 | string | Disseminated nontuberculous mycobacterial infection | |
![]() ![]() | 1..1 | string | Progressive multifocal leukoencephalopathy | |
![]() ![]() | 1..1 | string | Chronic cryptosporidiosis | |
![]() ![]() | 1..1 | string | Chronic cryptosporidiosis (with diarrhoea) | |
![]() ![]() | 1..1 | string | Chronic isosporiasis | |
![]() ![]() | 1..1 | string | Disseminated mycosis (extrapulmonary histoplasmosis, coccidioidomycosis) | |
![]() ![]() | 1..1 | string | Disseminated endemic mycosis (extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis) | |
![]() ![]() | 1..1 | string | Cerebral lymphoma | |
![]() ![]() | 1..1 | string | B-cell non-Hodgkin lymphoma | |
![]() ![]() | 1..1 | string | HIV-associated nephropathy or cardiomyopathy | |
![]() ![]() | 1..1 | string | Recurrent septicaemia (including nontyphoidal Salmonella) | |
![]() ![]() | 1..1 | string | Invasive cervical carcinoma | |
![]() ![]() | 1..1 | string | Atypical disseminated leishmaniasis | |
![]() ![]() | 1..1 | string | Neutropenia | |
![]() ![]() | 1..1 | string | Clinical stage at start of ART | |
![]() ![]() | 1..1 | string | WHO clinical stage 1 | |
![]() ![]() | 1..1 | string | WHO clinical stage 2 | |
![]() ![]() | 1..1 | string | WHO clinical stage 3 | |
![]() ![]() | 1..1 | string | WHO clinical stage 4 | |
![]() ![]() | 1..1 | string | Date of clinical status change | |
![]() ![]() | 1..1 | string | CD4 count | |
![]() ![]() | 1..1 | string | CD4 cell percentage | |
![]() ![]() | 1..1 | string | Date of CD4 count test | |
![]() ![]() | 1..1 | string | Baseline CD4 count | |
![]() ![]() | 1..1 | string | Date of baseline CD4 count test | |
![]() ![]() | 1..1 | string | Late ART initiation | |
![]() ![]() | 1..1 | string | Reasons for delayed ART initiation | |
![]() ![]() | 1..1 | string | Patient self-reported as not ready/willing | |
![]() ![]() | 1..1 | string | Not completed education, support and preparation for ART | |
![]() ![]() | 1..1 | string | Fear of disclosure | |
![]() ![]() | 1..1 | string | Patient lacks finances | |
![]() ![]() | 1..1 | string | Initiated on TB treatment | |
![]() ![]() | 1..1 | string | Patient initiated on treatment for TB meningitis | |
![]() ![]() | 1..1 | string | Patient diagnosed with cryptococcal meningitis | |
![]() ![]() | 1..1 | string | Patient diagnosed with histoplasmosis | |
![]() ![]() | 1..1 | string | Patient critically/severely ill | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | ART initiated within 7 days of diagnosis | |
![]() ![]() | 1..1 | string | Time to start ART | |
![]() ![]() | 1..1 | string | Within 7 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Within 30 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Within 90 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Viral load test result | |
![]() ![]() | 1..1 | string | Virally suppressed | |
![]() ![]() | 1..1 | string | Date viral load test results received | |
![]() ![]() | 1..1 | string | Viral load suppression date | |
![]() ![]() | 1..1 | string | Reason for HIV viral load test | |
![]() ![]() | 1..1 | string | Routine viral load test | |
![]() ![]() | 1..1 | string | Targeted viral load monitoring | |
![]() ![]() | 1..1 | string | Initial viral load test | |
![]() ![]() | 1..1 | string | Follow-up viral load test after receiving enhanced adherence counselling | |
![]() ![]() | 1..1 | string | Hepatitis B test required | |
![]() ![]() | 1..1 | string | Hepatitis C test recommended | |
![]() ![]() | 1..1 | string | Syphilis test required | |
![]() ![]() | 1..1 | string | Monitoring examinations | |
![]() ![]() | 1..1 | string | Haemoglobin (Hb) | |
![]() ![]() | 1..1 | string | Pregnancy test | |
![]() ![]() | 1..1 | string | Syphilis test | |
![]() ![]() | 1..1 | string | Chest X-ray (CXR) | |
![]() ![]() | 1..1 | string | Sputum or culture for TB | |
![]() ![]() | 1..1 | string | HBsAg test (HBV) | |
![]() ![]() | 1..1 | string | HIV viral load test ordered | |
![]() ![]() | 1..1 | string | HIV viral load test scheduled | |
![]() ![]() | 1..1 | string | CD4 count ordered | |
![]() ![]() | 1..1 | string | CD4 count test scheduled | |
![]() ![]() | 1..1 | string | Cryptococcal antigen test | |
![]() ![]() | 1..1 | string | Histoplasmosis antigen test | |
![]() ![]() | 1..1 | string | Cervical cancer screening scheduled | |
![]() ![]() | 1..1 | string | Date of scheduled monitoring examination | |
![]() ![]() | 1..1 | string | Hepatitis C test ordered | |
![]() ![]() | 1..1 | string | Syphilis test ordered | |
![]() ![]() | 1..1 | string | Received viral load test results | |
![]() ![]() | 1..1 | string | Date viral load test results received by client | |
![]() ![]() | 1..1 | string | Reason for ARV drug regimen substitution | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Drug-drug interaction | |
![]() ![]() | 1..1 | string | Pregnancy | |
![]() ![]() | 1..1 | string | New TB | |
![]() ![]() | 1..1 | string | New drug available | |
![]() ![]() | 1..1 | string | Drug out of stock | |
![]() ![]() | 1..1 | string | Other reason for regimen substitution | |
![]() ![]() | 1..1 | string | Other reason for regimen substitution (specify) | |
![]() ![]() | 1..1 | string | Switch to second-line ART regimen recommended | |
![]() ![]() | 1..1 | string | Switch to third-line ART regimen recommended | |
![]() ![]() | 1..1 | string | Regimen switch made | |
![]() ![]() | 1..1 | string | Reason for regimen switch | |
![]() ![]() | 1..1 | string | Clinical treatment failure | |
![]() ![]() | 1..1 | string | Immunological failure | |
![]() ![]() | 1..1 | string | Virological failure | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Regimen substitution recommended | |
![]() ![]() | 1..1 | string | Dose adjustment recommended | |
![]() ![]() | 1..1 | string | Regimen substitution made | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis start date | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis completion date | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis dosage | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis number of days prescribed | |
![]() ![]() | 1..1 | string | Suspicion of treatment failure or interruption | |
![]() ![]() | 1..1 | string | ART regimen prescribed | |
![]() ![]() | 1..1 | string | Antiretroviral toxicity | |
![]() ![]() | 1..1 | string | Coinfection status at ART start | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Hepatitis C | |
![]() ![]() | 1..1 | string | Pregnant and breastfeeding status at ART start | |
![]() ![]() | 1..1 | string | Pregnant at ART start | |
![]() ![]() | 1..1 | string | Postpartum at ART start | |
![]() ![]() | 1..1 | string | ART start at labour and delivery | |
![]() ![]() | 1..1 | string | Breastfeeding at ART start | |
![]() ![]() | 1..1 | string | Delivery date of infant | |
![]() ![]() | 1..1 | string | Serodiscordant partner at ART start | |
![]() ![]() | 1..1 | string | Regimen start date | |
![]() ![]() | 1..1 | string | Medications prescribed | |
![]() ![]() | 1..1 | string | Date medications prescribed | |
![]() ![]() | 1..1 | string | Dose of medications prescribed | |
![]() ![]() | 1..1 | string | Number of days medications prescribed | |
![]() ![]() | 1..1 | string | Medications dispensed | |
![]() ![]() | 1..1 | string | Number of days of medications dispensed | |
![]() ![]() | 1..1 | string | Dosage | |
![]() ![]() | 1..1 | string | Frequency | |
![]() ![]() | 1..1 | string | Adherence counselling provided | |
![]() ![]() | 1..1 | string | Type of treatment-limiting toxicity | |
![]() ![]() | 1..1 | string | Gastrointestinal | |
![]() ![]() | 1..1 | string | Skin issues | |
![]() ![]() | 1..1 | string | Peripheral neuropathy | |
![]() ![]() | 1..1 | string | Central nervous system symptoms | |
![]() ![]() | 1..1 | string | Weight gain | |
![]() ![]() | 1..1 | string | Hepatic dysfunction | |
![]() ![]() | 1..1 | string | Haematological disorders | |
![]() ![]() | 1..1 | string | Fatigue | |
![]() ![]() | 1..1 | string | Headache | |
![]() ![]() | 1..1 | string | Bone dysfunction | |
![]() ![]() | 1..1 | string | Metabolic symptoms | |
![]() ![]() | 1..1 | string | Kidney dysfunction | |
![]() ![]() | 1..1 | string | Unexpected adverse drug reaction | |
![]() ![]() | 1..1 | string | Unexpected adverse drug reaction (specify) | |
![]() ![]() | 1..1 | string | Date(s) of substitution within first-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within first-line regimen | |
![]() ![]() | 1..1 | string | New antiretroviral regimen after substitution within first-line regimen | |
![]() ![]() | 1..1 | string | Date of switch to second-line regimen | |
![]() ![]() | 1..1 | string | New regimen after switch to second-line regimen | |
![]() ![]() | 1..1 | string | Reason for switch to second-line regimen | |
![]() ![]() | 1..1 | string | Date(s) of substitution within second-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within second-line regimen | |
![]() ![]() | 1..1 | string | New regimen(s) after substitution within second-line regimen | |
![]() ![]() | 1..1 | string | Date of switch to third-line regimen | |
![]() ![]() | 1..1 | string | New regimen after switch to third-line regimen | |
![]() ![]() | 1..1 | string | Reason for switch to third-line regimen | |
![]() ![]() | 1..1 | string | Date(s) of substitution within third-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within third-line regimen | |
![]() ![]() | 1..1 | string | New regimen(s) after substitution within third-line regimen | |
![]() ![]() | 1..1 | string | Enhanced adherence counselling provided | |
![]() ![]() | 1..1 | string | First enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of first enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Second enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of second enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Third enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of third enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Name of treatment supporter | |
![]() ![]() | 1..1 | string | Address of treatment supporter | |
![]() ![]() | 1..1 | string | Telephone number of treatment supporter | |
![]() ![]() | 1..1 | string | Home-based care provider | |
![]() ![]() | 1..1 | string | Counselling provided on diagnoses | |
![]() ![]() | 1..1 | string | Hepatitis B positive counselling conducted | |
![]() ![]() | 1..1 | string | Hepatitis C positive counselling conducted | |
![]() ![]() | 1..1 | string | Syphilis counselling and treatment | |
![]() ![]() | 1..1 | string | Syphilis counselling, treatment and further testing | |
![]() ![]() | 1..1 | string | Accepted partner services | |
![]() ![]() | 1..1 | string | HIV testing for partners and biological children | |
![]() ![]() | 1..1 | string | HIV status of family member | |
![]() ![]() | 1..1 | string | Unique ID of family member | |
![]() ![]() | 1..1 | string | Date of death of family member | |
![]() ![]() | 1..1 | string | Offered voluntary partner services | |
![]() ![]() | 1..1 | string | Provided support for disclosure and partner services | |
![]() ![]() | 1..1 | string | Other support services | |
![]() ![]() | 1..1 | string | Mental health services | |
![]() ![]() | 1..1 | string | Psychosocial counselling, support and treatment adherence counselling | |
![]() ![]() | 1..1 | string | Legal and social services | |
![]() ![]() | 1..1 | string | Services for responding to violence against women | |
![]() ![]() | 1..1 | string | Date/time of follow-up appointment | |
![]() ![]() | 1..1 | string | Type of follow-up appointment | |
![]() ![]() | 1..1 | string | Clinical visit | |
![]() ![]() | 1..1 | string | Antiretroviral drug pick up | |
![]() ![]() | 1..1 | string | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Follow-up test recommended date | |
![]() ![]() | 1..1 | string | Reason blood pressure reading not done | |
![]() ![]() | 1..1 | string | BP cuff (sphygmomanometer) not available | |
![]() ![]() | 1..1 | string | BP cuff (sphygmomanometer) is broken | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Current medications | |
![]() ![]() | 1..1 | string | No medications | |
![]() ![]() | 1..1 | string | Dont know of any current medications | |
![]() ![]() | 1..1 | string | Analgesic | |
![]() ![]() | 1..1 | string | Antacids | |
![]() ![]() | 1..1 | string | Antibiotics (broad-spectrum) | |
![]() ![]() | 1..1 | string | Anticonvulsive | |
![]() ![]() | 1..1 | string | Antidiabetic | |
![]() ![]() | 1..1 | string | Antifungals | |
![]() ![]() | 1..1 | string | Antihelmintic | |
![]() ![]() | 1..1 | string | Antihypertensive | |
![]() ![]() | 1..1 | string | Antimalarials | |
![]() ![]() | 1..1 | string | Antiretrovirals (ARVs) | |
![]() ![]() | 1..1 | string | Antiparasitics | |
![]() ![]() | 1..1 | string | Antivirals | |
![]() ![]() | 1..1 | string | Buprenorphine | |
![]() ![]() | 1..1 | string | Co-trimoxazole preventive therapy (CPT) | |
![]() ![]() | 1..1 | string | Hormonal family planning method | |
![]() ![]() | 1..1 | string | Methadone | |
![]() ![]() | 1..1 | string | PrEP to prevent HIV | |
![]() ![]() | 1..1 | string | Other antibiotics | |
![]() ![]() | 1..1 | string | Other medications | |
![]() ![]() | 1..1 | string | Other medications (specify) | |
![]() ![]() | 1..1 | string | Allergies | |
![]() ![]() | 1..1 | string | No known allergies | |
![]() ![]() | 1..1 | string | Dont know of any allergies | |
![]() ![]() | 1..1 | string | Albendazole | |
![]() ![]() | 1..1 | string | Malaria medication (sulfadoxine-pyrimethamine) | |
![]() ![]() | 1..1 | string | Penicillin | |
![]() ![]() | 1..1 | string | Tenofovir disoproxil fumarate (TDF) | |
![]() ![]() | 1..1 | string | Other allergies | |
![]() ![]() | 1..1 | string | Other allergies (specify) | |
![]() ![]() | 1..1 | string | Family planning method used | |
![]() ![]() | 1..1 | string | Copper-bearing intrauterine device (Cu-IUD) | |
![]() ![]() | 1..1 | string | Levonorgestrel intrauterine device (LNG-IUD) | |
![]() ![]() | 1..1 | string | Etonogestrel (ETG) one-rod implant | |
![]() ![]() | 1..1 | string | Levonorgestrel (LNG) two-rod implant | |
![]() ![]() | 1..1 | string | DMPA-IM | |
![]() ![]() | 1..1 | string | DMPA-SC | |
![]() ![]() | 1..1 | string | NET-EN norethisterone enanthate | |
![]() ![]() | 1..1 | string | Progestogen-only pills (POP) | |
![]() ![]() | 1..1 | string | Combined oral contraceptives (COCs) | |
![]() ![]() | 1..1 | string | Combined contraceptive patch | |
![]() ![]() | 1..1 | string | Combined contraceptive vaginal ring (CVR) | |
![]() ![]() | 1..1 | string | Progesterone-releasing vaginal ring (PVR) | |
![]() ![]() | 1..1 | string | Lactational amenorrhea method (LAM) | |
![]() ![]() | 1..1 | string | Emergency contraceptive pills (ECPs) | |
![]() ![]() | 1..1 | string | Fertility awareness-based methods (FAB) | |
![]() ![]() | 1..1 | string | Male condoms | |
![]() ![]() | 1..1 | string | Female condoms | |
![]() ![]() | 1..1 | string | Withdrawal | |
![]() ![]() | 1..1 | string | Female relying on male method | |
![]() ![]() | 1..1 | string | Male relying on female method | |
![]() ![]() | 1..1 | string | Male sterilization | |
![]() ![]() | 1..1 | string | Female sterilization | |
![]() ![]() | 1..1 | string | No method | |
![]() ![]() | 1..1 | string | Medication status | |
![]() ![]() | 1..1 | string | Currently taking | |
![]() ![]() | 1..1 | string | Completed | |
![]() ![]() | 1..1 | string | Entered in error | |
![]() ![]() | 1..1 | string | Intended | |
![]() ![]() | 1..1 | string | Stopped | |
![]() ![]() | 1..1 | string | On hold | |
![]() ![]() | 1..1 | string | Unknown | |
![]() ![]() | 1..1 | string | Did not take | |
![]() ![]() | 1..1 | string | Hepatitis B negative counselling conducted | |
![]() ![]() | 1..1 | string | Vaccine brand | |
![]() ![]() | 1..1 | string | Vaccine type | |
![]() ![]() | 1..1 | string | Date and time of vaccination | |
![]() ![]() | 1..1 | string | Vaccination location | |
![]() ![]() | 1..1 | string | Dose number | |
![]() ![]() | 1..1 | string | Dose quantity | |
![]() ![]() | 1..1 | string | Total doses in series | |
![]() ![]() | 1..1 | string | Disease targeted | |
![]() ![]() | 1..1 | string | Hepatitis A | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Tetanus | |
![]() ![]() | 1..1 | string | COVID-19 | |
![]() ![]() | 1..1 | string | Influenza due to influenza B virus | |
![]() ![]() | 1..1 | string | Tuberculosis | |
![]() ![]() | 1..1 | string | Acute poliomyelitis | |
![]() ![]() | 1..1 | string | Measles | |
![]() ![]() | 1..1 | string | Diptheria | |
![]() ![]() | 1..1 | string | Rabies | |
![]() ![]() | 1..1 | string | Cholera | |
![]() ![]() | 1..1 | string | Mumps | |
![]() ![]() | 1..1 | string | HPV infection | |
![]() ![]() | 1..1 | string | Haemophilus influenzae type B | |
![]() ![]() | 1..1 | string | Varicella | |
![]() ![]() | 1..1 | string | Dengue | |
![]() ![]() | 1..1 | string | Yellow fever | |
![]() ![]() | 1..1 | string | Japanese Encephalitis | |
![]() ![]() | 1..1 | string | Rubella | |
![]() ![]() | 1..1 | string | Pertussis | |
![]() ![]() | 1..1 | string | Enteritis due to rotavirus | |
![]() ![]() | 1..1 | string | Pneumococcal disease | |
![]() ![]() | 1..1 | string | Meningococcal disease | |
![]() ![]() | 1..1 | string | Tick-borne encephalitis | |
![]() ![]() | 1..1 | string | Typhoid | |
![]() ![]() | 1..1 | string | Reason immunization was not provided | |
![]() ![]() | 1..1 | string | Stock-out | |
![]() ![]() | 1..1 | string | Client is ill | |
![]() ![]() | 1..1 | string | Client refused | |
![]() ![]() | 1..1 | string | Allergy to vaccine | |
![]() ![]() | 1..1 | string | Other reason immunization not provided | |
![]() ![]() | 1..1 | string | Other reason immunization not provided (specify) | |
![]() ![]() | 1..1 | string | Malaria prophylaxis | |
![]() ![]() | 1..1 | string | IPTp-SP dose number provided | |
![]() ![]() | 1..1 | string | Date IPTp-SP dose provided | |
![]() ![]() | 1..1 | string | Reason malaria prophylaxis not provided | |
![]() ![]() | 1..1 | string | Client was referred | |
![]() ![]() | 1..1 | string | Stock out | |
![]() ![]() | 1..1 | string | Expired | |
![]() ![]() | 1..1 | string | Other reason not provided | |
![]() ![]() | 1..1 | string | Other reason not provided (specify) | |
![]() ![]() | 1..1 | string | >28 days since last missed appointment | |
![]() ![]() | 1..1 | string | AIDS-related death | |
![]() ![]() | 1..1 | string | Date of first AIDS diagnosis | |
![]() ![]() | 1..1 | string | Age at final HPV vaccination dose received | |
![]() ![]() | 1..1 | string | Date of cervical cancer screening test | |
![]() ![]() | 1..1 | string | Lifetime screening test number | |
![]() ![]() | 1..1 | string | Cervical cancer primary screening test type | |
![]() ![]() | 1..1 | string | HPV-DNA | |
![]() ![]() | 1..1 | string | VIA | |
![]() ![]() | 1..1 | string | Cervical cytology | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | HPV-DNA cervical cancer screening test result | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Invalid | |
![]() ![]() | 1..1 | string | VIA cervical cancer screening test result | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Suspected cancer | |
![]() ![]() | 1..1 | string | Invalid | |
![]() ![]() | 1..1 | string | Cervical cytology screening test result | |
![]() ![]() | 1..1 | string | NILM | |
![]() ![]() | 1..1 | string | ASCUS | |
![]() ![]() | 1..1 | string | LSIL | |
![]() ![]() | 1..1 | string | HSIL | |
![]() ![]() | 1..1 | string | Cancer | |
![]() ![]() | 1..1 | string | Invalid/inadequate | |
![]() ![]() | 1..1 | string | Cervical cancer triage test date | |
![]() ![]() | 1..1 | string | Cervical cancer triage test type | |
![]() ![]() | 1..1 | string | VIA | |
![]() ![]() | 1..1 | string | Colposcopy | |
![]() ![]() | 1..1 | string | Cervical cytology | |
![]() ![]() | 1..1 | string | HPV16/18 | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | HPV16/18 test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Cervical cancer colposcopy result | |
![]() ![]() | 1..1 | string | Normal colposcopic findings | |
![]() ![]() | 1..1 | string | Abnormal colposcopic findings | |
![]() ![]() | 1..1 | string | Suspicious for invasive cervical cancer | |
![]() ![]() | 1..1 | string | Miscellaneous findings | |
![]() ![]() | 1..1 | string | Inadequate | |
![]() ![]() | 1..1 | string | Cervical cancer histopathology result | |
![]() ![]() | 1..1 | string | Normal | |
![]() ![]() | 1..1 | string | LSIL (inclusive of LSIL-CIN1) | |
![]() ![]() | 1..1 | string | HSIL (inclusive of HSIL-CIN2 or HSIL-CIN3) | |
![]() ![]() | 1..1 | string | Invasive cervical cancer | |
![]() ![]() | 1..1 | string | Date of additional cervical cancer triage test | |
![]() ![]() | 1..1 | string | Additional cervical cancer triage test type (specify) | |
![]() ![]() | 1..1 | string | Additional cervical cancer triage test result (specify) | |
![]() ![]() | 1..1 | string | Date of diagnosis of cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Cervical cancer screening outcome | |
![]() ![]() | 1..1 | string | Positive for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Negative for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Cervical cancer diagnosis | |
![]() ![]() | 1..1 | string | Cervical precancer lesions | |
![]() ![]() | 1..1 | string | Invasive cervical cancer | |
![]() ![]() | 1..1 | string | Cervical cancer stage at diagnosis | |
![]() ![]() | 1..1 | string | Stage 0 | |
![]() ![]() | 1..1 | string | Stage I | |
![]() ![]() | 1..1 | string | Stage II | |
![]() ![]() | 1..1 | string | Stage III | |
![]() ![]() | 1..1 | string | Stage IV | |
![]() ![]() | 1..1 | string | Date of treatment for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Treatment method for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Cryotherapy | |
![]() ![]() | 1..1 | string | Thermal ablation | |
![]() ![]() | 1..1 | string | Laser ablation | |
![]() ![]() | 1..1 | string | CKC | |
![]() ![]() | 1..1 | string | Laser cone biopsy | |
![]() ![]() | 1..1 | string | LLETZ/LEEP | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Date of follow-up for treatment for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Date of start of invasive cancer treatment | |
![]() ![]() | 1..1 | string | Invasive cervical cancer treatment episode | |
![]() ![]() | 1..1 | string | Invasive cervical cancer treatment method | |
![]() ![]() | 1..1 | string | Conization | |
![]() ![]() | 1..1 | string | Trachelectomy | |
![]() ![]() | 1..1 | string | Hysterectomy | |
![]() ![]() | 1..1 | string | Management of invasive cervical cancer | |
![]() ![]() | 1..1 | string | Radiotherapy | |
![]() ![]() | 1..1 | string | Chemotherapy | |
![]() ![]() | 1..1 | string | Chemoradiation | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Treatment outcome | |
![]() ![]() | 1..1 | string | Secondary/other cancers diagnosed | |
![]() ![]() | 1..1 | string | Cancers at other sites (HPV- and non-HPV related) | |
![]() ![]() | 1..1 | string | Date of death | |
![]() ![]() | 1..1 | string | Cervical cancer screening interval amongst WLHIV | |
![]() ![]() | 1..1 | string | Entry point for facility-level testing | |
![]() ![]() | 1..1 | string | Provider-initiated tested in a clinic or emergency facility | |
![]() ![]() | 1..1 | string | Antenatal care clinic | |
![]() ![]() | 1..1 | string | Voluntary counselling and testing (within a health facility setting) | |
![]() ![]() | 1..1 | string | Family planning clinic | |
![]() ![]() | 1..1 | string | Other facility-level testing | |
![]() ![]() | 1..1 | string | Tuberculosis (TB) clinic | |
![]() ![]() | 1..1 | string | Offer other clinical services | |
![]() ![]() | 1..1 | string | Assessment and provision of vaccinations | |
![]() ![]() | 1..1 | string | Hepatitis B (HBV) and hepatitis C virus (HCV) testing and treatment | |
![]() ![]() | 1..1 | string | Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia | |
![]() ![]() | 1..1 | string | Intensified TB case finding and linkage to TB treatment | |
![]() ![]() | 1..1 | string | Provision of isoniazid preventive therapy if person does not have TB | |
![]() ![]() | 1..1 | string | Malaria prevention (such as bed nets and prophylaxis), depending on epidemiology | |
![]() ![]() | 1..1 | string | Eligible for DSD ART | |
![]() ![]() | 1..1 | string | Date DSD ART eligibility assessed | |
![]() ![]() | 1..1 | string | Currently enrolled in DSD ART model | |
![]() ![]() | 1..1 | string | DSD ART start date | |
![]() ![]() | 1..1 | string | DSD ART model(s) | |
![]() ![]() | 1..1 | string | Fast track ART refill | |
![]() ![]() | 1..1 | string | Facility adherence club | |
![]() ![]() | 1..1 | string | Community ART distribution point | |
![]() ![]() | 1..1 | string | CHW/peer educator community ART group | |
![]() ![]() | 1..1 | string | Patient/client community ART group | |
![]() ![]() | 1..1 | string | Other DSD ART model | |
![]() ![]() | 1..1 | string | Other DSD ART model (specify) | |
![]() ![]() | 1..1 | string | Partner testing offered | |
![]() ![]() | 1..1 | string | Partner testing accepted | |
![]() ![]() | 1..1 | string | Date partner contacted for index testing | |
![]() ![]() | 1..1 | string | Date partner tested for HIV | |
![]() ![]() | 1..1 | string | Date of next scheduled follow-up appointment | |
![]() ![]() | 1..1 | string | Type of next follow-up appointment | |
![]() ![]() | 1..1 | string | Syndrome/STI diagnosed | |
![]() ![]() | 1..1 | string | Urethral discharge syndrome | |
![]() ![]() | 1..1 | string | Vaginal discharge syndrome | |
![]() ![]() | 1..1 | string | Lower Abdominal pain | |
![]() ![]() | 1..1 | string | Genital ulcer disease syndrome | |
![]() ![]() | 1..1 | string | Anorectal discharge | |
![]() ![]() | 1..1 | string | Sent for testing | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Any STI syndrome diagnosed | |
![]() ![]() | 1..1 | string | Date of STI test | |
![]() ![]() | 1..1 | string | STI tested for | |
![]() ![]() | 1..1 | string | Neisseria gonorrhoeae | |
![]() ![]() | 1..1 | string | Chlamydia trachomatis | |
![]() ![]() | 1..1 | string | Trichomonas vaginalis | |
![]() ![]() | 1..1 | string | Syphilis (Treponema pallidum) | |
![]() ![]() | 1..1 | string | Herpes simplex virus (HSV1, HSV2) | |
![]() ![]() | 1..1 | string | Mycoplasma genitalium | |
![]() ![]() | 1..1 | string | Mpox | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Hepatitis C | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Syphilis test date | |
![]() ![]() | 1..1 | string | Syphilis test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Syphilis treatment start date | |
![]() ![]() | 1..1 | string | Gonorrhoea test date | |
![]() ![]() | 1..1 | string | Gonorrhoea test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Gonorrhoea treatment start date | |
![]() ![]() | 1..1 | string | Type of specimen | |
![]() ![]() | 1..1 | string | Blood | |
![]() ![]() | 1..1 | string | Urine | |
![]() ![]() | 1..1 | string | Cervical or vaginal swab | |
![]() ![]() | 1..1 | string | Urethral or penile swab | |
![]() ![]() | 1..1 | string | Rectal swab | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other type of specimen (specify) | |
![]() ![]() | 1..1 | string | Syphilis test type | |
![]() ![]() | 1..1 | string | Treponemal | |
![]() ![]() | 1..1 | string | Non-treponemal | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other syphilis test type (specify) | |
![]() ![]() | 1..1 | string | Neisseria gonorrhoeae test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | POC Test for Neisseria gonorrhoeae (specify) | |
![]() ![]() | 1..1 | string | Chlamydia trachomatis test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | ELISA | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other test for Chlamydia (specify) | |
![]() ![]() | 1..1 | string | POC Test type for Chlamydia test (specify) | |
![]() ![]() | 1..1 | string | Trichomonas vaginalis test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | POC Test type for Trichomonas vaginalis test (specify) | |
![]() ![]() | 1..1 | string | Herpes simplex virus (HSV) test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Antibody test | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Mycoplasma genitalium test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Test type for other STI tested for (specify) | |
![]() ![]() | 1..1 | string | STI test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Date of STI confirmatory test | |
![]() ![]() | 1..1 | string | Confirmatory syphilis test type | |
![]() ![]() | 1..1 | string | Treponemal | |
![]() ![]() | 1..1 | string | Non-treponemal | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Confirmatory test type for other STI (specify) | |
![]() ![]() | 1..1 | string | Confirmatory STI test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Date STI treatment prescribed | |
![]() ![]() | 1..1 | string | Date STI treatment dispensed | |
![]() ![]() | 1..1 | string | STI treatment dispensed (specify) | |
![]() ![]() | 1..1 | string | Mid-upper arm circumference (MUAC) | |
![]() ![]() | 1..1 | string | Date of start of fluconazole prophylaxis | |
![]() ![]() | 1..1 | string | Fluconazole prophylaxis | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment induction regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment induction regimen | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment maintenance regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment maintenance regimen | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment consolidation regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment consolidation regimen | |
![]() ![]() | 1..1 | string | Staging of liver disease | |
![]() ![]() | 1..1 | string | F0-4, fibrosis staging | |
![]() ![]() | 1..1 | string | F4 or cirrhosis, presence of cirrhosis | |
![]() ![]() | 1..1 | string | Advanced HIV disease | |
![]() ![]() | 1..1 | string | WHO functional status | |
![]() ![]() | 1..1 | string | Working, able to perform usual work inside and outside the home | |
![]() ![]() | 1..1 | string | Ambulatory, able to perform activity of daily living (ADL), not able to work | |
![]() ![]() | 1..1 | string | Bedridden not able to perform ADL | |
![]() ![]() | 1..1 | string | Tailored adherence counselling for advanced HIV disease | |
![]() ![]() | 1..1 | string | Date(s) of tracing interventions | |
![]() ![]() | 1..1 | string | Medication/drug | |
![]() ![]() | 1..1 | string | Rifampicin | |
![]() ![]() | 1..1 | string | Halofantrine | |
![]() ![]() | 1..1 | string | Lovastatin | |
![]() ![]() | 1..1 | string | Simvastatin | |
![]() ![]() | 1..1 | string | Hormonal contraception | |
![]() ![]() | 1..1 | string | Metformin | |
![]() ![]() | 1..1 | string | Astemizole | |
![]() ![]() | 1..1 | string | Terfenadine | |
![]() ![]() | 1..1 | string | TDF | |
![]() ![]() | 1..1 | string | Simeprevir | |
![]() ![]() | 1..1 | string | Ombitasvir + paritaprevir/ritonavir + dasabuvir | |
![]() ![]() | 1..1 | string | Methadone | |
![]() ![]() | 1..1 | string | Buprenorphine | |
![]() ![]() | 1..1 | string | Dofetilide | |
![]() ![]() | 1..1 | string | Carbamazepine | |
![]() ![]() | 1..1 | string | Phenobarbital | |
![]() ![]() | 1..1 | string | Phenytoin | |
![]() ![]() | 1..1 | string | Polyvalent cation products containing Mg, Al, Fe, Ca and Zn | |
![]() ![]() | 1..1 | string | Amodiaquine | |
![]() ![]() | 1..1 | string | Cisapride | |
![]() ![]() | 1..1 | string | Ergotamine | |
![]() ![]() | 1..1 | string | Dihydroergotamine | |
![]() ![]() | 1..1 | string | Midazolam | |
![]() ![]() | 1..1 | string | Triazolam | |
![]() ![]() | 1..1 | string | Estrogen-based hormonal contraception | |
![]() ![]() | 1..1 | string | Ribavirin | |
![]() ![]() | 1..1 | string | Peginterferon alfa-2a | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Medication change recommended | |
Documentation for this format | ||||
Snapshot View
| Name | Flags | Card. | Type | Description & Constraints![]() |
|---|---|---|---|---|
![]() | 0..* | Base | HIV.D Care-Treatment Logical Model Instances of this logical model are not marked to be the target of a Reference | |
![]() ![]() | 1..1 | string | Reason for visit | |
![]() ![]() | 1..1 | string | First clinical visit | |
![]() ![]() | 1..1 | string | Clinical visit | |
![]() ![]() | 1..1 | string | ART initiation | |
![]() ![]() | 1..1 | string | ART drug pick up | |
![]() ![]() | 1..1 | string | Issues and concerns | |
![]() ![]() | 1..1 | string | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Scheduled visit | |
![]() ![]() | 1..1 | string | Body temperature | |
![]() ![]() | 1..1 | string | Respiratory rate | |
![]() ![]() | 1..1 | string | Heart rate | |
![]() ![]() | 1..1 | string | Body height | |
![]() ![]() | 1..1 | string | Body weight | |
![]() ![]() | 1..1 | string | Systolic blood pressure | |
![]() ![]() | 1..1 | string | Diastolic blood pressure | |
![]() ![]() | 1..1 | string | Blood pressure cannot be taken | |
![]() ![]() | 1..1 | string | Signs of serious illness | |
![]() ![]() | 1..1 | string | Fever of 39 C or greater | |
![]() ![]() | 1..1 | string | Tachycardia | |
![]() ![]() | 1..1 | string | Tachypnea | |
![]() ![]() | 1..1 | string | Unable to walk unaided | |
![]() ![]() | 1..1 | string | Lethargy | |
![]() ![]() | 1..1 | string | Unconsciousness | |
![]() ![]() | 1..1 | string | Convulsions | |
![]() ![]() | 1..1 | string | Unable to drink | |
![]() ![]() | 1..1 | string | Unable to breastfeed | |
![]() ![]() | 1..1 | string | Repeated vomiting | |
![]() ![]() | 1..1 | string | Headache | |
![]() ![]() | 1..1 | string | Other sign of serious illness | |
![]() ![]() | 1..1 | string | Other sign of serious illness (specify) | |
![]() ![]() | 1..1 | string | Currently pregnant | |
![]() ![]() | 1..1 | string | Breastfeeding | |
![]() ![]() | 1..1 | string | Number of pregnancies (gravida) | |
![]() ![]() | 1..1 | string | Number of miscarriages and/or abortions | |
![]() ![]() | 1..1 | string | Number of live births | |
![]() ![]() | 1..1 | string | Parity | |
![]() ![]() | 1..1 | string | Serodiscordant partner | |
![]() ![]() | 1..1 | string | On ART | |
![]() ![]() | 1..1 | string | ART start date | |
![]() ![]() | 1..1 | string | Stopped ART | |
![]() ![]() | 1..1 | string | Date ART stopped | |
![]() ![]() | 1..1 | string | Established on ART | |
![]() ![]() | 1..1 | string | ART start type | |
![]() ![]() | 1..1 | string | First-time user of ART | |
![]() ![]() | 1..1 | string | Restarting ART | |
![]() ![]() | 1..1 | string | Date of initiation on ART | |
![]() ![]() | 1..1 | string | Time on ART | |
![]() ![]() | 1..1 | string | Date(s) ART restarted | |
![]() ![]() | 1..1 | string | ART cohort | |
![]() ![]() | 1..1 | string | Transfer in for HIV care | |
![]() ![]() | 1..1 | string | Date of transfer in | |
![]() ![]() | 1..1 | string | Facility transferred from | |
![]() ![]() | 1..1 | string | Date enrolled in HIV care | |
![]() ![]() | 1..1 | string | Age at enrolment | |
![]() ![]() | 1..1 | string | Facility where client first enrolled in HIV care | |
![]() ![]() | 1..1 | string | Antiretroviral (ARV) drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | No prior ARVs | |
![]() ![]() | 1..1 | string | Received ARVs prior without records/documentation | |
![]() ![]() | 1..1 | string | Received ARVs during pregnancy or breastfeeding | |
![]() ![]() | 1..1 | string | Received ARVs for PEP or PrEP | |
![]() ![]() | 1..1 | string | ARV prophylaxis for an HIV-exposed infant | |
![]() ![]() | 1..1 | string | Date ARV drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | Location ARV drugs received prior to enrolment | |
![]() ![]() | 1..1 | string | ARV drug regimen received prior to enrolment | |
![]() ![]() | 1..1 | string | Existing chronic health conditions | |
![]() ![]() | 1..1 | string | No chronic or past health conditions | |
![]() ![]() | 1..1 | string | Dont know | |
![]() ![]() | 1..1 | string | Diabetes other or unspecified | |
![]() ![]() | 1..1 | string | Diabetes pre-existing type 1 | |
![]() ![]() | 1..1 | string | Diabetes pre-existing type 2 | |
![]() ![]() | 1..1 | string | Hypertension | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Original first-line ART regimen | |
![]() ![]() | 1..1 | string | Current ART regimen | |
![]() ![]() | 1..1 | string | Current ART regimen start date | |
![]() ![]() | 1..1 | string | Preferred first-line ART regimen | |
![]() ![]() | 1..1 | string | Alternative first-line ART regimen | |
![]() ![]() | 1..1 | string | First-line ART regimen under special circumstances | |
![]() ![]() | 1..1 | string | Preferred second-line ART regimen | |
![]() ![]() | 1..1 | string | Alternative second-line ART regimen | |
![]() ![]() | 1..1 | string | Optimal regimen for transition | |
![]() ![]() | 1..1 | string | Current ART regimen (first-, second-, or third-line) | |
![]() ![]() | 1..1 | string | First-line ART regimen for adults and adolescents | |
![]() ![]() | 1..1 | string | First-line ART regimen for children | |
![]() ![]() | 1..1 | string | First-line ART regimen for neonates | |
![]() ![]() | 1..1 | string | Second-line ART regimen for adults and adolescents | |
![]() ![]() | 1..1 | string | Second-line ART regimen for children | |
![]() ![]() | 1..1 | string | Third-line ART regimen | |
![]() ![]() | 1..1 | string | ART regimen | |
![]() ![]() | 1..1 | string | ABC + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | ABC + 3TC + DTG | |
![]() ![]() | 1..1 | string | ABC + 3TC + EFV | |
![]() ![]() | 1..1 | string | ABC + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | ABC + 3TC + NVP | |
![]() ![]() | 1..1 | string | ABC + 3TC + RAL | |
![]() ![]() | 1..1 | string | AZT + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + DRV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + DTG | |
![]() ![]() | 1..1 | string | AZT + 3TC + EFV | |
![]() ![]() | 1..1 | string | AZT + 3TC + EFV 600 mg | |
![]() ![]() | 1..1 | string | AZT + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | AZT + 3TC + NVP | |
![]() ![]() | 1..1 | string | AZT + 3TC + RAL | |
![]() ![]() | 1..1 | string | TAF + 3TC + DTG | |
![]() ![]() | 1..1 | string | TAF + FTC + DTG | |
![]() ![]() | 1..1 | string | TDF + 3TC + ATV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + DRV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + DTG | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV 400 mg | |
![]() ![]() | 1..1 | string | TDF + 3TC + EFV 600 mg | |
![]() ![]() | 1..1 | string | TDF + 3TC + LPV/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + NVP | |
![]() ![]() | 1..1 | string | TDF + 3TC + PI/r | |
![]() ![]() | 1..1 | string | TDF + 3TC + RAL | |
![]() ![]() | 1..1 | string | TDF + FTC + ATV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + DRV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + DTG | |
![]() ![]() | 1..1 | string | TDF + FTC + EFV | |
![]() ![]() | 1..1 | string | TDF + FTC + EFV 600 mg | |
![]() ![]() | 1..1 | string | TDF + FTC + LPV/r | |
![]() ![]() | 1..1 | string | TDF + FTC + NVP | |
![]() ![]() | 1..1 | string | TDF + FTC + PI/r | |
![]() ![]() | 1..1 | string | TDF + FTC + RAL | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | ART regimen composition | |
![]() ![]() | 1..1 | string | ABC | |
![]() ![]() | 1..1 | string | FTC | |
![]() ![]() | 1..1 | string | 3TC | |
![]() ![]() | 1..1 | string | AZT | |
![]() ![]() | 1..1 | string | DDI | |
![]() ![]() | 1..1 | string | D4T | |
![]() ![]() | 1..1 | string | TDF | |
![]() ![]() | 1..1 | string | EFV | |
![]() ![]() | 1..1 | string | ETV | |
![]() ![]() | 1..1 | string | NVP | |
![]() ![]() | 1..1 | string | RIL | |
![]() ![]() | 1..1 | string | ATV/r | |
![]() ![]() | 1..1 | string | LPV/r | |
![]() ![]() | 1..1 | string | DRV/r | |
![]() ![]() | 1..1 | string | RTV | |
![]() ![]() | 1..1 | string | DTG | |
![]() ![]() | 1..1 | string | RAL | |
![]() ![]() | 1..1 | string | ART regimen drug class | |
![]() ![]() | 1..1 | string | NRTI | |
![]() ![]() | 1..1 | string | NtRTI | |
![]() ![]() | 1..1 | string | NNRTI | |
![]() ![]() | 1..1 | string | PI | |
![]() ![]() | 1..1 | string | INSTI | |
![]() ![]() | 1..1 | string | Prevention services offered and referrals | |
![]() ![]() | 1..1 | string | Offer male and female condoms and condom-compatible lubricants | |
![]() ![]() | 1..1 | string | Harm reduction for people who inject drugs | |
![]() ![]() | 1..1 | string | Behavioural interventions to support risk reduction | |
![]() ![]() | 1..1 | string | Sexual and reproductive health integrated services | |
![]() ![]() | 1..1 | string | Contraception and family planning | |
![]() ![]() | 1..1 | string | Check pregnancy status | |
![]() ![]() | 1..1 | string | Prevention of mother-to-child transmission | |
![]() ![]() | 1..1 | string | STI testing and treatment | |
![]() ![]() | 1..1 | string | HBsAg test date | |
![]() ![]() | 1..1 | string | HBsAg test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Indeterminate | |
![]() ![]() | 1..1 | string | Date HBV test result returned to client | |
![]() ![]() | 1..1 | string | HBV treatment (TDF) start date | |
![]() ![]() | 1..1 | string | HBV treatment regimen prescribed | |
![]() ![]() | 1..1 | string | HCV test date | |
![]() ![]() | 1..1 | string | HCV test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Indeterminate | |
![]() ![]() | 1..1 | string | Date HCV test result returned to client | |
![]() ![]() | 1..1 | string | HCV treatment start date | |
![]() ![]() | 1..1 | string | HCV treatment completion date | |
![]() ![]() | 1..1 | string | HCV treatment regimen prescribed | |
![]() ![]() | 1..1 | string | HCV viral load test date | |
![]() ![]() | 1..1 | string | HCV viral load test result | |
![]() ![]() | 1..1 | string | Detected | |
![]() ![]() | 1..1 | string | Not detected | |
![]() ![]() | 1..1 | string | HCV medicine type | |
![]() ![]() | 1..1 | string | Interferon | |
![]() ![]() | 1..1 | string | Direct acting antivirals | |
![]() ![]() | 1..1 | string | Currently on TDF-based ART | |
![]() ![]() | 1..1 | string | HIV clinical stage | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 1 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 2 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 3 | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage 4 | |
![]() ![]() | 1..1 | string | Number of missed doses | |
![]() ![]() | 1..1 | string | Received viral load test result | |
![]() ![]() | 1..1 | string | Date viral load test results received by client | |
![]() ![]() | 1..1 | string | Date of viral load sample collection | |
![]() ![]() | 1..1 | string | Date of scheduled review of viral load test results | |
![]() ![]() | 1..1 | string | Date of ART interruption | |
![]() ![]() | 1..1 | string | Reason(s) for adherence problem | |
![]() ![]() | 1..1 | string | Forgot | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Busy | |
![]() ![]() | 1..1 | string | Change of routine | |
![]() ![]() | 1..1 | string | Travel cost | |
![]() ![]() | 1..1 | string | Distance to clinic | |
![]() ![]() | 1..1 | string | Client lost/ran out of pills | |
![]() ![]() | 1..1 | string | Stock-out | |
![]() ![]() | 1..1 | string | Too ill | |
![]() ![]() | 1..1 | string | Pill burden | |
![]() ![]() | 1..1 | string | Felt well | |
![]() ![]() | 1..1 | string | Depression | |
![]() ![]() | 1..1 | string | Alcohol use | |
![]() ![]() | 1..1 | string | Substance use | |
![]() ![]() | 1..1 | string | Stigma/disclosure concerns | |
![]() ![]() | 1..1 | string | Lack of food | |
![]() ![]() | 1..1 | string | Poor palatability | |
![]() ![]() | 1..1 | string | Other reason for nonadherence | |
![]() ![]() | 1..1 | string | Other reason for nonadherence (specify) | |
![]() ![]() | 1..1 | string | Reason ART stopped | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Severe illness, hospitalization | |
![]() ![]() | 1..1 | string | Drugs out of stock | |
![]() ![]() | 1..1 | string | Client lacks finances | |
![]() ![]() | 1..1 | string | Excluded HIV infection in infant | |
![]() ![]() | 1..1 | string | Other reason for stopping ART | |
![]() ![]() | 1..1 | string | Other reason for stopping ART (specify) | |
![]() ![]() | 1..1 | string | Treatment failure | |
![]() ![]() | 1..1 | string | Clinical failure | |
![]() ![]() | 1..1 | string | Immunological failure | |
![]() ![]() | 1..1 | string | Virological failure | |
![]() ![]() | 1..1 | string | General care activities recommended | |
![]() ![]() | 1..1 | string | Determine WHO clinical stage | |
![]() ![]() | 1..1 | string | Determine if advanced disease | |
![]() ![]() | 1..1 | string | Prepare for ART | |
![]() ![]() | 1..1 | string | Prepare, assess and support adherence | |
![]() ![]() | 1..1 | string | Manage current medications | |
![]() ![]() | 1..1 | string | Check pregnancy status | |
![]() ![]() | 1..1 | string | Provide family planning and contraception | |
![]() ![]() | 1..1 | string | Support disclosure and partner notification | |
![]() ![]() | 1..1 | string | Counsel on risk reduction and prevention | |
![]() ![]() | 1..1 | string | Assess, prevent and manage noncommunicable diseases | |
![]() ![]() | 1..1 | string | Screen for and manage mental health problems | |
![]() ![]() | 1..1 | string | Screen for and manage and substance use issues | |
![]() ![]() | 1..1 | string | Provide psychosocial counselling and support | |
![]() ![]() | 1..1 | string | Manage pain and symptoms | |
![]() ![]() | 1..1 | string | Conduct a nutritional assessment and counsel on nutrition | |
![]() ![]() | 1..1 | string | Conduct a growth and development assessment | |
![]() ![]() | 1..1 | string | Provide support on infant and child feeding | |
![]() ![]() | 1..1 | string | Preventing and treating coinfections | |
![]() ![]() | 1..1 | string | Provide co-trimoxazole preventive therapy (CPT) | |
![]() ![]() | 1..1 | string | Intensified TB case finding and linkage to TB treatment | |
![]() ![]() | 1..1 | string | Provide isoniazid preventive therapy | |
![]() ![]() | 1..1 | string | Screen for cryptococcal infection and fungal prophylaxis | |
![]() ![]() | 1..1 | string | Screen for hepatitis B | |
![]() ![]() | 1..1 | string | Screen for hepatitis C | |
![]() ![]() | 1..1 | string | Prevent malaria | |
![]() ![]() | 1..1 | string | Screen for STIs | |
![]() ![]() | 1..1 | string | Prevent and screen for cervical cancer | |
![]() ![]() | 1..1 | string | Anal cancer screening (for men who have sex with men) | |
![]() ![]() | 1..1 | string | Assessment and provision of vaccinations | |
![]() ![]() | 1..1 | string | Risk factors, comorbidities and coinfections signs and symptoms | |
![]() ![]() | 1..1 | string | Oral candidiasis | |
![]() ![]() | 1..1 | string | Vaginal candidiasis | |
![]() ![]() | 1..1 | string | Cough | |
![]() ![]() | 1..1 | string | Prolonged fever | |
![]() ![]() | 1..1 | string | Night sweats | |
![]() ![]() | 1..1 | string | Weight loss | |
![]() ![]() | 1..1 | string | Difficulty breathing | |
![]() ![]() | 1..1 | string | Pneumonia | |
![]() ![]() | 1..1 | string | Urethral discharge | |
![]() ![]() | 1..1 | string | Syphilis | |
![]() ![]() | 1..1 | string | Pelvic inflammatory disease | |
![]() ![]() | 1..1 | string | Ulcers - skin | |
![]() ![]() | 1..1 | string | Ulcers - mouth or other | |
![]() ![]() | 1..1 | string | Ulcers - male genital | |
![]() ![]() | 1..1 | string | Vaginal discharge | |
![]() ![]() | 1..1 | string | Malaria | |
![]() ![]() | 1..1 | string | Chronic obstructive pulmonary disease | |
![]() ![]() | 1..1 | string | Hypertension | |
![]() ![]() | 1..1 | string | Diabetes | |
![]() ![]() | 1..1 | string | Gestational diabetes | |
![]() ![]() | 1..1 | string | Mental health disorders | |
![]() ![]() | 1..1 | string | Diarrhoea or abdominal pain | |
![]() ![]() | 1..1 | string | Presumptive TB | |
![]() ![]() | 1..1 | string | Severe or complicated malnutrition | |
![]() ![]() | 1..1 | string | Poor growth or development | |
![]() ![]() | 1..1 | string | Oedema | |
![]() ![]() | 1..1 | string | Previously treated for TB | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | WHO HIV clinical stage condition or symptom | |
![]() ![]() | 1..1 | string | Asymptomatic | |
![]() ![]() | 1..1 | string | Persistent generalized lymphadenopathy | |
![]() ![]() | 1..1 | string | Moderate unexplained weight loss | |
![]() ![]() | 1..1 | string | Recurrent respiratory tract infections | |
![]() ![]() | 1..1 | string | Unexplained persistent hepatosplenomegaly | |
![]() ![]() | 1..1 | string | Herpes zoster | |
![]() ![]() | 1..1 | string | Angular cheilitis | |
![]() ![]() | 1..1 | string | Linear gingival erythema | |
![]() ![]() | 1..1 | string | Recurrent oral ulceration | |
![]() ![]() | 1..1 | string | Papular pruritic eruption | |
![]() ![]() | 1..1 | string | Fungal nail infections | |
![]() ![]() | 1..1 | string | Seborrhoeic dermatitis | |
![]() ![]() | 1..1 | string | Extensive wart virus infection | |
![]() ![]() | 1..1 | string | Extensive molluscum contagiosum | |
![]() ![]() | 1..1 | string | Unexplained persistent parotid enlargement | |
![]() ![]() | 1..1 | string | Unexplained severe weight loss in adults | |
![]() ![]() | 1..1 | string | Unexplained moderate malnutrition not adequately responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained chronic diarrhoea for longer than 1 month | |
![]() ![]() | 1..1 | string | Unexplained persistent diarrhoea (14 days or more) | |
![]() ![]() | 1..1 | string | Unexplained persistent fever (above 37.5 C, intermittent or constant, for longer than one 1 month) | |
![]() ![]() | 1..1 | string | Persistent oral candidiasis | |
![]() ![]() | 1..1 | string | Oral hairy leukoplakia | |
![]() ![]() | 1..1 | string | Pulmonary TB | |
![]() ![]() | 1..1 | string | Lymph node TB | |
![]() ![]() | 1..1 | string | Severe bacterial infections (such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia) | |
![]() ![]() | 1..1 | string | Severe recurrent bacterial pneumonia | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative stomatitis | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative gingivitis | |
![]() ![]() | 1..1 | string | Acute necrotizing ulcerative periodontitis | |
![]() ![]() | 1..1 | string | Unexplained anaemia (<8 g/dL) | |
![]() ![]() | 1..1 | string | Neutropaenia (<0.5 x 10^9/L) | |
![]() ![]() | 1..1 | string | Chronic thrombocytopaenia (<50 x 10^9/L) | |
![]() ![]() | 1..1 | string | Symptomatic lymphoid interstitial pneumonitis | |
![]() ![]() | 1..1 | string | Chronic HIV-associated lung disease, including bronchiectasis | |
![]() ![]() | 1..1 | string | HIV wasting syndrome | |
![]() ![]() | 1..1 | string | Unexplained severe wasting not responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained stunting not responding to standard therapy | |
![]() ![]() | 1..1 | string | Unexplained severe malnutrition not responding to standard therapy | |
![]() ![]() | 1..1 | string | Pneumocystis (jirovecii) pneumonia | |
![]() ![]() | 1..1 | string | Recurrent severe bacterial pneumonia | |
![]() ![]() | 1..1 | string | Recurrent severe bacterial infections (such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia) | |
![]() ![]() | 1..1 | string | Empyema | |
![]() ![]() | 1..1 | string | Pyomyositis | |
![]() ![]() | 1..1 | string | Bone or joint infection | |
![]() ![]() | 1..1 | string | Meningitis | |
![]() ![]() | 1..1 | string | Chronic herpes simplex infection (orolabial or cutaneous of more than 1 month duration or visceral at any site) | |
![]() ![]() | 1..1 | string | Chronic herpes simplex infection (orolabial, genital or anorectal of more than 1 month in duration or visceral at any site) | |
![]() ![]() | 1..1 | string | Oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs) | |
![]() ![]() | 1..1 | string | Extrapulmonary TB | |
![]() ![]() | 1..1 | string | Kaposi sarcoma | |
![]() ![]() | 1..1 | string | Cytomegalovirus infection (retinitis or infection of other organs) | |
![]() ![]() | 1..1 | string | Central nervous system toxoplasmosis | |
![]() ![]() | 1..1 | string | HIV encephalopathy | |
![]() ![]() | 1..1 | string | Extrapulmonary cryptococcosis, including meningitis | |
![]() ![]() | 1..1 | string | Disseminated nontuberculous mycobacterial infection | |
![]() ![]() | 1..1 | string | Progressive multifocal leukoencephalopathy | |
![]() ![]() | 1..1 | string | Chronic cryptosporidiosis | |
![]() ![]() | 1..1 | string | Chronic cryptosporidiosis (with diarrhoea) | |
![]() ![]() | 1..1 | string | Chronic isosporiasis | |
![]() ![]() | 1..1 | string | Disseminated mycosis (extrapulmonary histoplasmosis, coccidioidomycosis) | |
![]() ![]() | 1..1 | string | Disseminated endemic mycosis (extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis) | |
![]() ![]() | 1..1 | string | Cerebral lymphoma | |
![]() ![]() | 1..1 | string | B-cell non-Hodgkin lymphoma | |
![]() ![]() | 1..1 | string | HIV-associated nephropathy or cardiomyopathy | |
![]() ![]() | 1..1 | string | Recurrent septicaemia (including nontyphoidal Salmonella) | |
![]() ![]() | 1..1 | string | Invasive cervical carcinoma | |
![]() ![]() | 1..1 | string | Atypical disseminated leishmaniasis | |
![]() ![]() | 1..1 | string | Neutropenia | |
![]() ![]() | 1..1 | string | Clinical stage at start of ART | |
![]() ![]() | 1..1 | string | WHO clinical stage 1 | |
![]() ![]() | 1..1 | string | WHO clinical stage 2 | |
![]() ![]() | 1..1 | string | WHO clinical stage 3 | |
![]() ![]() | 1..1 | string | WHO clinical stage 4 | |
![]() ![]() | 1..1 | string | Date of clinical status change | |
![]() ![]() | 1..1 | string | CD4 count | |
![]() ![]() | 1..1 | string | CD4 cell percentage | |
![]() ![]() | 1..1 | string | Date of CD4 count test | |
![]() ![]() | 1..1 | string | Baseline CD4 count | |
![]() ![]() | 1..1 | string | Date of baseline CD4 count test | |
![]() ![]() | 1..1 | string | Late ART initiation | |
![]() ![]() | 1..1 | string | Reasons for delayed ART initiation | |
![]() ![]() | 1..1 | string | Patient self-reported as not ready/willing | |
![]() ![]() | 1..1 | string | Not completed education, support and preparation for ART | |
![]() ![]() | 1..1 | string | Fear of disclosure | |
![]() ![]() | 1..1 | string | Patient lacks finances | |
![]() ![]() | 1..1 | string | Initiated on TB treatment | |
![]() ![]() | 1..1 | string | Patient initiated on treatment for TB meningitis | |
![]() ![]() | 1..1 | string | Patient diagnosed with cryptococcal meningitis | |
![]() ![]() | 1..1 | string | Patient diagnosed with histoplasmosis | |
![]() ![]() | 1..1 | string | Patient critically/severely ill | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | ART initiated within 7 days of diagnosis | |
![]() ![]() | 1..1 | string | Time to start ART | |
![]() ![]() | 1..1 | string | Within 7 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Within 30 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Within 90 days of HIV diagnosis | |
![]() ![]() | 1..1 | string | Viral load test result | |
![]() ![]() | 1..1 | string | Virally suppressed | |
![]() ![]() | 1..1 | string | Date viral load test results received | |
![]() ![]() | 1..1 | string | Viral load suppression date | |
![]() ![]() | 1..1 | string | Reason for HIV viral load test | |
![]() ![]() | 1..1 | string | Routine viral load test | |
![]() ![]() | 1..1 | string | Targeted viral load monitoring | |
![]() ![]() | 1..1 | string | Initial viral load test | |
![]() ![]() | 1..1 | string | Follow-up viral load test after receiving enhanced adherence counselling | |
![]() ![]() | 1..1 | string | Hepatitis B test required | |
![]() ![]() | 1..1 | string | Hepatitis C test recommended | |
![]() ![]() | 1..1 | string | Syphilis test required | |
![]() ![]() | 1..1 | string | Monitoring examinations | |
![]() ![]() | 1..1 | string | Haemoglobin (Hb) | |
![]() ![]() | 1..1 | string | Pregnancy test | |
![]() ![]() | 1..1 | string | Syphilis test | |
![]() ![]() | 1..1 | string | Chest X-ray (CXR) | |
![]() ![]() | 1..1 | string | Sputum or culture for TB | |
![]() ![]() | 1..1 | string | HBsAg test (HBV) | |
![]() ![]() | 1..1 | string | HIV viral load test ordered | |
![]() ![]() | 1..1 | string | HIV viral load test scheduled | |
![]() ![]() | 1..1 | string | CD4 count ordered | |
![]() ![]() | 1..1 | string | CD4 count test scheduled | |
![]() ![]() | 1..1 | string | Cryptococcal antigen test | |
![]() ![]() | 1..1 | string | Histoplasmosis antigen test | |
![]() ![]() | 1..1 | string | Cervical cancer screening scheduled | |
![]() ![]() | 1..1 | string | Date of scheduled monitoring examination | |
![]() ![]() | 1..1 | string | Hepatitis C test ordered | |
![]() ![]() | 1..1 | string | Syphilis test ordered | |
![]() ![]() | 1..1 | string | Received viral load test results | |
![]() ![]() | 1..1 | string | Date viral load test results received by client | |
![]() ![]() | 1..1 | string | Reason for ARV drug regimen substitution | |
![]() ![]() | 1..1 | string | Toxicity/side effects | |
![]() ![]() | 1..1 | string | Drug-drug interaction | |
![]() ![]() | 1..1 | string | Pregnancy | |
![]() ![]() | 1..1 | string | New TB | |
![]() ![]() | 1..1 | string | New drug available | |
![]() ![]() | 1..1 | string | Drug out of stock | |
![]() ![]() | 1..1 | string | Other reason for regimen substitution | |
![]() ![]() | 1..1 | string | Other reason for regimen substitution (specify) | |
![]() ![]() | 1..1 | string | Switch to second-line ART regimen recommended | |
![]() ![]() | 1..1 | string | Switch to third-line ART regimen recommended | |
![]() ![]() | 1..1 | string | Regimen switch made | |
![]() ![]() | 1..1 | string | Reason for regimen switch | |
![]() ![]() | 1..1 | string | Clinical treatment failure | |
![]() ![]() | 1..1 | string | Immunological failure | |
![]() ![]() | 1..1 | string | Virological failure | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Regimen substitution recommended | |
![]() ![]() | 1..1 | string | Dose adjustment recommended | |
![]() ![]() | 1..1 | string | Regimen substitution made | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis start date | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis completion date | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis dosage | |
![]() ![]() | 1..1 | string | Co-trimoxazole prophylaxis number of days prescribed | |
![]() ![]() | 1..1 | string | Suspicion of treatment failure or interruption | |
![]() ![]() | 1..1 | string | ART regimen prescribed | |
![]() ![]() | 1..1 | string | Antiretroviral toxicity | |
![]() ![]() | 1..1 | string | Coinfection status at ART start | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Hepatitis C | |
![]() ![]() | 1..1 | string | Pregnant and breastfeeding status at ART start | |
![]() ![]() | 1..1 | string | Pregnant at ART start | |
![]() ![]() | 1..1 | string | Postpartum at ART start | |
![]() ![]() | 1..1 | string | ART start at labour and delivery | |
![]() ![]() | 1..1 | string | Breastfeeding at ART start | |
![]() ![]() | 1..1 | string | Delivery date of infant | |
![]() ![]() | 1..1 | string | Serodiscordant partner at ART start | |
![]() ![]() | 1..1 | string | Regimen start date | |
![]() ![]() | 1..1 | string | Medications prescribed | |
![]() ![]() | 1..1 | string | Date medications prescribed | |
![]() ![]() | 1..1 | string | Dose of medications prescribed | |
![]() ![]() | 1..1 | string | Number of days medications prescribed | |
![]() ![]() | 1..1 | string | Medications dispensed | |
![]() ![]() | 1..1 | string | Number of days of medications dispensed | |
![]() ![]() | 1..1 | string | Dosage | |
![]() ![]() | 1..1 | string | Frequency | |
![]() ![]() | 1..1 | string | Adherence counselling provided | |
![]() ![]() | 1..1 | string | Type of treatment-limiting toxicity | |
![]() ![]() | 1..1 | string | Gastrointestinal | |
![]() ![]() | 1..1 | string | Skin issues | |
![]() ![]() | 1..1 | string | Peripheral neuropathy | |
![]() ![]() | 1..1 | string | Central nervous system symptoms | |
![]() ![]() | 1..1 | string | Weight gain | |
![]() ![]() | 1..1 | string | Hepatic dysfunction | |
![]() ![]() | 1..1 | string | Haematological disorders | |
![]() ![]() | 1..1 | string | Fatigue | |
![]() ![]() | 1..1 | string | Headache | |
![]() ![]() | 1..1 | string | Bone dysfunction | |
![]() ![]() | 1..1 | string | Metabolic symptoms | |
![]() ![]() | 1..1 | string | Kidney dysfunction | |
![]() ![]() | 1..1 | string | Unexpected adverse drug reaction | |
![]() ![]() | 1..1 | string | Unexpected adverse drug reaction (specify) | |
![]() ![]() | 1..1 | string | Date(s) of substitution within first-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within first-line regimen | |
![]() ![]() | 1..1 | string | New antiretroviral regimen after substitution within first-line regimen | |
![]() ![]() | 1..1 | string | Date of switch to second-line regimen | |
![]() ![]() | 1..1 | string | New regimen after switch to second-line regimen | |
![]() ![]() | 1..1 | string | Reason for switch to second-line regimen | |
![]() ![]() | 1..1 | string | Date(s) of substitution within second-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within second-line regimen | |
![]() ![]() | 1..1 | string | New regimen(s) after substitution within second-line regimen | |
![]() ![]() | 1..1 | string | Date of switch to third-line regimen | |
![]() ![]() | 1..1 | string | New regimen after switch to third-line regimen | |
![]() ![]() | 1..1 | string | Reason for switch to third-line regimen | |
![]() ![]() | 1..1 | string | Date(s) of substitution within third-line regimen | |
![]() ![]() | 1..1 | string | Reason(s) for substitution within third-line regimen | |
![]() ![]() | 1..1 | string | New regimen(s) after substitution within third-line regimen | |
![]() ![]() | 1..1 | string | Enhanced adherence counselling provided | |
![]() ![]() | 1..1 | string | First enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of first enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Second enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of second enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Third enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Date of third enhanced adherence counselling session completed | |
![]() ![]() | 1..1 | string | Name of treatment supporter | |
![]() ![]() | 1..1 | string | Address of treatment supporter | |
![]() ![]() | 1..1 | string | Telephone number of treatment supporter | |
![]() ![]() | 1..1 | string | Home-based care provider | |
![]() ![]() | 1..1 | string | Counselling provided on diagnoses | |
![]() ![]() | 1..1 | string | Hepatitis B positive counselling conducted | |
![]() ![]() | 1..1 | string | Hepatitis C positive counselling conducted | |
![]() ![]() | 1..1 | string | Syphilis counselling and treatment | |
![]() ![]() | 1..1 | string | Syphilis counselling, treatment and further testing | |
![]() ![]() | 1..1 | string | Accepted partner services | |
![]() ![]() | 1..1 | string | HIV testing for partners and biological children | |
![]() ![]() | 1..1 | string | HIV status of family member | |
![]() ![]() | 1..1 | string | Unique ID of family member | |
![]() ![]() | 1..1 | string | Date of death of family member | |
![]() ![]() | 1..1 | string | Offered voluntary partner services | |
![]() ![]() | 1..1 | string | Provided support for disclosure and partner services | |
![]() ![]() | 1..1 | string | Other support services | |
![]() ![]() | 1..1 | string | Mental health services | |
![]() ![]() | 1..1 | string | Psychosocial counselling, support and treatment adherence counselling | |
![]() ![]() | 1..1 | string | Legal and social services | |
![]() ![]() | 1..1 | string | Services for responding to violence against women | |
![]() ![]() | 1..1 | string | Date/time of follow-up appointment | |
![]() ![]() | 1..1 | string | Type of follow-up appointment | |
![]() ![]() | 1..1 | string | Clinical visit | |
![]() ![]() | 1..1 | string | Antiretroviral drug pick up | |
![]() ![]() | 1..1 | string | Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Follow-up test recommended date | |
![]() ![]() | 1..1 | string | Reason blood pressure reading not done | |
![]() ![]() | 1..1 | string | BP cuff (sphygmomanometer) not available | |
![]() ![]() | 1..1 | string | BP cuff (sphygmomanometer) is broken | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Current medications | |
![]() ![]() | 1..1 | string | No medications | |
![]() ![]() | 1..1 | string | Dont know of any current medications | |
![]() ![]() | 1..1 | string | Analgesic | |
![]() ![]() | 1..1 | string | Antacids | |
![]() ![]() | 1..1 | string | Antibiotics (broad-spectrum) | |
![]() ![]() | 1..1 | string | Anticonvulsive | |
![]() ![]() | 1..1 | string | Antidiabetic | |
![]() ![]() | 1..1 | string | Antifungals | |
![]() ![]() | 1..1 | string | Antihelmintic | |
![]() ![]() | 1..1 | string | Antihypertensive | |
![]() ![]() | 1..1 | string | Antimalarials | |
![]() ![]() | 1..1 | string | Antiretrovirals (ARVs) | |
![]() ![]() | 1..1 | string | Antiparasitics | |
![]() ![]() | 1..1 | string | Antivirals | |
![]() ![]() | 1..1 | string | Buprenorphine | |
![]() ![]() | 1..1 | string | Co-trimoxazole preventive therapy (CPT) | |
![]() ![]() | 1..1 | string | Hormonal family planning method | |
![]() ![]() | 1..1 | string | Methadone | |
![]() ![]() | 1..1 | string | PrEP to prevent HIV | |
![]() ![]() | 1..1 | string | Other antibiotics | |
![]() ![]() | 1..1 | string | Other medications | |
![]() ![]() | 1..1 | string | Other medications (specify) | |
![]() ![]() | 1..1 | string | Allergies | |
![]() ![]() | 1..1 | string | No known allergies | |
![]() ![]() | 1..1 | string | Dont know of any allergies | |
![]() ![]() | 1..1 | string | Albendazole | |
![]() ![]() | 1..1 | string | Malaria medication (sulfadoxine-pyrimethamine) | |
![]() ![]() | 1..1 | string | Penicillin | |
![]() ![]() | 1..1 | string | Tenofovir disoproxil fumarate (TDF) | |
![]() ![]() | 1..1 | string | Other allergies | |
![]() ![]() | 1..1 | string | Other allergies (specify) | |
![]() ![]() | 1..1 | string | Family planning method used | |
![]() ![]() | 1..1 | string | Copper-bearing intrauterine device (Cu-IUD) | |
![]() ![]() | 1..1 | string | Levonorgestrel intrauterine device (LNG-IUD) | |
![]() ![]() | 1..1 | string | Etonogestrel (ETG) one-rod implant | |
![]() ![]() | 1..1 | string | Levonorgestrel (LNG) two-rod implant | |
![]() ![]() | 1..1 | string | DMPA-IM | |
![]() ![]() | 1..1 | string | DMPA-SC | |
![]() ![]() | 1..1 | string | NET-EN norethisterone enanthate | |
![]() ![]() | 1..1 | string | Progestogen-only pills (POP) | |
![]() ![]() | 1..1 | string | Combined oral contraceptives (COCs) | |
![]() ![]() | 1..1 | string | Combined contraceptive patch | |
![]() ![]() | 1..1 | string | Combined contraceptive vaginal ring (CVR) | |
![]() ![]() | 1..1 | string | Progesterone-releasing vaginal ring (PVR) | |
![]() ![]() | 1..1 | string | Lactational amenorrhea method (LAM) | |
![]() ![]() | 1..1 | string | Emergency contraceptive pills (ECPs) | |
![]() ![]() | 1..1 | string | Fertility awareness-based methods (FAB) | |
![]() ![]() | 1..1 | string | Male condoms | |
![]() ![]() | 1..1 | string | Female condoms | |
![]() ![]() | 1..1 | string | Withdrawal | |
![]() ![]() | 1..1 | string | Female relying on male method | |
![]() ![]() | 1..1 | string | Male relying on female method | |
![]() ![]() | 1..1 | string | Male sterilization | |
![]() ![]() | 1..1 | string | Female sterilization | |
![]() ![]() | 1..1 | string | No method | |
![]() ![]() | 1..1 | string | Medication status | |
![]() ![]() | 1..1 | string | Currently taking | |
![]() ![]() | 1..1 | string | Completed | |
![]() ![]() | 1..1 | string | Entered in error | |
![]() ![]() | 1..1 | string | Intended | |
![]() ![]() | 1..1 | string | Stopped | |
![]() ![]() | 1..1 | string | On hold | |
![]() ![]() | 1..1 | string | Unknown | |
![]() ![]() | 1..1 | string | Did not take | |
![]() ![]() | 1..1 | string | Hepatitis B negative counselling conducted | |
![]() ![]() | 1..1 | string | Vaccine brand | |
![]() ![]() | 1..1 | string | Vaccine type | |
![]() ![]() | 1..1 | string | Date and time of vaccination | |
![]() ![]() | 1..1 | string | Vaccination location | |
![]() ![]() | 1..1 | string | Dose number | |
![]() ![]() | 1..1 | string | Dose quantity | |
![]() ![]() | 1..1 | string | Total doses in series | |
![]() ![]() | 1..1 | string | Disease targeted | |
![]() ![]() | 1..1 | string | Hepatitis A | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Tetanus | |
![]() ![]() | 1..1 | string | COVID-19 | |
![]() ![]() | 1..1 | string | Influenza due to influenza B virus | |
![]() ![]() | 1..1 | string | Tuberculosis | |
![]() ![]() | 1..1 | string | Acute poliomyelitis | |
![]() ![]() | 1..1 | string | Measles | |
![]() ![]() | 1..1 | string | Diptheria | |
![]() ![]() | 1..1 | string | Rabies | |
![]() ![]() | 1..1 | string | Cholera | |
![]() ![]() | 1..1 | string | Mumps | |
![]() ![]() | 1..1 | string | HPV infection | |
![]() ![]() | 1..1 | string | Haemophilus influenzae type B | |
![]() ![]() | 1..1 | string | Varicella | |
![]() ![]() | 1..1 | string | Dengue | |
![]() ![]() | 1..1 | string | Yellow fever | |
![]() ![]() | 1..1 | string | Japanese Encephalitis | |
![]() ![]() | 1..1 | string | Rubella | |
![]() ![]() | 1..1 | string | Pertussis | |
![]() ![]() | 1..1 | string | Enteritis due to rotavirus | |
![]() ![]() | 1..1 | string | Pneumococcal disease | |
![]() ![]() | 1..1 | string | Meningococcal disease | |
![]() ![]() | 1..1 | string | Tick-borne encephalitis | |
![]() ![]() | 1..1 | string | Typhoid | |
![]() ![]() | 1..1 | string | Reason immunization was not provided | |
![]() ![]() | 1..1 | string | Stock-out | |
![]() ![]() | 1..1 | string | Client is ill | |
![]() ![]() | 1..1 | string | Client refused | |
![]() ![]() | 1..1 | string | Allergy to vaccine | |
![]() ![]() | 1..1 | string | Other reason immunization not provided | |
![]() ![]() | 1..1 | string | Other reason immunization not provided (specify) | |
![]() ![]() | 1..1 | string | Malaria prophylaxis | |
![]() ![]() | 1..1 | string | IPTp-SP dose number provided | |
![]() ![]() | 1..1 | string | Date IPTp-SP dose provided | |
![]() ![]() | 1..1 | string | Reason malaria prophylaxis not provided | |
![]() ![]() | 1..1 | string | Client was referred | |
![]() ![]() | 1..1 | string | Stock out | |
![]() ![]() | 1..1 | string | Expired | |
![]() ![]() | 1..1 | string | Other reason not provided | |
![]() ![]() | 1..1 | string | Other reason not provided (specify) | |
![]() ![]() | 1..1 | string | >28 days since last missed appointment | |
![]() ![]() | 1..1 | string | AIDS-related death | |
![]() ![]() | 1..1 | string | Date of first AIDS diagnosis | |
![]() ![]() | 1..1 | string | Age at final HPV vaccination dose received | |
![]() ![]() | 1..1 | string | Date of cervical cancer screening test | |
![]() ![]() | 1..1 | string | Lifetime screening test number | |
![]() ![]() | 1..1 | string | Cervical cancer primary screening test type | |
![]() ![]() | 1..1 | string | HPV-DNA | |
![]() ![]() | 1..1 | string | VIA | |
![]() ![]() | 1..1 | string | Cervical cytology | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | HPV-DNA cervical cancer screening test result | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Invalid | |
![]() ![]() | 1..1 | string | VIA cervical cancer screening test result | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Suspected cancer | |
![]() ![]() | 1..1 | string | Invalid | |
![]() ![]() | 1..1 | string | Cervical cytology screening test result | |
![]() ![]() | 1..1 | string | NILM | |
![]() ![]() | 1..1 | string | ASCUS | |
![]() ![]() | 1..1 | string | LSIL | |
![]() ![]() | 1..1 | string | HSIL | |
![]() ![]() | 1..1 | string | Cancer | |
![]() ![]() | 1..1 | string | Invalid/inadequate | |
![]() ![]() | 1..1 | string | Cervical cancer triage test date | |
![]() ![]() | 1..1 | string | Cervical cancer triage test type | |
![]() ![]() | 1..1 | string | VIA | |
![]() ![]() | 1..1 | string | Colposcopy | |
![]() ![]() | 1..1 | string | Cervical cytology | |
![]() ![]() | 1..1 | string | HPV16/18 | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | HPV16/18 test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Cervical cancer colposcopy result | |
![]() ![]() | 1..1 | string | Normal colposcopic findings | |
![]() ![]() | 1..1 | string | Abnormal colposcopic findings | |
![]() ![]() | 1..1 | string | Suspicious for invasive cervical cancer | |
![]() ![]() | 1..1 | string | Miscellaneous findings | |
![]() ![]() | 1..1 | string | Inadequate | |
![]() ![]() | 1..1 | string | Cervical cancer histopathology result | |
![]() ![]() | 1..1 | string | Normal | |
![]() ![]() | 1..1 | string | LSIL (inclusive of LSIL-CIN1) | |
![]() ![]() | 1..1 | string | HSIL (inclusive of HSIL-CIN2 or HSIL-CIN3) | |
![]() ![]() | 1..1 | string | Invasive cervical cancer | |
![]() ![]() | 1..1 | string | Date of additional cervical cancer triage test | |
![]() ![]() | 1..1 | string | Additional cervical cancer triage test type (specify) | |
![]() ![]() | 1..1 | string | Additional cervical cancer triage test result (specify) | |
![]() ![]() | 1..1 | string | Date of diagnosis of cervical precancer lesions or invasive cervical cancer | |
![]() ![]() | 1..1 | string | Cervical cancer screening outcome | |
![]() ![]() | 1..1 | string | Positive for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Negative for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Cervical cancer diagnosis | |
![]() ![]() | 1..1 | string | Cervical precancer lesions | |
![]() ![]() | 1..1 | string | Invasive cervical cancer | |
![]() ![]() | 1..1 | string | Cervical cancer stage at diagnosis | |
![]() ![]() | 1..1 | string | Stage 0 | |
![]() ![]() | 1..1 | string | Stage I | |
![]() ![]() | 1..1 | string | Stage II | |
![]() ![]() | 1..1 | string | Stage III | |
![]() ![]() | 1..1 | string | Stage IV | |
![]() ![]() | 1..1 | string | Date of treatment for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Treatment method for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Cryotherapy | |
![]() ![]() | 1..1 | string | Thermal ablation | |
![]() ![]() | 1..1 | string | Laser ablation | |
![]() ![]() | 1..1 | string | CKC | |
![]() ![]() | 1..1 | string | Laser cone biopsy | |
![]() ![]() | 1..1 | string | LLETZ/LEEP | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Date of follow-up for treatment for cervical precancer lesions | |
![]() ![]() | 1..1 | string | Date of start of invasive cancer treatment | |
![]() ![]() | 1..1 | string | Invasive cervical cancer treatment episode | |
![]() ![]() | 1..1 | string | Invasive cervical cancer treatment method | |
![]() ![]() | 1..1 | string | Conization | |
![]() ![]() | 1..1 | string | Trachelectomy | |
![]() ![]() | 1..1 | string | Hysterectomy | |
![]() ![]() | 1..1 | string | Management of invasive cervical cancer | |
![]() ![]() | 1..1 | string | Radiotherapy | |
![]() ![]() | 1..1 | string | Chemotherapy | |
![]() ![]() | 1..1 | string | Chemoradiation | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Treatment outcome | |
![]() ![]() | 1..1 | string | Secondary/other cancers diagnosed | |
![]() ![]() | 1..1 | string | Cancers at other sites (HPV- and non-HPV related) | |
![]() ![]() | 1..1 | string | Date of death | |
![]() ![]() | 1..1 | string | Cervical cancer screening interval amongst WLHIV | |
![]() ![]() | 1..1 | string | Entry point for facility-level testing | |
![]() ![]() | 1..1 | string | Provider-initiated tested in a clinic or emergency facility | |
![]() ![]() | 1..1 | string | Antenatal care clinic | |
![]() ![]() | 1..1 | string | Voluntary counselling and testing (within a health facility setting) | |
![]() ![]() | 1..1 | string | Family planning clinic | |
![]() ![]() | 1..1 | string | Other facility-level testing | |
![]() ![]() | 1..1 | string | Tuberculosis (TB) clinic | |
![]() ![]() | 1..1 | string | Offer other clinical services | |
![]() ![]() | 1..1 | string | Assessment and provision of vaccinations | |
![]() ![]() | 1..1 | string | Hepatitis B (HBV) and hepatitis C virus (HCV) testing and treatment | |
![]() ![]() | 1..1 | string | Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia | |
![]() ![]() | 1..1 | string | Intensified TB case finding and linkage to TB treatment | |
![]() ![]() | 1..1 | string | Provision of isoniazid preventive therapy if person does not have TB | |
![]() ![]() | 1..1 | string | Malaria prevention (such as bed nets and prophylaxis), depending on epidemiology | |
![]() ![]() | 1..1 | string | Eligible for DSD ART | |
![]() ![]() | 1..1 | string | Date DSD ART eligibility assessed | |
![]() ![]() | 1..1 | string | Currently enrolled in DSD ART model | |
![]() ![]() | 1..1 | string | DSD ART start date | |
![]() ![]() | 1..1 | string | DSD ART model(s) | |
![]() ![]() | 1..1 | string | Fast track ART refill | |
![]() ![]() | 1..1 | string | Facility adherence club | |
![]() ![]() | 1..1 | string | Community ART distribution point | |
![]() ![]() | 1..1 | string | CHW/peer educator community ART group | |
![]() ![]() | 1..1 | string | Patient/client community ART group | |
![]() ![]() | 1..1 | string | Other DSD ART model | |
![]() ![]() | 1..1 | string | Other DSD ART model (specify) | |
![]() ![]() | 1..1 | string | Partner testing offered | |
![]() ![]() | 1..1 | string | Partner testing accepted | |
![]() ![]() | 1..1 | string | Date partner contacted for index testing | |
![]() ![]() | 1..1 | string | Date partner tested for HIV | |
![]() ![]() | 1..1 | string | Date of next scheduled follow-up appointment | |
![]() ![]() | 1..1 | string | Type of next follow-up appointment | |
![]() ![]() | 1..1 | string | Syndrome/STI diagnosed | |
![]() ![]() | 1..1 | string | Urethral discharge syndrome | |
![]() ![]() | 1..1 | string | Vaginal discharge syndrome | |
![]() ![]() | 1..1 | string | Lower Abdominal pain | |
![]() ![]() | 1..1 | string | Genital ulcer disease syndrome | |
![]() ![]() | 1..1 | string | Anorectal discharge | |
![]() ![]() | 1..1 | string | Sent for testing | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Any STI syndrome diagnosed | |
![]() ![]() | 1..1 | string | Date of STI test | |
![]() ![]() | 1..1 | string | STI tested for | |
![]() ![]() | 1..1 | string | Neisseria gonorrhoeae | |
![]() ![]() | 1..1 | string | Chlamydia trachomatis | |
![]() ![]() | 1..1 | string | Trichomonas vaginalis | |
![]() ![]() | 1..1 | string | Syphilis (Treponema pallidum) | |
![]() ![]() | 1..1 | string | Herpes simplex virus (HSV1, HSV2) | |
![]() ![]() | 1..1 | string | Mycoplasma genitalium | |
![]() ![]() | 1..1 | string | Mpox | |
![]() ![]() | 1..1 | string | Hepatitis B | |
![]() ![]() | 1..1 | string | Hepatitis C | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Syphilis test date | |
![]() ![]() | 1..1 | string | Syphilis test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Syphilis treatment start date | |
![]() ![]() | 1..1 | string | Gonorrhoea test date | |
![]() ![]() | 1..1 | string | Gonorrhoea test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Gonorrhoea treatment start date | |
![]() ![]() | 1..1 | string | Type of specimen | |
![]() ![]() | 1..1 | string | Blood | |
![]() ![]() | 1..1 | string | Urine | |
![]() ![]() | 1..1 | string | Cervical or vaginal swab | |
![]() ![]() | 1..1 | string | Urethral or penile swab | |
![]() ![]() | 1..1 | string | Rectal swab | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other type of specimen (specify) | |
![]() ![]() | 1..1 | string | Syphilis test type | |
![]() ![]() | 1..1 | string | Treponemal | |
![]() ![]() | 1..1 | string | Non-treponemal | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other syphilis test type (specify) | |
![]() ![]() | 1..1 | string | Neisseria gonorrhoeae test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | POC Test for Neisseria gonorrhoeae (specify) | |
![]() ![]() | 1..1 | string | Chlamydia trachomatis test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | ELISA | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other test for Chlamydia (specify) | |
![]() ![]() | 1..1 | string | POC Test type for Chlamydia test (specify) | |
![]() ![]() | 1..1 | string | Trichomonas vaginalis test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | Culture | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | POC Test type for Trichomonas vaginalis test (specify) | |
![]() ![]() | 1..1 | string | Herpes simplex virus (HSV) test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Antibody test | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Mycoplasma genitalium test type | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Microscopy | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Test type for other STI tested for (specify) | |
![]() ![]() | 1..1 | string | STI test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Date of STI confirmatory test | |
![]() ![]() | 1..1 | string | Confirmatory syphilis test type | |
![]() ![]() | 1..1 | string | Treponemal | |
![]() ![]() | 1..1 | string | Non-treponemal | |
![]() ![]() | 1..1 | string | POC Test | |
![]() ![]() | 1..1 | string | NAAT | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Confirmatory test type for other STI (specify) | |
![]() ![]() | 1..1 | string | Confirmatory STI test result | |
![]() ![]() | 1..1 | string | Positive | |
![]() ![]() | 1..1 | string | Negative | |
![]() ![]() | 1..1 | string | Inconclusive | |
![]() ![]() | 1..1 | string | Date STI treatment prescribed | |
![]() ![]() | 1..1 | string | Date STI treatment dispensed | |
![]() ![]() | 1..1 | string | STI treatment dispensed (specify) | |
![]() ![]() | 1..1 | string | Mid-upper arm circumference (MUAC) | |
![]() ![]() | 1..1 | string | Date of start of fluconazole prophylaxis | |
![]() ![]() | 1..1 | string | Fluconazole prophylaxis | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment induction regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment induction regimen | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment maintenance regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment maintenance regimen | |
![]() ![]() | 1..1 | string | Date started cryptococcal meningitis treatment consolidation regimen | |
![]() ![]() | 1..1 | string | Date completed cryptococcal meningitis treatment consolidation regimen | |
![]() ![]() | 1..1 | string | Staging of liver disease | |
![]() ![]() | 1..1 | string | F0-4, fibrosis staging | |
![]() ![]() | 1..1 | string | F4 or cirrhosis, presence of cirrhosis | |
![]() ![]() | 1..1 | string | Advanced HIV disease | |
![]() ![]() | 1..1 | string | WHO functional status | |
![]() ![]() | 1..1 | string | Working, able to perform usual work inside and outside the home | |
![]() ![]() | 1..1 | string | Ambulatory, able to perform activity of daily living (ADL), not able to work | |
![]() ![]() | 1..1 | string | Bedridden not able to perform ADL | |
![]() ![]() | 1..1 | string | Tailored adherence counselling for advanced HIV disease | |
![]() ![]() | 1..1 | string | Date(s) of tracing interventions | |
![]() ![]() | 1..1 | string | Medication/drug | |
![]() ![]() | 1..1 | string | Rifampicin | |
![]() ![]() | 1..1 | string | Halofantrine | |
![]() ![]() | 1..1 | string | Lovastatin | |
![]() ![]() | 1..1 | string | Simvastatin | |
![]() ![]() | 1..1 | string | Hormonal contraception | |
![]() ![]() | 1..1 | string | Metformin | |
![]() ![]() | 1..1 | string | Astemizole | |
![]() ![]() | 1..1 | string | Terfenadine | |
![]() ![]() | 1..1 | string | TDF | |
![]() ![]() | 1..1 | string | Simeprevir | |
![]() ![]() | 1..1 | string | Ombitasvir + paritaprevir/ritonavir + dasabuvir | |
![]() ![]() | 1..1 | string | Methadone | |
![]() ![]() | 1..1 | string | Buprenorphine | |
![]() ![]() | 1..1 | string | Dofetilide | |
![]() ![]() | 1..1 | string | Carbamazepine | |
![]() ![]() | 1..1 | string | Phenobarbital | |
![]() ![]() | 1..1 | string | Phenytoin | |
![]() ![]() | 1..1 | string | Polyvalent cation products containing Mg, Al, Fe, Ca and Zn | |
![]() ![]() | 1..1 | string | Amodiaquine | |
![]() ![]() | 1..1 | string | Cisapride | |
![]() ![]() | 1..1 | string | Ergotamine | |
![]() ![]() | 1..1 | string | Dihydroergotamine | |
![]() ![]() | 1..1 | string | Midazolam | |
![]() ![]() | 1..1 | string | Triazolam | |
![]() ![]() | 1..1 | string | Estrogen-based hormonal contraception | |
![]() ![]() | 1..1 | string | Ribavirin | |
![]() ![]() | 1..1 | string | Peginterferon alfa-2a | |
![]() ![]() | 1..1 | string | Other | |
![]() ![]() | 1..1 | string | Other (specify) | |
![]() ![]() | 1..1 | string | Medication change recommended | |
Documentation for this format | ||||
This structure is derived from Base